id	sid	tid	token	lemma	pos
ajlm-1429	1	1	background	background	NOUN
ajlm-1429	1	2	complexities	complexity	NOUN
ajlm-1429	1	3	of	of	ADP
ajlm-1429	1	4	naat	naat	NOUN
ajlm-1429	1	5	selection	selection	NOUN
ajlm-1429	1	6	challenges	challenge	NOUN
ajlm-1429	1	7	of	of	ADP
ajlm-1429	1	8	robust	robust	ADJ
ajlm-1429	1	9	and	and	CCONJ
ajlm-1429	1	10	rapid	rapid	ADJ
ajlm-1429	1	11	naat	naat	NOUN
ajlm-1429	1	12	evaluations	evaluation	NOUN
ajlm-1429	1	13	conclusion	conclusion	VERB
ajlm-1429	1	14	acknowledgements	acknowledgement	NOUN
ajlm-1429	1	15	references	reference	NOUN
ajlm-1429	1	16	about	about	ADP
ajlm-1429	1	17	the	the	DET
ajlm-1429	1	18	author(s	author(s	NOUN
ajlm-1429	1	19	)	)	PUNCT
ajlm-1429	1	20	lesley	lesley	PROPN
ajlm-1429	1	21	e.	e.	PROPN
ajlm-1429	1	22	scott	scott	PROPN
ajlm-1429	1	23	department	department	PROPN
ajlm-1429	1	24	of	of	ADP
ajlm-1429	1	25	molecular	molecular	ADJ
ajlm-1429	1	26	medicine	medicine	NOUN
ajlm-1429	1	27	and	and	CCONJ
ajlm-1429	1	28	haematology	haematology	NOUN
ajlm-1429	1	29	,	,	PUNCT
ajlm-1429	1	30	school	school	NOUN
ajlm-1429	1	31	of	of	ADP
ajlm-1429	1	32	pathology	pathology	NOUN
ajlm-1429	1	33	,	,	PUNCT
ajlm-1429	1	34	faculty	faculty	NOUN
ajlm-1429	1	35	of	of	ADP
ajlm-1429	1	36	health	health	NOUN
ajlm-1429	1	37	sciences	sciences	PROPN
ajlm-1429	1	38	,	,	PUNCT
ajlm-1429	1	39	university	university	NOUN
ajlm-1429	1	40	of	of	ADP
ajlm-1429	1	41	the	the	DET
ajlm-1429	1	42	witwatersrand	witwatersrand	NOUN
ajlm-1429	1	43	,	,	PUNCT
ajlm-1429	1	44	johannesburg	johannesburg	PROPN
ajlm-1429	1	45	,	,	PUNCT
ajlm-1429	1	46	south	south	PROPN
ajlm-1429	1	47	africa	africa	PROPN
ajlm-1429	1	48	lara	lara	PROPN
ajlm-1429	1	49	d.	d.	PROPN
ajlm-1429	1	50	noble	noble	PROPN
ajlm-1429	1	51	department	department	PROPN
ajlm-1429	1	52	of	of	ADP
ajlm-1429	1	53	molecular	molecular	ADJ
ajlm-1429	1	54	medicine	medicine	NOUN
ajlm-1429	1	55	and	and	CCONJ
ajlm-1429	1	56	haematology	haematology	NOUN
ajlm-1429	1	57	,	,	PUNCT
ajlm-1429	1	58	school	school	NOUN
ajlm-1429	1	59	of	of	ADP
ajlm-1429	1	60	pathology	pathology	NOUN
ajlm-1429	1	61	,	,	PUNCT
ajlm-1429	1	62	faculty	faculty	NOUN
ajlm-1429	1	63	of	of	ADP
ajlm-1429	1	64	health	health	NOUN
ajlm-1429	1	65	sciences	sciences	PROPN
ajlm-1429	1	66	,	,	PUNCT
ajlm-1429	1	67	university	university	NOUN
ajlm-1429	1	68	of	of	ADP
ajlm-1429	1	69	the	the	DET
ajlm-1429	1	70	witwatersrand	witwatersrand	NOUN
ajlm-1429	1	71	,	,	PUNCT
ajlm-1429	1	72	johannesburg	johannesburg	PROPN
ajlm-1429	1	73	,	,	PUNCT
ajlm-1429	1	74	south	south	PROPN
ajlm-1429	1	75	africa	africa	PROPN
ajlm-1429	1	76	ashika	ashika	PROPN
ajlm-1429	1	77	singh	singh	PROPN
ajlm-1429	1	78	-	-	PUNCT
ajlm-1429	1	79	moodley	moodley	NOUN
ajlm-1429	1	80	department	department	NOUN
ajlm-1429	1	81	of	of	ADP
ajlm-1429	1	82	molecular	molecular	ADJ
ajlm-1429	1	83	medicine	medicine	NOUN
ajlm-1429	1	84	and	and	CCONJ
ajlm-1429	1	85	haematology	haematology	NOUN
ajlm-1429	1	86	,	,	PUNCT
ajlm-1429	1	87	school	school	NOUN
ajlm-1429	1	88	of	of	ADP
ajlm-1429	1	89	pathology	pathology	NOUN
ajlm-1429	1	90	,	,	PUNCT
ajlm-1429	1	91	faculty	faculty	NOUN
ajlm-1429	1	92	of	of	ADP
ajlm-1429	1	93	health	health	NOUN
ajlm-1429	1	94	sciences	sciences	PROPN
ajlm-1429	1	95	,	,	PUNCT
ajlm-1429	1	96	university	university	NOUN
ajlm-1429	1	97	of	of	ADP
ajlm-1429	1	98	the	the	DET
ajlm-1429	1	99	witwatersrand	witwatersrand	NOUN
ajlm-1429	1	100	,	,	PUNCT
ajlm-1429	1	101	johannesburg	johannesburg	PROPN
ajlm-1429	1	102	,	,	PUNCT
ajlm-1429	1	103	south	south	PROPN
ajlm-1429	1	104	africanational	africanational	ADJ
ajlm-1429	1	105	priority	priority	NOUN
ajlm-1429	1	106	programme	programme	NOUN
ajlm-1429	1	107	,	,	PUNCT
ajlm-1429	1	108	national	national	ADJ
ajlm-1429	1	109	laboratory	laboratory	NOUN
ajlm-1429	1	110	services	services	PROPN
ajlm-1429	1	111	,	,	PUNCT
ajlm-1429	1	112	johannesburg	johannesburg	PROPN
ajlm-1429	1	113	,	,	PUNCT
ajlm-1429	1	114	south	south	PROPN
ajlm-1429	1	115	africa	africa	PROPN
ajlm-1429	1	116	trish	trish	PROPN
ajlm-1429	1	117	kahamba	kahamba	PROPN
ajlm-1429	1	118	department	department	PROPN
ajlm-1429	1	119	of	of	ADP
ajlm-1429	1	120	molecular	molecular	ADJ
ajlm-1429	1	121	medicine	medicine	NOUN
ajlm-1429	1	122	and	and	CCONJ
ajlm-1429	1	123	haematology	haematology	NOUN
ajlm-1429	1	124	,	,	PUNCT
ajlm-1429	1	125	school	school	NOUN
ajlm-1429	1	126	of	of	ADP
ajlm-1429	1	127	pathology	pathology	NOUN
ajlm-1429	1	128	,	,	PUNCT
ajlm-1429	1	129	faculty	faculty	NOUN
ajlm-1429	1	130	of	of	ADP
ajlm-1429	1	131	health	health	NOUN
ajlm-1429	1	132	sciences	sciences	PROPN
ajlm-1429	1	133	,	,	PUNCT
ajlm-1429	1	134	university	university	NOUN
ajlm-1429	1	135	of	of	ADP
ajlm-1429	1	136	the	the	DET
ajlm-1429	1	137	witwatersrand	witwatersrand	NOUN
ajlm-1429	1	138	,	,	PUNCT
ajlm-1429	1	139	johannesburg	johannesburg	PROPN
ajlm-1429	1	140	,	,	PUNCT
ajlm-1429	1	141	south	south	PROPN
ajlm-1429	1	142	africa	africa	PROPN
ajlm-1429	1	143	diana	diana	PROPN
ajlm-1429	1	144	r.	r.	PROPN
ajlm-1429	1	145	hardie	hardie	PROPN
ajlm-1429	1	146	division	division	PROPN
ajlm-1429	1	147	of	of	ADP
ajlm-1429	1	148	medical	medical	ADJ
ajlm-1429	1	149	virology	virology	NOUN
ajlm-1429	1	150	,	,	PUNCT
ajlm-1429	1	151	faculty	faculty	NOUN
ajlm-1429	1	152	of	of	ADP
ajlm-1429	1	153	health	health	NOUN
ajlm-1429	1	154	sciences	sciences	PROPN
ajlm-1429	1	155	,	,	PUNCT
ajlm-1429	1	156	university	university	NOUN
ajlm-1429	1	157	of	of	ADP
ajlm-1429	1	158	cape	cape	PROPN
ajlm-1429	1	159	town	town	NOUN
ajlm-1429	1	160	,	,	PUNCT
ajlm-1429	1	161	cape	cape	NOUN
ajlm-1429	1	162	town	town	NOUN
ajlm-1429	1	163	,	,	PUNCT
ajlm-1429	1	164	south	south	PROPN
ajlm-1429	1	165	africa	africa	PROPN
ajlm-1429	1	166	wolfgang	wolfgang	PROPN
ajlm-1429	1	167	preiser	preiser	PROPN
ajlm-1429	1	168	division	division	PROPN
ajlm-1429	1	169	of	of	ADP
ajlm-1429	1	170	medical	medical	ADJ
ajlm-1429	1	171	virology	virology	NOUN
ajlm-1429	1	172	,	,	PUNCT
ajlm-1429	1	173	faculty	faculty	NOUN
ajlm-1429	1	174	of	of	ADP
ajlm-1429	1	175	medicine	medicine	NOUN
ajlm-1429	1	176	and	and	CCONJ
ajlm-1429	1	177	health	health	NOUN
ajlm-1429	1	178	sciences	sciences	PROPN
ajlm-1429	1	179	,	,	PUNCT
ajlm-1429	1	180	stellenbosch	stellenbosch	PROPN
ajlm-1429	1	181	university	university	PROPN
ajlm-1429	1	182	,	,	PUNCT
ajlm-1429	1	183	cape	cape	NOUN
ajlm-1429	1	184	town	town	NOUN
ajlm-1429	1	185	,	,	PUNCT
ajlm-1429	1	186	south	south	PROPN
ajlm-1429	1	187	africa	africa	PROPN
ajlm-1429	1	188	national	national	PROPN
ajlm-1429	1	189	health	health	PROPN
ajlm-1429	1	190	laboratory	laboratory	PROPN
ajlm-1429	1	191	service	service	PROPN
ajlm-1429	1	192	,	,	PUNCT
ajlm-1429	1	193	cape	cape	NOUN
ajlm-1429	1	194	town	town	NOUN
ajlm-1429	1	195	,	,	PUNCT
ajlm-1429	1	196	south	south	PROPN
ajlm-1429	1	197	africa	africa	PROPN
ajlm-1429	1	198	wendy	wendy	PROPN
ajlm-1429	1	199	s.	s.	PROPN
ajlm-1429	1	200	stevens	stevens	PROPN
ajlm-1429	1	201	department	department	PROPN
ajlm-1429	1	202	of	of	ADP
ajlm-1429	1	203	molecular	molecular	ADJ
ajlm-1429	1	204	medicine	medicine	NOUN
ajlm-1429	1	205	and	and	CCONJ
ajlm-1429	1	206	haematology	haematology	NOUN
ajlm-1429	1	207	,	,	PUNCT
ajlm-1429	1	208	school	school	NOUN
ajlm-1429	1	209	of	of	ADP
ajlm-1429	1	210	pathology	pathology	NOUN
ajlm-1429	1	211	,	,	PUNCT
ajlm-1429	1	212	faculty	faculty	NOUN
ajlm-1429	1	213	of	of	ADP
ajlm-1429	1	214	health	health	NOUN
ajlm-1429	1	215	sciences	sciences	PROPN
ajlm-1429	1	216	,	,	PUNCT
ajlm-1429	1	217	university	university	NOUN
ajlm-1429	1	218	of	of	ADP
ajlm-1429	1	219	the	the	DET
ajlm-1429	1	220	witwatersrand	witwatersrand	NOUN
ajlm-1429	1	221	,	,	PUNCT
ajlm-1429	1	222	johannesburg	johannesburg	PROPN
ajlm-1429	1	223	,	,	PUNCT
ajlm-1429	1	224	south	south	PROPN
ajlm-1429	1	225	africa	africa	PROPN
ajlm-1429	1	226	national	national	PROPN
ajlm-1429	1	227	priority	priority	PROPN
ajlm-1429	1	228	programme	programme	PROPN
ajlm-1429	1	229	,	,	PUNCT
ajlm-1429	1	230	national	national	ADJ
ajlm-1429	1	231	laboratory	laboratory	NOUN
ajlm-1429	1	232	services	services	PROPN
ajlm-1429	1	233	,	,	PUNCT
ajlm-1429	1	234	johannesburg	johannesburg	PROPN
ajlm-1429	1	235	,	,	PUNCT
ajlm-1429	1	236	south	south	PROPN
ajlm-1429	1	237	africa	africa	PROPN
ajlm-1429	1	238	citation	citation	PROPN
ajlm-1429	1	239	scott	scott	PROPN
ajlm-1429	1	240	le	le	PROPN
ajlm-1429	1	241	,	,	PUNCT
ajlm-1429	1	242	noble	noble	ADJ
ajlm-1429	1	243	ld	ld	PROPN
ajlm-1429	1	244	,	,	PUNCT
ajlm-1429	1	245	singh	singh	ADJ
ajlm-1429	1	246	-	-	PUNCT
ajlm-1429	1	247	moodley	moodley	NOUN
ajlm-1429	1	248	a	a	NOUN
ajlm-1429	1	249	,	,	PUNCT
ajlm-1429	1	250	et	et	PROPN
ajlm-1429	1	251	al	al	PROPN
ajlm-1429	1	252	.	.	PUNCT
ajlm-1429	1	253	challenges	challenge	NOUN
ajlm-1429	1	254	and	and	CCONJ
ajlm-1429	1	255	complexities	complexity	NOUN
ajlm-1429	1	256	in	in	ADP
ajlm-1429	1	257	evaluating	evaluate	VERB
ajlm-1429	1	258	severe	severe	ADJ
ajlm-1429	1	259	acute	acute	ADJ
ajlm-1429	1	260	respiratory	respiratory	ADJ
ajlm-1429	1	261	syndrome	syndrome	NOUN
ajlm-1429	1	262	coronavirus	coronavirus	NOUN
ajlm-1429	1	263	2	2	NUM
ajlm-1429	1	264	molecular	molecular	ADJ
ajlm-1429	1	265	diagnostics	diagnostic	NOUN
ajlm-1429	1	266	during	during	ADP
ajlm-1429	1	267	the	the	DET
ajlm-1429	1	268	covid-19	covid-19	PROPN
ajlm-1429	1	269	pandemic	pandemic	NOUN
ajlm-1429	1	270	.	.	PUNCT
ajlm-1429	2	1	afr	afr	PROPN
ajlm-1429	2	2	j	j	PROPN
ajlm-1429	2	3	lab	lab	PROPN
ajlm-1429	2	4	med	med	PROPN
ajlm-1429	2	5	.	.	PUNCT
ajlm-1429	3	1	2022;11(1	2022;11(1	NUM
ajlm-1429	3	2	)	)	PUNCT
ajlm-1429	3	3	,	,	PUNCT
ajlm-1429	4	1	a1429	a1429	PROPN
ajlm-1429	4	2	.	.	NOUN
ajlm-1429	4	3	https://doi.org/10.4102/ajlm.v11i1.1429	https://doi.org/10.4102/ajlm.v11i1.1429	ADP
ajlm-1429	4	4	opinion	opinion	NOUN
ajlm-1429	4	5	paper	paper	NOUN
ajlm-1429	4	6	challenges	challenge	NOUN
ajlm-1429	4	7	and	and	CCONJ
ajlm-1429	4	8	complexities	complexity	NOUN
ajlm-1429	4	9	in	in	ADP
ajlm-1429	4	10	evaluating	evaluate	VERB
ajlm-1429	4	11	severe	severe	ADJ
ajlm-1429	4	12	acute	acute	ADJ
ajlm-1429	4	13	respiratory	respiratory	ADJ
ajlm-1429	4	14	syndrome	syndrome	NOUN
ajlm-1429	4	15	coronavirus	coronavirus	NOUN
ajlm-1429	4	16	2	2	NUM
ajlm-1429	4	17	molecular	molecular	ADJ
ajlm-1429	4	18	diagnostics	diagnostic	NOUN
ajlm-1429	4	19	during	during	ADP
ajlm-1429	4	20	the	the	DET
ajlm-1429	4	21	covid-19	covid-19	PROPN
ajlm-1429	4	22	pandemic	pandemic	ADJ
ajlm-1429	4	23	lesley	lesley	PROPN
ajlm-1429	4	24	e.	e.	PROPN
ajlm-1429	4	25	scott	scott	PROPN
ajlm-1429	4	26	,	,	PUNCT
ajlm-1429	4	27	lara	lara	PROPN
ajlm-1429	4	28	d.	d.	PROPN
ajlm-1429	4	29	noble	noble	PROPN
ajlm-1429	4	30	,	,	PUNCT
ajlm-1429	4	31	ashika	ashika	PROPN
ajlm-1429	4	32	singh	singh	NOUN
ajlm-1429	4	33	-	-	PUNCT
ajlm-1429	4	34	moodley	moodley	NOUN
ajlm-1429	4	35	,	,	PUNCT
ajlm-1429	4	36	trish	trish	PROPN
ajlm-1429	4	37	kahamba	kahamba	PROPN
ajlm-1429	4	38	,	,	PUNCT
ajlm-1429	4	39	diana	diana	PROPN
ajlm-1429	4	40	r.	r.	PROPN
ajlm-1429	4	41	hardie	hardie	PROPN
ajlm-1429	4	42	,	,	PUNCT
ajlm-1429	4	43	wolfgang	wolfgang	PROPN
ajlm-1429	4	44	preiser	preiser	PROPN
ajlm-1429	4	45	,	,	PUNCT
ajlm-1429	4	46	wendy	wendy	PROPN
ajlm-1429	4	47	s.	s.	PROPN
ajlm-1429	4	48	stevens	stevens	PROPN
ajlm-1429	4	49	received	receive	VERB
ajlm-1429	4	50	:	:	PUNCT
ajlm-1429	4	51	15	15	NUM
ajlm-1429	4	52	oct	oct	NOUN
ajlm-1429	4	53	.	.	PROPN
ajlm-1429	4	54	2021	2021	NUM
ajlm-1429	4	55	;	;	PUNCT
ajlm-1429	4	56	accepted	accept	VERB
ajlm-1429	4	57	:	:	PUNCT
ajlm-1429	4	58	07	07	NUM
ajlm-1429	4	59	feb	feb	PROPN
ajlm-1429	4	60	.	.	PROPN
ajlm-1429	4	61	2022	2022	NUM
ajlm-1429	4	62	;	;	PUNCT
ajlm-1429	4	63	published	publish	VERB
ajlm-1429	4	64	:	:	PUNCT
ajlm-1429	4	65	26	26	NUM
ajlm-1429	4	66	apr	apr	NOUN
ajlm-1429	4	67	.	.	PUNCT
ajlm-1429	5	1	2022	2022	NUM
ajlm-1429	5	2	copyright	copyright	NOUN
ajlm-1429	5	3	:	:	PUNCT
ajlm-1429	5	4	©	©	PROPN
ajlm-1429	5	5	2022	2022	NUM
ajlm-1429	5	6	.	.	PUNCT
ajlm-1429	6	1	the	the	DET
ajlm-1429	6	2	author(s	author(s	PROPN
ajlm-1429	6	3	)	)	PUNCT
ajlm-1429	6	4	.	.	PUNCT
ajlm-1429	7	1	licensee	licensee	NOUN
ajlm-1429	7	2	:	:	PUNCT
ajlm-1429	7	3	aosis	aosis	NOUN
ajlm-1429	7	4	.	.	PUNCT
ajlm-1429	8	1	this	this	PRON
ajlm-1429	8	2	is	be	AUX
ajlm-1429	8	3	an	an	DET
ajlm-1429	8	4	open	open	ADJ
ajlm-1429	8	5	access	access	NOUN
ajlm-1429	8	6	article	article	NOUN
ajlm-1429	8	7	distributed	distribute	VERB
ajlm-1429	8	8	under	under	ADP
ajlm-1429	8	9	the	the	DET
ajlm-1429	8	10	terms	term	NOUN
ajlm-1429	8	11	of	of	ADP
ajlm-1429	8	12	the	the	DET
ajlm-1429	8	13	creative	creative	ADJ
ajlm-1429	8	14	commons	common	NOUN
ajlm-1429	8	15	attribution	attribution	NOUN
ajlm-1429	8	16	license	license	NOUN
ajlm-1429	8	17	,	,	PUNCT
ajlm-1429	8	18	which	which	PRON
ajlm-1429	8	19	permits	permit	VERB
ajlm-1429	8	20	unrestricted	unrestricted	ADJ
ajlm-1429	8	21	use	use	NOUN
ajlm-1429	8	22	,	,	PUNCT
ajlm-1429	8	23	distribution	distribution	NOUN
ajlm-1429	8	24	,	,	PUNCT
ajlm-1429	8	25	and	and	CCONJ
ajlm-1429	8	26	reproduction	reproduction	NOUN
ajlm-1429	8	27	in	in	ADP
ajlm-1429	8	28	any	any	DET
ajlm-1429	8	29	medium	medium	NOUN
ajlm-1429	8	30	,	,	PUNCT
ajlm-1429	8	31	provided	provide	VERB
ajlm-1429	8	32	the	the	DET
ajlm-1429	8	33	original	original	ADJ
ajlm-1429	8	34	work	work	NOUN
ajlm-1429	8	35	is	be	AUX
ajlm-1429	8	36	properly	properly	ADV
ajlm-1429	8	37	cited	cite	VERB
ajlm-1429	8	38	.	.	PUNCT
ajlm-1429	9	1	background	background	NOUN
ajlm-1429	9	2	severe	severe	ADJ
ajlm-1429	9	3	acute	acute	ADJ
ajlm-1429	9	4	respiratory	respiratory	ADJ
ajlm-1429	9	5	syndrome	syndrome	NOUN
ajlm-1429	9	6	coronavirus	coronavirus	NOUN
ajlm-1429	9	7	2	2	NUM
ajlm-1429	9	8	(	(	PUNCT
ajlm-1429	9	9	sars	sar	NOUN
ajlm-1429	9	10	-	-	PUNCT
ajlm-1429	9	11	cov-2	cov-2	NOUN
ajlm-1429	9	12	)	)	PUNCT
ajlm-1429	9	13	,	,	PUNCT
ajlm-1429	9	14	the	the	DET
ajlm-1429	9	15	causative	causative	ADJ
ajlm-1429	9	16	agent	agent	NOUN
ajlm-1429	9	17	of	of	ADP
ajlm-1429	9	18	coronavirus	coronavirus	NOUN
ajlm-1429	9	19	disease	disease	NOUN
ajlm-1429	9	20	2019	2019	NUM
ajlm-1429	9	21	(	(	PUNCT
ajlm-1429	9	22	covid-19	covid-19	PROPN
ajlm-1429	9	23	)	)	PUNCT
ajlm-1429	9	24	,	,	PUNCT
ajlm-1429	9	25	was	be	AUX
ajlm-1429	9	26	first	first	ADV
ajlm-1429	9	27	identified	identify	VERB
ajlm-1429	9	28	in	in	ADP
ajlm-1429	9	29	wuhan	wuhan	PROPN
ajlm-1429	9	30	,	,	PUNCT
ajlm-1429	9	31	china	china	PROPN
ajlm-1429	9	32	,	,	PUNCT
ajlm-1429	9	33	in	in	ADP
ajlm-1429	9	34	december	december	PROPN
ajlm-1429	9	35	2019.1	2019.1	NUM
ajlm-1429	9	36	since	since	SCONJ
ajlm-1429	9	37	the	the	DET
ajlm-1429	9	38	world	world	PROPN
ajlm-1429	9	39	health	health	NOUN
ajlm-1429	9	40	organization	organization	NOUN
ajlm-1429	9	41	(	(	PUNCT
ajlm-1429	9	42	who	who	PRON
ajlm-1429	9	43	)	)	PUNCT
ajlm-1429	9	44	declared	declare	VERB
ajlm-1429	9	45	covid-19	covid-19	PROPN
ajlm-1429	9	46	a	a	DET
ajlm-1429	9	47	global	global	ADJ
ajlm-1429	9	48	pandemic	pandemic	NOUN
ajlm-1429	9	49	on	on	ADP
ajlm-1429	9	50	11	11	NUM
ajlm-1429	9	51	march	march	NOUN
ajlm-1429	9	52	2020,2	2020,2	NUM
ajlm-1429	9	53	more	more	ADJ
ajlm-1429	9	54	than	than	ADP
ajlm-1429	9	55	280	280	NUM
ajlm-1429	9	56	million	million	NUM
ajlm-1429	9	57	cases	case	NOUN
ajlm-1429	9	58	of	of	ADP
ajlm-1429	9	59	infection	infection	NOUN
ajlm-1429	9	60	and	and	CCONJ
ajlm-1429	9	61	over	over	ADP
ajlm-1429	9	62	5	5	NUM
ajlm-1429	9	63	million	million	NUM
ajlm-1429	9	64	deaths	death	NOUN
ajlm-1429	9	65	had	have	AUX
ajlm-1429	9	66	been	be	AUX
ajlm-1429	9	67	reported	report	VERB
ajlm-1429	9	68	globally	globally	ADV
ajlm-1429	9	69	by	by	ADP
ajlm-1429	9	70	31	31	NUM
ajlm-1429	9	71	december	december	PROPN
ajlm-1429	9	72	2021.3	2021.3	NUM
ajlm-1429	9	73	the	the	DET
ajlm-1429	9	74	primary	primary	ADJ
ajlm-1429	9	75	method	method	NOUN
ajlm-1429	9	76	of	of	ADP
ajlm-1429	9	77	diagnosing	diagnose	VERB
ajlm-1429	9	78	infection	infection	NOUN
ajlm-1429	9	79	with	with	ADP
ajlm-1429	9	80	sars	sar	NOUN
ajlm-1429	9	81	-	-	PUNCT
ajlm-1429	9	82	cov-2	cov-2	PART
ajlm-1429	9	83	is	be	AUX
ajlm-1429	9	84	by	by	ADP
ajlm-1429	9	85	nucleic	nucleic	ADJ
ajlm-1429	9	86	acid	acid	NOUN
ajlm-1429	9	87	amplification	amplification	NOUN
ajlm-1429	9	88	technology	technology	NOUN
ajlm-1429	9	89	(	(	PUNCT
ajlm-1429	9	90	naat	naat	PROPN
ajlm-1429	9	91	)	)	PUNCT
ajlm-1429	9	92	.	.	PUNCT
ajlm-1429	10	1	diagnostic	diagnostic	ADJ
ajlm-1429	10	2	assays	assay	NOUN
ajlm-1429	10	3	have	have	AUX
ajlm-1429	10	4	become	become	VERB
ajlm-1429	10	5	available	available	ADJ
ajlm-1429	10	6	at	at	ADP
ajlm-1429	10	7	an	an	DET
ajlm-1429	10	8	impressive	impressive	ADJ
ajlm-1429	10	9	rate	rate	NOUN
ajlm-1429	10	10	,	,	PUNCT
ajlm-1429	10	11	with	with	ADP
ajlm-1429	10	12	a	a	DET
ajlm-1429	10	13	total	total	NOUN
ajlm-1429	10	14	of	of	ADP
ajlm-1429	10	15	514	514	NUM
ajlm-1429	10	16	molecular	molecular	ADJ
ajlm-1429	10	17	assays	assay	NOUN
ajlm-1429	10	18	listed	list	VERB
ajlm-1429	10	19	by	by	ADP
ajlm-1429	10	20	december	december	PROPN
ajlm-1429	10	21	2021.4	2021.4	NUM
ajlm-1429	10	22	regulatory	regulatory	ADJ
ajlm-1429	10	23	bodies	body	NOUN
ajlm-1429	10	24	in	in	ADP
ajlm-1429	10	25	australia	australia	PROPN
ajlm-1429	10	26	,	,	PUNCT
ajlm-1429	10	27	brazil	brazil	PROPN
ajlm-1429	10	28	,	,	PUNCT
ajlm-1429	10	29	canada	canada	PROPN
ajlm-1429	10	30	,	,	PUNCT
ajlm-1429	10	31	europe	europe	PROPN
ajlm-1429	10	32	,	,	PUNCT
ajlm-1429	10	33	japan	japan	PROPN
ajlm-1429	10	34	and	and	CCONJ
ajlm-1429	10	35	the	the	DET
ajlm-1429	10	36	united	united	PROPN
ajlm-1429	10	37	states	states	PROPN
ajlm-1429	10	38	,	,	PUNCT
ajlm-1429	10	39	and	and	CCONJ
ajlm-1429	10	40	organisations	organisation	NOUN
ajlm-1429	10	41	such	such	ADJ
ajlm-1429	10	42	as	as	ADP
ajlm-1429	10	43	the	the	DET
ajlm-1429	10	44	who	who	PRON
ajlm-1429	10	45	,	,	PUNCT
ajlm-1429	10	46	the	the	DET
ajlm-1429	10	47	united	united	PROPN
ajlm-1429	10	48	states	states	PROPN
ajlm-1429	10	49	food	food	PROPN
ajlm-1429	10	50	and	and	CCONJ
ajlm-1429	10	51	drug	drug	NOUN
ajlm-1429	10	52	administration	administration	NOUN
ajlm-1429	10	53	,	,	PUNCT
ajlm-1429	10	54	the	the	DET
ajlm-1429	10	55	foundation	foundation	NOUN
ajlm-1429	10	56	for	for	ADP
ajlm-1429	10	57	innovative	innovative	ADJ
ajlm-1429	10	58	new	new	ADJ
ajlm-1429	10	59	diagnostics	diagnostic	NOUN
ajlm-1429	10	60	(	(	PUNCT
ajlm-1429	10	61	find	find	NOUN
ajlm-1429	10	62	)	)	PUNCT
ajlm-1429	10	63	,	,	PUNCT
ajlm-1429	10	64	and	and	CCONJ
ajlm-1429	10	65	the	the	DET
ajlm-1429	10	66	united	united	PROPN
ajlm-1429	10	67	states	states	PROPN
ajlm-1429	10	68	centers	center	NOUN
ajlm-1429	10	69	for	for	ADP
ajlm-1429	10	70	disease	disease	NOUN
ajlm-1429	10	71	control	control	NOUN
ajlm-1429	10	72	and	and	CCONJ
ajlm-1429	10	73	prevention	prevention	NOUN
ajlm-1429	10	74	(	(	PUNCT
ajlm-1429	10	75	cdc	cdc	PROPN
ajlm-1429	10	76	)	)	PUNCT
ajlm-1429	10	77	provide	provide	VERB
ajlm-1429	10	78	ongoing	ongoing	ADJ
ajlm-1429	10	79	updates	update	NOUN
ajlm-1429	10	80	on	on	ADP
ajlm-1429	10	81	assay	assay	ADJ
ajlm-1429	10	82	performance	performance	NOUN
ajlm-1429	10	83	.	.	PUNCT
ajlm-1429	11	1	many	many	ADJ
ajlm-1429	11	2	assays	assay	NOUN
ajlm-1429	11	3	,	,	PUNCT
ajlm-1429	11	4	however	however	ADV
ajlm-1429	11	5	,	,	PUNCT
ajlm-1429	11	6	remain	remain	VERB
ajlm-1429	11	7	unavailable	unavailable	ADJ
ajlm-1429	11	8	in	in	ADP
ajlm-1429	11	9	certain	certain	ADJ
ajlm-1429	11	10	geographic	geographic	ADJ
ajlm-1429	11	11	regions	region	NOUN
ajlm-1429	11	12	;	;	PUNCT
ajlm-1429	11	13	in	in	ADP
ajlm-1429	11	14	-	-	PUNCT
ajlm-1429	11	15	house	house	NOUN
ajlm-1429	11	16	assays	assay	NOUN
ajlm-1429	11	17	are	be	AUX
ajlm-1429	11	18	in	in	ADP
ajlm-1429	11	19	use	use	NOUN
ajlm-1429	11	20	that	that	PRON
ajlm-1429	11	21	are	be	AUX
ajlm-1429	11	22	not	not	PART
ajlm-1429	11	23	accessible	accessible	ADJ
ajlm-1429	11	24	to	to	ADP
ajlm-1429	11	25	these	these	DET
ajlm-1429	11	26	evaluation	evaluation	NOUN
ajlm-1429	11	27	bodies	body	NOUN
ajlm-1429	11	28	,	,	PUNCT
ajlm-1429	11	29	and	and	CCONJ
ajlm-1429	11	30	the	the	DET
ajlm-1429	11	31	ongoing	ongoing	ADJ
ajlm-1429	11	32	emergency	emergency	NOUN
ajlm-1429	11	33	use	use	NOUN
ajlm-1429	11	34	need	need	NOUN
ajlm-1429	11	35	has	have	AUX
ajlm-1429	11	36	meant	mean	VERB
ajlm-1429	11	37	that	that	SCONJ
ajlm-1429	11	38	national	national	ADJ
ajlm-1429	11	39	programmes	programme	NOUN
ajlm-1429	11	40	have	have	AUX
ajlm-1429	11	41	had	have	VERB
ajlm-1429	11	42	to	to	PART
ajlm-1429	11	43	perform	perform	VERB
ajlm-1429	11	44	their	their	PRON
ajlm-1429	11	45	own	own	ADJ
ajlm-1429	11	46	evaluations	evaluation	NOUN
ajlm-1429	11	47	.	.	PUNCT
ajlm-1429	12	1	furthermore	furthermore	ADV
ajlm-1429	12	2	,	,	PUNCT
ajlm-1429	12	3	in	in	ADP
ajlm-1429	12	4	mid-2020	mid-2020	NOUN
ajlm-1429	12	5	,	,	PUNCT
ajlm-1429	12	6	limited	limited	ADJ
ajlm-1429	12	7	guidance	guidance	NOUN
ajlm-1429	12	8	was	be	AUX
ajlm-1429	12	9	available	available	ADJ
ajlm-1429	12	10	for	for	ADP
ajlm-1429	12	11	performing	perform	VERB
ajlm-1429	12	12	such	such	ADJ
ajlm-1429	12	13	evaluations	evaluation	NOUN
ajlm-1429	12	14	and	and	CCONJ
ajlm-1429	12	15	equally	equally	ADV
ajlm-1429	12	16	limited	limited	ADJ
ajlm-1429	12	17	guidance	guidance	NOUN
ajlm-1429	12	18	existed	exist	VERB
ajlm-1429	12	19	on	on	ADP
ajlm-1429	12	20	acceptance	acceptance	NOUN
ajlm-1429	12	21	criteria	criterion	NOUN
ajlm-1429	12	22	or	or	CCONJ
ajlm-1429	12	23	patient	patient	ADJ
ajlm-1429	12	24	use	use	NOUN
ajlm-1429	12	25	cases.5	cases.5	NOUN
ajlm-1429	12	26	the	the	DET
ajlm-1429	12	27	find	find	NOUN
ajlm-1429	12	28	had	have	AUX
ajlm-1429	12	29	verified	verify	VERB
ajlm-1429	12	30	21	21	NUM
ajlm-1429	12	31	naat	naat	NOUN
ajlm-1429	12	32	assay	assay	NOUN
ajlm-1429	12	33	manufacturer	manufacturer	NOUN
ajlm-1429	12	34	claims6	claims6	NOUN
ajlm-1429	13	1	(	(	PUNCT
ajlm-1429	13	2	<	<	X
ajlm-1429	13	3	8	8	NUM
ajlm-1429	13	4	%	%	NOUN
ajlm-1429	13	5	of	of	ADP
ajlm-1429	13	6	available	available	ADJ
ajlm-1429	13	7	assays	assay	NOUN
ajlm-1429	13	8	by	by	ADP
ajlm-1429	13	9	july	july	PROPN
ajlm-1429	13	10	2020	2020	NUM
ajlm-1429	13	11	)	)	PUNCT
ajlm-1429	13	12	,	,	PUNCT
ajlm-1429	13	13	and	and	CCONJ
ajlm-1429	13	14	the	the	PRON
ajlm-1429	13	15	who	who	PRON
ajlm-1429	13	16	target	target	VERB
ajlm-1429	13	17	product	product	NOUN
ajlm-1429	13	18	profile	profile	NOUN
ajlm-1429	13	19	(	(	PUNCT
ajlm-1429	13	20	tpp	tpp	PROPN
ajlm-1429	13	21	)	)	PUNCT
ajlm-1429	13	22	version	version	NOUN
ajlm-1429	13	23	0.1	0.1	NUM
ajlm-1429	13	24	was	be	AUX
ajlm-1429	13	25	only	only	ADV
ajlm-1429	13	26	released	release	VERB
ajlm-1429	13	27	in	in	ADP
ajlm-1429	13	28	august	august	PROPN
ajlm-1429	13	29	2020.7	2020.7	NUM
ajlm-1429	13	30	through	through	ADP
ajlm-1429	13	31	emergency	emergency	NOUN
ajlm-1429	13	32	validations	validation	NOUN
ajlm-1429	13	33	in	in	ADP
ajlm-1429	13	34	south	south	PROPN
ajlm-1429	13	35	africa	africa	PROPN
ajlm-1429	13	36	,	,	PUNCT
ajlm-1429	13	37	numerous	numerous	ADJ
ajlm-1429	13	38	complexities	complexity	NOUN
ajlm-1429	13	39	of	of	ADP
ajlm-1429	13	40	molecular	molecular	ADJ
ajlm-1429	13	41	testing	testing	NOUN
ajlm-1429	13	42	were	be	AUX
ajlm-1429	13	43	quickly	quickly	ADV
ajlm-1429	13	44	realised	realise	VERB
ajlm-1429	13	45	.	.	PUNCT
ajlm-1429	14	1	many	many	ADJ
ajlm-1429	14	2	of	of	ADP
ajlm-1429	14	3	these	these	DET
ajlm-1429	14	4	align	align	NOUN
ajlm-1429	14	5	with	with	ADP
ajlm-1429	14	6	those	those	PRON
ajlm-1429	14	7	described	describe	VERB
ajlm-1429	14	8	elsewhere,8,9	elsewhere,8,9	PROPN
ajlm-1429	14	9	but	but	CCONJ
ajlm-1429	14	10	additional	additional	ADJ
ajlm-1429	14	11	difficulties	difficulty	NOUN
ajlm-1429	14	12	arose	arise	VERB
ajlm-1429	14	13	due	due	ADJ
ajlm-1429	14	14	to	to	ADP
ajlm-1429	14	15	drastic	drastic	ADJ
ajlm-1429	14	16	local	local	ADJ
ajlm-1429	14	17	lockdown	lockdown	NOUN
ajlm-1429	14	18	measures	measure	NOUN
ajlm-1429	14	19	,	,	PUNCT
ajlm-1429	14	20	and	and	CCONJ
ajlm-1429	14	21	the	the	DET
ajlm-1429	14	22	experience	experience	NOUN
ajlm-1429	14	23	of	of	ADP
ajlm-1429	14	24	using	use	VERB
ajlm-1429	14	25	assays	assay	NOUN
ajlm-1429	14	26	during	during	ADP
ajlm-1429	14	27	lockdown	lockdown	NOUN
ajlm-1429	14	28	yielded	yield	VERB
ajlm-1429	14	29	several	several	ADJ
ajlm-1429	14	30	relevant	relevant	ADJ
ajlm-1429	14	31	insights	insight	NOUN
ajlm-1429	14	32	.	.	PUNCT
ajlm-1429	15	1	complexities	complexity	NOUN
ajlm-1429	15	2	of	of	ADP
ajlm-1429	15	3	naat	naat	NOUN
ajlm-1429	15	4	selection	selection	NOUN
ajlm-1429	15	5	the	the	DET
ajlm-1429	15	6	entire	entire	ADJ
ajlm-1429	15	7	pathology	pathology	NOUN
ajlm-1429	15	8	value	value	NOUN
ajlm-1429	15	9	chain	chain	NOUN
ajlm-1429	15	10	needs	need	VERB
ajlm-1429	15	11	to	to	PART
ajlm-1429	15	12	be	be	AUX
ajlm-1429	15	13	considered	consider	VERB
ajlm-1429	15	14	when	when	SCONJ
ajlm-1429	15	15	selecting	select	VERB
ajlm-1429	15	16	suitable	suitable	ADJ
ajlm-1429	15	17	naats	naat	NOUN
ajlm-1429	15	18	.	.	PUNCT
ajlm-1429	16	1	each	each	DET
ajlm-1429	16	2	step	step	NOUN
ajlm-1429	16	3	contributes	contribute	VERB
ajlm-1429	16	4	to	to	ADP
ajlm-1429	16	5	meaningful	meaningful	ADJ
ajlm-1429	16	6	and	and	CCONJ
ajlm-1429	16	7	valid	valid	ADJ
ajlm-1429	16	8	test	test	NOUN
ajlm-1429	16	9	results	result	NOUN
ajlm-1429	16	10	:	:	PUNCT
ajlm-1429	16	11	patient	patient	ADJ
ajlm-1429	16	12	sampling	sampling	NOUN
ajlm-1429	16	13	,	,	PUNCT
ajlm-1429	16	14	specimen	speciman	NOUN
ajlm-1429	16	15	type	type	NOUN
ajlm-1429	16	16	,	,	PUNCT
ajlm-1429	16	17	specimen	speciman	NOUN
ajlm-1429	16	18	collection	collection	NOUN
ajlm-1429	16	19	and	and	CCONJ
ajlm-1429	16	20	handling	handling	NOUN
ajlm-1429	16	21	(	(	PUNCT
ajlm-1429	16	22	stability	stability	NOUN
ajlm-1429	16	23	)	)	PUNCT
ajlm-1429	16	24	,	,	PUNCT
ajlm-1429	16	25	viral	viral	ADJ
ajlm-1429	16	26	rna	rna	NOUN
ajlm-1429	16	27	purification	purification	NOUN
ajlm-1429	16	28	,	,	PUNCT
ajlm-1429	16	29	amplification	amplification	NOUN
ajlm-1429	16	30	and	and	CCONJ
ajlm-1429	16	31	detection	detection	NOUN
ajlm-1429	16	32	,	,	PUNCT
ajlm-1429	16	33	and	and	CCONJ
ajlm-1429	16	34	result	result	VERB
ajlm-1429	16	35	interpretation	interpretation	NOUN
ajlm-1429	16	36	(	(	PUNCT
ajlm-1429	16	37	figure	figure	NOUN
ajlm-1429	16	38	1	1	NUM
ajlm-1429	16	39	)	)	PUNCT
ajlm-1429	16	40	.	.	PUNCT
ajlm-1429	17	1	specimen	speciman	NOUN
ajlm-1429	17	2	collection	collection	NOUN
ajlm-1429	17	3	and	and	CCONJ
ajlm-1429	17	4	handling	handling	NOUN
ajlm-1429	17	5	challenges	challenge	NOUN
ajlm-1429	17	6	include	include	VERB
ajlm-1429	17	7	swab	swab	NOUN
ajlm-1429	17	8	type	type	NOUN
ajlm-1429	17	9	,	,	PUNCT
ajlm-1429	17	10	collection	collection	NOUN
ajlm-1429	17	11	site	site	NOUN
ajlm-1429	17	12	,	,	PUNCT
ajlm-1429	17	13	collection	collection	NOUN
ajlm-1429	17	14	and	and	CCONJ
ajlm-1429	17	15	pre	pre	ADJ
ajlm-1429	17	16	-	-	ADJ
ajlm-1429	17	17	treatment	treatment	ADJ
ajlm-1429	17	18	methods	method	NOUN
ajlm-1429	17	19	,	,	PUNCT
ajlm-1429	17	20	and	and	CCONJ
ajlm-1429	17	21	transport	transport	NOUN
ajlm-1429	17	22	.	.	PUNCT
ajlm-1429	18	1	swabs	swab	NOUN
ajlm-1429	18	2	are	be	AUX
ajlm-1429	18	3	manufactured	manufacture	VERB
ajlm-1429	18	4	from	from	ADP
ajlm-1429	18	5	different	different	ADJ
ajlm-1429	18	6	materials	material	NOUN
ajlm-1429	18	7	(	(	PUNCT
ajlm-1429	18	8	cotton	cotton	NOUN
ajlm-1429	18	9	,	,	PUNCT
ajlm-1429	18	10	nylon	nylon	NOUN
ajlm-1429	18	11	,	,	PUNCT
ajlm-1429	18	12	polyester	polyester	NOUN
ajlm-1429	18	13	,	,	PUNCT
ajlm-1429	18	14	rayon	rayon	NOUN
ajlm-1429	18	15	and	and	CCONJ
ajlm-1429	18	16	foam	foam	NOUN
ajlm-1429	18	17	)	)	PUNCT
ajlm-1429	18	18	and	and	CCONJ
ajlm-1429	18	19	may	may	AUX
ajlm-1429	18	20	be	be	AUX
ajlm-1429	18	21	spun	spin	VERB
ajlm-1429	18	22	or	or	CCONJ
ajlm-1429	18	23	flocked.10,11	flocked.10,11	NOUN
ajlm-1429	18	24	thus	thus	ADV
ajlm-1429	18	25	,	,	PUNCT
ajlm-1429	18	26	swabs	swab	NOUN
ajlm-1429	18	27	differ	differ	VERB
ajlm-1429	18	28	in	in	ADP
ajlm-1429	18	29	absorption	absorption	NOUN
ajlm-1429	18	30	properties	property	NOUN
ajlm-1429	18	31	,	,	PUNCT
ajlm-1429	18	32	viral	viral	ADJ
ajlm-1429	18	33	capture	capture	NOUN
ajlm-1429	18	34	and	and	CCONJ
ajlm-1429	18	35	release	release	NOUN
ajlm-1429	18	36	.	.	PUNCT
ajlm-1429	19	1	swab	swab	NOUN
ajlm-1429	19	2	shafts	shafts	ADJ
ajlm-1429	19	3	may	may	AUX
ajlm-1429	19	4	be	be	AUX
ajlm-1429	19	5	made	make	VERB
ajlm-1429	19	6	from	from	ADP
ajlm-1429	19	7	wood	wood	NOUN
ajlm-1429	19	8	,	,	PUNCT
ajlm-1429	19	9	plastic	plastic	NOUN
ajlm-1429	19	10	or	or	CCONJ
ajlm-1429	19	11	aluminium	aluminium	NOUN
ajlm-1429	19	12	,	,	PUNCT
ajlm-1429	19	13	and	and	CCONJ
ajlm-1429	19	14	some	some	PRON
ajlm-1429	19	15	of	of	ADP
ajlm-1429	19	16	these	these	DET
ajlm-1429	19	17	materials	material	NOUN
ajlm-1429	19	18	are	be	AUX
ajlm-1429	19	19	incompatible	incompatible	ADJ
ajlm-1429	19	20	with	with	ADP
ajlm-1429	19	21	certain	certain	ADJ
ajlm-1429	19	22	collection	collection	NOUN
ajlm-1429	19	23	and	and	CCONJ
ajlm-1429	19	24	laboratory	laboratory	NOUN
ajlm-1429	19	25	techniques	technique	NOUN
ajlm-1429	19	26	(	(	PUNCT
ajlm-1429	19	27	e.g.	e.g.	ADV
ajlm-1429	19	28	wooden	wooden	ADJ
ajlm-1429	19	29	shafts	shaft	NOUN
ajlm-1429	19	30	are	be	AUX
ajlm-1429	19	31	unsuitable	unsuitable	ADJ
ajlm-1429	19	32	for	for	ADP
ajlm-1429	19	33	paediatric	paediatric	ADJ
ajlm-1429	19	34	sampling	sampling	NOUN
ajlm-1429	19	35	and	and	CCONJ
ajlm-1429	19	36	may	may	AUX
ajlm-1429	19	37	inhibit	inhibit	VERB
ajlm-1429	19	38	naat).10	naat).10	PROPN
ajlm-1429	19	39	commonly	commonly	ADV
ajlm-1429	19	40	used	use	VERB
ajlm-1429	19	41	swab	swab	NOUN
ajlm-1429	19	42	collection	collection	NOUN
ajlm-1429	19	43	sites	site	NOUN
ajlm-1429	19	44	are	be	AUX
ajlm-1429	19	45	the	the	DET
ajlm-1429	19	46	nasopharynx	nasopharynx	NOUN
ajlm-1429	19	47	,	,	PUNCT
ajlm-1429	19	48	mid	mid	ADJ
ajlm-1429	19	49	-	-	ADJ
ajlm-1429	19	50	turbinate	turbinate	ADJ
ajlm-1429	19	51	region	region	NOUN
ajlm-1429	19	52	,	,	PUNCT
ajlm-1429	19	53	nasal	nasal	ADJ
ajlm-1429	19	54	cavity	cavity	NOUN
ajlm-1429	19	55	or	or	CCONJ
ajlm-1429	19	56	oropharynx	oropharynx	NOUN
ajlm-1429	19	57	,	,	PUNCT
ajlm-1429	19	58	but	but	CCONJ
ajlm-1429	19	59	the	the	DET
ajlm-1429	19	60	method	method	NOUN
ajlm-1429	19	61	used	use	VERB
ajlm-1429	19	62	for	for	ADP
ajlm-1429	19	63	a	a	DET
ajlm-1429	19	64	particular	particular	ADJ
ajlm-1429	19	65	specimen	speciman	NOUN
ajlm-1429	19	66	is	be	AUX
ajlm-1429	19	67	often	often	ADV
ajlm-1429	19	68	not	not	PART
ajlm-1429	19	69	documented	document	VERB
ajlm-1429	19	70	or	or	CCONJ
ajlm-1429	19	71	made	make	VERB
ajlm-1429	19	72	known	known	ADJ
ajlm-1429	19	73	to	to	ADP
ajlm-1429	19	74	a	a	DET
ajlm-1429	19	75	testing	testing	NOUN
ajlm-1429	19	76	laboratory	laboratory	NOUN
ajlm-1429	19	77	.	.	PUNCT
ajlm-1429	20	1	alternative	alternative	ADJ
ajlm-1429	20	2	specimen	speciman	NOUN
ajlm-1429	20	3	types	type	NOUN
ajlm-1429	20	4	include	include	VERB
ajlm-1429	20	5	saliva	saliva	NOUN
ajlm-1429	20	6	,	,	PUNCT
ajlm-1429	20	7	gargle	gargle	NOUN
ajlm-1429	20	8	,	,	PUNCT
ajlm-1429	20	9	sputum	sputum	NOUN
ajlm-1429	20	10	and	and	CCONJ
ajlm-1429	20	11	faecal	faecal	ADJ
ajlm-1429	20	12	material	material	NOUN
ajlm-1429	20	13	.	.	PUNCT
ajlm-1429	21	1	furthermore	furthermore	ADV
ajlm-1429	21	2	,	,	PUNCT
ajlm-1429	21	3	multiple	multiple	ADJ
ajlm-1429	21	4	swabs	swab	NOUN
ajlm-1429	21	5	may	may	AUX
ajlm-1429	21	6	be	be	AUX
ajlm-1429	21	7	combined	combine	VERB
ajlm-1429	21	8	in	in	ADP
ajlm-1429	21	9	a	a	DET
ajlm-1429	21	10	single	single	ADJ
ajlm-1429	21	11	testing	testing	NOUN
ajlm-1429	21	12	vial	vial	NOUN
ajlm-1429	21	13	.	.	PUNCT
ajlm-1429	22	1	after	after	ADP
ajlm-1429	22	2	collection	collection	NOUN
ajlm-1429	22	3	,	,	PUNCT
ajlm-1429	22	4	the	the	DET
ajlm-1429	22	5	swabs	swab	NOUN
ajlm-1429	22	6	may	may	AUX
ajlm-1429	22	7	be	be	AUX
ajlm-1429	22	8	transported	transport	VERB
ajlm-1429	22	9	dry	dry	ADJ
ajlm-1429	22	10	or	or	CCONJ
ajlm-1429	22	11	in	in	ADP
ajlm-1429	22	12	plain	plain	ADJ
ajlm-1429	22	13	saline	saline	NOUN
ajlm-1429	22	14	,	,	PUNCT
ajlm-1429	22	15	phosphate	phosphate	NOUN
ajlm-1429	22	16	-	-	PUNCT
ajlm-1429	22	17	buffered	buffer	VERB
ajlm-1429	22	18	saline	saline	NOUN
ajlm-1429	22	19	,	,	PUNCT
ajlm-1429	22	20	or	or	CCONJ
ajlm-1429	22	21	various	various	ADJ
ajlm-1429	22	22	preservation	preservation	NOUN
ajlm-1429	22	23	media	medium	NOUN
ajlm-1429	22	24	(	(	PUNCT
ajlm-1429	22	25	e.g.	e.g.	ADV
ajlm-1429	22	26	viral	viral	ADJ
ajlm-1429	22	27	transport	transport	NOUN
ajlm-1429	22	28	media	medium	NOUN
ajlm-1429	22	29	)	)	PUNCT
ajlm-1429	22	30	.	.	PUNCT
ajlm-1429	23	1	the	the	DET
ajlm-1429	23	2	medium	medium	NOUN
ajlm-1429	23	3	may	may	AUX
ajlm-1429	23	4	vary	vary	VERB
ajlm-1429	23	5	in	in	ADP
ajlm-1429	23	6	volume	volume	NOUN
ajlm-1429	23	7	(	(	PUNCT
ajlm-1429	23	8	1	1	NUM
ajlm-1429	23	9	ml	ml	NOUN
ajlm-1429	23	10	–	–	PUNCT
ajlm-1429	23	11	3	3	NUM
ajlm-1429	23	12	ml	ml	NOUN
ajlm-1429	23	13	)	)	PUNCT
ajlm-1429	23	14	,	,	PUNCT
ajlm-1429	23	15	impacting	impact	VERB
ajlm-1429	23	16	viral	viral	ADJ
ajlm-1429	23	17	concentration	concentration	NOUN
ajlm-1429	23	18	.	.	PUNCT
ajlm-1429	24	1	specimens	specimen	NOUN
ajlm-1429	24	2	are	be	AUX
ajlm-1429	24	3	transported	transport	VERB
ajlm-1429	24	4	at	at	ADP
ajlm-1429	24	5	2	2	NUM
ajlm-1429	24	6	°	°	ADP
ajlm-1429	24	7	c	c	NOUN
ajlm-1429	24	8	–	–	PUNCT
ajlm-1429	24	9	8	8	NUM
ajlm-1429	24	10	°	°	ADP
ajlm-1429	24	11	c	c	NOUN
ajlm-1429	24	12	or	or	CCONJ
ajlm-1429	24	13	at	at	ADP
ajlm-1429	24	14	ambient	ambient	ADJ
ajlm-1429	24	15	temperature	temperature	NOUN
ajlm-1429	24	16	,	,	PUNCT
ajlm-1429	24	17	which	which	PRON
ajlm-1429	24	18	,	,	PUNCT
ajlm-1429	24	19	in	in	ADP
ajlm-1429	24	20	some	some	DET
ajlm-1429	24	21	settings	setting	NOUN
ajlm-1429	24	22	,	,	PUNCT
ajlm-1429	24	23	means	mean	VERB
ajlm-1429	24	24	high	high	ADJ
ajlm-1429	24	25	humidity	humidity	NOUN
ajlm-1429	24	26	and	and	CCONJ
ajlm-1429	24	27	temperature	temperature	NOUN
ajlm-1429	24	28	.	.	PUNCT
ajlm-1429	25	1	certain	certain	ADJ
ajlm-1429	25	2	testing	testing	NOUN
ajlm-1429	25	3	laboratories	laboratory	NOUN
ajlm-1429	25	4	insist	insist	VERB
ajlm-1429	25	5	on	on	ADP
ajlm-1429	25	6	inactivation	inactivation	NOUN
ajlm-1429	25	7	of	of	ADP
ajlm-1429	25	8	viral	viral	ADJ
ajlm-1429	25	9	swabs	swab	NOUN
ajlm-1429	25	10	for	for	ADP
ajlm-1429	25	11	biosafety	biosafety	NOUN
ajlm-1429	25	12	,	,	PUNCT
ajlm-1429	25	13	which	which	PRON
ajlm-1429	25	14	could	could	AUX
ajlm-1429	25	15	include	include	VERB
ajlm-1429	25	16	chemical	chemical	NOUN
ajlm-1429	25	17	or	or	CCONJ
ajlm-1429	25	18	heat	heat	NOUN
ajlm-1429	25	19	pre	pre	NOUN
ajlm-1429	25	20	-	-	NOUN
ajlm-1429	25	21	treatment	treatment	NOUN
ajlm-1429	25	22	.	.	PUNCT
ajlm-1429	26	1	figure	figure	NOUN
ajlm-1429	26	2	1	1	NUM
ajlm-1429	26	3	:	:	PUNCT
ajlm-1429	26	4	considerations	consideration	NOUN
ajlm-1429	26	5	for	for	ADP
ajlm-1429	26	6	severe	severe	ADJ
ajlm-1429	26	7	acute	acute	ADJ
ajlm-1429	26	8	respiratory	respiratory	ADJ
ajlm-1429	26	9	syndrome	syndrome	NOUN
ajlm-1429	26	10	coronavirus	coronavirus	NOUN
ajlm-1429	26	11	2	2	NUM
ajlm-1429	26	12	molecular	molecular	ADJ
ajlm-1429	26	13	assays	assay	NOUN
ajlm-1429	26	14	across	across	ADP
ajlm-1429	26	15	the	the	DET
ajlm-1429	26	16	pathology	pathology	NOUN
ajlm-1429	26	17	value	value	NOUN
ajlm-1429	26	18	chain	chain	NOUN
ajlm-1429	26	19	.	.	PUNCT
ajlm-1429	27	1	viral	viral	ADJ
ajlm-1429	27	2	rna	rna	NOUN
ajlm-1429	27	3	extraction	extraction	NOUN
ajlm-1429	27	4	(	(	PUNCT
ajlm-1429	27	5	or	or	CCONJ
ajlm-1429	27	6	purification	purification	NOUN
ajlm-1429	27	7	)	)	PUNCT
ajlm-1429	27	8	is	be	AUX
ajlm-1429	27	9	prone	prone	ADJ
ajlm-1429	27	10	to	to	ADP
ajlm-1429	27	11	variability	variability	NOUN
ajlm-1429	27	12	.	.	PUNCT
ajlm-1429	28	1	the	the	DET
ajlm-1429	28	2	majority	majority	NOUN
ajlm-1429	28	3	of	of	ADP
ajlm-1429	28	4	rna	rna	NOUN
ajlm-1429	28	5	purification	purification	NOUN
ajlm-1429	28	6	methods	method	NOUN
ajlm-1429	28	7	rely	rely	VERB
ajlm-1429	28	8	on	on	ADP
ajlm-1429	28	9	automated	automate	VERB
ajlm-1429	28	10	magnetic	magnetic	ADJ
ajlm-1429	28	11	bead	bead	NOUN
ajlm-1429	28	12	extraction	extraction	NOUN
ajlm-1429	28	13	performed	perform	VERB
ajlm-1429	28	14	on	on	ADP
ajlm-1429	28	15	automated	automate	VERB
ajlm-1429	28	16	platforms	platform	NOUN
ajlm-1429	28	17	(	(	PUNCT
ajlm-1429	28	18	e.g.	e.g.	ADV
ajlm-1429	28	19	nuclisens	nuclisen	NOUN
ajlm-1429	28	20	®	®	NOUN
ajlm-1429	28	21	easymag	easymag	NOUN
ajlm-1429	28	22	®	®	NOUN
ajlm-1429	28	23	[	[	X
ajlm-1429	28	24	biomérieux	biomérieux	PROPN
ajlm-1429	28	25	,	,	PUNCT
ajlm-1429	28	26	johannesburg	johannesburg	PROPN
ajlm-1429	28	27	,	,	PUNCT
ajlm-1429	28	28	south	south	PROPN
ajlm-1429	28	29	africa	africa	PROPN
ajlm-1429	28	30	]	]	PUNCT
ajlm-1429	28	31	)	)	PUNCT
ajlm-1429	28	32	.	.	PUNCT
ajlm-1429	29	1	these	these	PRON
ajlm-1429	29	2	differ	differ	VERB
ajlm-1429	29	3	in	in	ADP
ajlm-1429	29	4	processing	processing	NOUN
ajlm-1429	29	5	capacity	capacity	NOUN
ajlm-1429	29	6	,	,	PUNCT
ajlm-1429	29	7	input	input	NOUN
ajlm-1429	29	8	volume	volume	NOUN
ajlm-1429	29	9	,	,	PUNCT
ajlm-1429	29	10	purified	purified	ADJ
ajlm-1429	29	11	rna	rna	NOUN
ajlm-1429	29	12	elution	elution	NOUN
ajlm-1429	29	13	yield	yield	NOUN
ajlm-1429	29	14	and	and	CCONJ
ajlm-1429	29	15	turnaround	turnaround	NOUN
ajlm-1429	29	16	time	time	NOUN
ajlm-1429	29	17	(	(	PUNCT
ajlm-1429	29	18	tat	tat	NOUN
ajlm-1429	29	19	)	)	PUNCT
ajlm-1429	29	20	.	.	PUNCT
ajlm-1429	30	1	manual	manual	ADJ
ajlm-1429	30	2	methods	method	NOUN
ajlm-1429	30	3	range	range	VERB
ajlm-1429	30	4	from	from	ADP
ajlm-1429	30	5	spin	spin	NOUN
ajlm-1429	30	6	columns	column	NOUN
ajlm-1429	30	7	(	(	PUNCT
ajlm-1429	30	8	e.g.	e.g.	ADV
ajlm-1429	30	9	rneasy	rneasy	VERB
ajlm-1429	30	10	mini	mini	ADJ
ajlm-1429	30	11	spin	spin	NOUN
ajlm-1429	30	12	[	[	X
ajlm-1429	30	13	qiagen	qiagen	PROPN
ajlm-1429	30	14	,	,	PUNCT
ajlm-1429	30	15	hilden	hilden	PROPN
ajlm-1429	30	16	,	,	PUNCT
ajlm-1429	30	17	germany	germany	PROPN
ajlm-1429	30	18	]	]	PUNCT
ajlm-1429	30	19	)	)	PUNCT
ajlm-1429	30	20	,	,	PUNCT
ajlm-1429	30	21	which	which	PRON
ajlm-1429	30	22	rely	rely	VERB
ajlm-1429	30	23	on	on	ADP
ajlm-1429	30	24	centrifugation	centrifugation	NOUN
ajlm-1429	30	25	,	,	PUNCT
ajlm-1429	30	26	to	to	ADP
ajlm-1429	30	27	crude	crude	ADJ
ajlm-1429	30	28	approaches	approach	NOUN
ajlm-1429	30	29	that	that	PRON
ajlm-1429	30	30	are	be	AUX
ajlm-1429	30	31	used	use	VERB
ajlm-1429	30	32	where	where	SCONJ
ajlm-1429	30	33	no	no	DET
ajlm-1429	30	34	extraction	extraction	NOUN
ajlm-1429	30	35	instrumentation	instrumentation	NOUN
ajlm-1429	30	36	is	be	AUX
ajlm-1429	30	37	available	available	ADJ
ajlm-1429	30	38	.	.	PUNCT
ajlm-1429	31	1	the	the	DET
ajlm-1429	31	2	latter	latter	ADJ
ajlm-1429	31	3	include	include	VERB
ajlm-1429	31	4	direct	direct	ADJ
ajlm-1429	31	5	lysis	lysis	NOUN
ajlm-1429	31	6	-	-	PUNCT
ajlm-1429	31	7	to	to	ADP
ajlm-1429	31	8	-	-	PUNCT
ajlm-1429	31	9	polymerase	polymerase	NOUN
ajlm-1429	31	10	chain	chain	NOUN
ajlm-1429	31	11	reaction	reaction	NOUN
ajlm-1429	31	12	(	(	PUNCT
ajlm-1429	31	13	pcr	pcr	NOUN
ajlm-1429	31	14	)	)	PUNCT
ajlm-1429	31	15	kits	kit	NOUN
ajlm-1429	31	16	(	(	PUNCT
ajlm-1429	31	17	e.g.	e.g.	ADV
ajlm-1429	31	18	lyra	lyra	PROPN
ajlm-1429	31	19	®	®	NOUN
ajlm-1429	31	20	direct	direct	ADJ
ajlm-1429	31	21	sars	sar	NOUN
ajlm-1429	31	22	-	-	PUNCT
ajlm-1429	31	23	cov-2	cov-2	PART
ajlm-1429	31	24	assay	assay	NOUN
ajlm-1429	31	25	[	[	X
ajlm-1429	31	26	quidel	quidel	PROPN
ajlm-1429	31	27	®	®	PROPN
ajlm-1429	31	28	,	,	PUNCT
ajlm-1429	31	29	san	san	PROPN
ajlm-1429	31	30	diego	diego	PROPN
ajlm-1429	31	31	,	,	PUNCT
ajlm-1429	31	32	california	california	PROPN
ajlm-1429	31	33	,	,	PUNCT
ajlm-1429	31	34	united	united	PROPN
ajlm-1429	31	35	states	states	PROPN
ajlm-1429	31	36	]	]	PUNCT
ajlm-1429	31	37	)	)	PUNCT
ajlm-1429	31	38	,	,	PUNCT
ajlm-1429	31	39	proprietary	proprietary	ADJ
ajlm-1429	31	40	lysis	lysis	NOUN
ajlm-1429	31	41	buffers	buffer	NOUN
ajlm-1429	31	42	(	(	PUNCT
ajlm-1429	31	43	e.g.	e.g.	ADV
ajlm-1429	31	44	bosphore	bosphore	ADJ
ajlm-1429	31	45	ex	ex	ADJ
ajlm-1429	31	46	-	-	ADJ
ajlm-1429	31	47	tract	tract	ADJ
ajlm-1429	31	48	dry	dry	ADJ
ajlm-1429	31	49	swab	swab	NOUN
ajlm-1429	31	50	rna	rna	PROPN
ajlm-1429	31	51	[	[	X
ajlm-1429	31	52	anatolia	anatolia	PROPN
ajlm-1429	31	53	geneworks	geneworks	PROPN
ajlm-1429	31	54	,	,	PUNCT
ajlm-1429	31	55	istanbul	istanbul	PROPN
ajlm-1429	31	56	,	,	PUNCT
ajlm-1429	31	57	turkey	turkey	PROPN
ajlm-1429	31	58	]	]	PUNCT
ajlm-1429	31	59	)	)	PUNCT
ajlm-1429	31	60	or	or	CCONJ
ajlm-1429	31	61	simply	simply	ADV
ajlm-1429	31	62	heat	heat	VERB
ajlm-1429	31	63	(	(	PUNCT
ajlm-1429	31	64	where	where	SCONJ
ajlm-1429	31	65	rapid	rapid	ADJ
ajlm-1429	31	66	sample	sample	NOUN
ajlm-1429	31	67	preparation	preparation	NOUN
ajlm-1429	31	68	is	be	AUX
ajlm-1429	31	69	needed).12	needed).12	NOUN
ajlm-1429	31	70	these	these	DET
ajlm-1429	31	71	procedures	procedure	NOUN
ajlm-1429	31	72	aim	aim	VERB
ajlm-1429	31	73	to	to	PART
ajlm-1429	31	74	disrupt	disrupt	VERB
ajlm-1429	31	75	viral	viral	ADJ
ajlm-1429	31	76	particles	particle	NOUN
ajlm-1429	31	77	to	to	PART
ajlm-1429	31	78	release	release	VERB
ajlm-1429	31	79	rna	rna	NOUN
ajlm-1429	31	80	and	and	CCONJ
ajlm-1429	31	81	inactivate	inactivate	VERB
ajlm-1429	31	82	inhibitory	inhibitory	ADJ
ajlm-1429	31	83	enzymes	enzyme	NOUN
ajlm-1429	31	84	.	.	PUNCT
ajlm-1429	32	1	added	add	VERB
ajlm-1429	32	2	variables	variable	NOUN
ajlm-1429	32	3	with	with	ADP
ajlm-1429	32	4	the	the	DET
ajlm-1429	32	5	lysis	lysis	NOUN
ajlm-1429	32	6	approach	approach	NOUN
ajlm-1429	32	7	could	could	AUX
ajlm-1429	32	8	be	be	AUX
ajlm-1429	32	9	a	a	DET
ajlm-1429	32	10	specimen	speciman	NOUN
ajlm-1429	32	11	’s	’s	PART
ajlm-1429	32	12	exposure	exposure	NOUN
ajlm-1429	32	13	time	time	NOUN
ajlm-1429	32	14	to	to	ADP
ajlm-1429	32	15	the	the	DET
ajlm-1429	32	16	buffer	buffer	NOUN
ajlm-1429	32	17	and	and	CCONJ
ajlm-1429	32	18	buffer	buffer	VERB
ajlm-1429	32	19	compatibility	compatibility	NOUN
ajlm-1429	32	20	with	with	ADP
ajlm-1429	32	21	pcr	pcr	PROPN
ajlm-1429	32	22	.	.	PUNCT
ajlm-1429	33	1	the	the	DET
ajlm-1429	33	2	primary	primary	ADJ
ajlm-1429	33	3	specimen	speciman	NOUN
ajlm-1429	33	4	input	input	NOUN
ajlm-1429	33	5	testing	testing	NOUN
ajlm-1429	33	6	volume	volume	NOUN
ajlm-1429	33	7	also	also	ADV
ajlm-1429	33	8	differs	differ	VERB
ajlm-1429	33	9	between	between	ADP
ajlm-1429	33	10	technologies	technology	NOUN
ajlm-1429	33	11	:	:	PUNCT
ajlm-1429	33	12	300	300	NUM
ajlm-1429	33	13	µl	µl	AUX
ajlm-1429	33	14	added	add	VERB
ajlm-1429	33	15	directly	directly	ADV
ajlm-1429	33	16	to	to	ADP
ajlm-1429	33	17	an	an	DET
ajlm-1429	33	18	xpert	xpert	PROPN
ajlm-1429	33	19	®	®	PROPN
ajlm-1429	33	20	xpress	xpress	PROPN
ajlm-1429	33	21	®	®	PROPN
ajlm-1429	33	22	sars	sar	NOUN
ajlm-1429	33	23	-	-	PUNCT
ajlm-1429	33	24	cov-2	cov-2	PART
ajlm-1429	33	25	cartridge	cartridge	NOUN
ajlm-1429	33	26	(	(	PUNCT
ajlm-1429	33	27	cepheid	cepheid	NOUN
ajlm-1429	33	28	,	,	PUNCT
ajlm-1429	33	29	sunnyvale	sunnyvale	PROPN
ajlm-1429	33	30	,	,	PUNCT
ajlm-1429	33	31	california	california	PROPN
ajlm-1429	33	32	,	,	PUNCT
ajlm-1429	33	33	united	united	PROPN
ajlm-1429	33	34	states	states	PROPN
ajlm-1429	33	35	)	)	PUNCT
ajlm-1429	33	36	,	,	PUNCT
ajlm-1429	33	37	400	400	NUM
ajlm-1429	33	38	µl	µl	NOUN
ajlm-1429	33	39	to	to	ADP
ajlm-1429	33	40	the	the	DET
ajlm-1429	33	41	cobas	cobas	ADJ
ajlm-1429	33	42	®	®	NOUN
ajlm-1429	33	43	sars	sar	NOUN
ajlm-1429	33	44	-	-	PUNCT
ajlm-1429	33	45	cov-2	cov-2	PART
ajlm-1429	33	46	assay	assay	PROPN
ajlm-1429	33	47	(	(	PUNCT
ajlm-1429	33	48	roche	roche	PROPN
ajlm-1429	33	49	,	,	PUNCT
ajlm-1429	33	50	basel	basel	PROPN
ajlm-1429	33	51	,	,	PUNCT
ajlm-1429	33	52	switzer;and	switzer;and	PROPN
ajlm-1429	33	53	)	)	PUNCT
ajlm-1429	33	54	and	and	CCONJ
ajlm-1429	33	55	500	500	NUM
ajlm-1429	33	56	µl	µl	NOUN
ajlm-1429	33	57	to	to	ADP
ajlm-1429	33	58	the	the	DET
ajlm-1429	33	59	realtime	realtime	ADJ
ajlm-1429	33	60	sars	sar	NOUN
ajlm-1429	33	61	-	-	PUNCT
ajlm-1429	33	62	cov-2	cov-2	NOUN
ajlm-1429	33	63	assay	assay	PROPN
ajlm-1429	33	64	(	(	PUNCT
ajlm-1429	33	65	abbott	abbott	PROPN
ajlm-1429	33	66	,	,	PUNCT
ajlm-1429	33	67	chicago	chicago	PROPN
ajlm-1429	33	68	,	,	PUNCT
ajlm-1429	33	69	illinois	illinois	PROPN
ajlm-1429	33	70	,	,	PUNCT
ajlm-1429	33	71	united	united	PROPN
ajlm-1429	33	72	states	states	PROPN
ajlm-1429	33	73	)	)	PUNCT
ajlm-1429	33	74	.	.	PUNCT
ajlm-1429	34	1	similarly	similarly	ADV
ajlm-1429	34	2	,	,	PUNCT
ajlm-1429	34	3	most	most	ADJ
ajlm-1429	34	4	rna	rna	NOUN
ajlm-1429	34	5	extraction	extraction	NOUN
ajlm-1429	34	6	platforms	platform	NOUN
ajlm-1429	34	7	require	require	VERB
ajlm-1429	34	8	input	input	NOUN
ajlm-1429	34	9	of	of	ADP
ajlm-1429	34	10	anywhere	anywhere	ADV
ajlm-1429	34	11	between	between	ADP
ajlm-1429	34	12	100	100	NUM
ajlm-1429	34	13	µl	µl	ADP
ajlm-1429	34	14	and	and	CCONJ
ajlm-1429	34	15	300	300	NUM
ajlm-1429	34	16	µl	µl	NOUN
ajlm-1429	34	17	of	of	ADP
ajlm-1429	34	18	raw	raw	ADJ
ajlm-1429	34	19	specimen	speciman	NOUN
ajlm-1429	34	20	.	.	PUNCT
ajlm-1429	35	1	furthermore	furthermore	ADV
ajlm-1429	35	2	,	,	PUNCT
ajlm-1429	35	3	for	for	ADP
ajlm-1429	35	4	a	a	DET
ajlm-1429	35	5	direct	direct	ADJ
ajlm-1429	35	6	lysis	lysis	NOUN
ajlm-1429	35	7	-	-	PUNCT
ajlm-1429	35	8	to	to	ADP
ajlm-1429	35	9	-	-	PUNCT
ajlm-1429	35	10	pcr	pcr	NOUN
ajlm-1429	35	11	assay	assay	NOUN
ajlm-1429	35	12	,	,	PUNCT
ajlm-1429	35	13	input	input	NOUN
ajlm-1429	35	14	volume	volume	NOUN
ajlm-1429	35	15	can	can	AUX
ajlm-1429	35	16	range	range	VERB
ajlm-1429	35	17	from	from	ADP
ajlm-1429	35	18	10	10	NUM
ajlm-1429	35	19	µl	µl	ADP
ajlm-1429	35	20	preservation	preservation	NOUN
ajlm-1429	35	21	buffer	buffer	NOUN
ajlm-1429	35	22	(	(	PUNCT
ajlm-1429	35	23	nagene	nagene	NOUN
ajlm-1429	35	24	[	[	X
ajlm-1429	35	25	diagnóstica	diagnóstica	NOUN
ajlm-1429	35	26	longwood	longwood	PROPN
ajlm-1429	35	27	,	,	PUNCT
ajlm-1429	35	28	zaragoza	zaragoza	PROPN
ajlm-1429	35	29	,	,	PUNCT
ajlm-1429	35	30	spain	spain	PROPN
ajlm-1429	35	31	]	]	PUNCT
ajlm-1429	35	32	)	)	PUNCT
ajlm-1429	35	33	to	to	ADP
ajlm-1429	35	34	30	30	NUM
ajlm-1429	35	35	µl	µl	ADP
ajlm-1429	35	36	raw	raw	ADJ
ajlm-1429	35	37	specimen	speciman	NOUN
ajlm-1429	35	38	(	(	PUNCT
ajlm-1429	35	39	smartchek	smartchek	PROPN
ajlm-1429	35	40	®	®	PROPN
ajlm-1429	35	41	)	)	PUNCT
ajlm-1429	35	42	,	,	PUNCT
ajlm-1429	35	43	and	and	CCONJ
ajlm-1429	35	44	ideally	ideally	ADV
ajlm-1429	35	45	the	the	DET
ajlm-1429	35	46	patient	patient	ADJ
ajlm-1429	35	47	swab	swab	NOUN
ajlm-1429	35	48	should	should	AUX
ajlm-1429	35	49	be	be	AUX
ajlm-1429	35	50	added	add	VERB
ajlm-1429	35	51	directly	directly	ADV
ajlm-1429	35	52	to	to	ADP
ajlm-1429	35	53	the	the	DET
ajlm-1429	35	54	proprietary	proprietary	ADJ
ajlm-1429	35	55	medium	medium	NOUN
ajlm-1429	35	56	.	.	PUNCT
ajlm-1429	36	1	the	the	DET
ajlm-1429	36	2	naats	naat	NOUN
ajlm-1429	36	3	used	use	VERB
ajlm-1429	36	4	are	be	AUX
ajlm-1429	36	5	also	also	ADV
ajlm-1429	36	6	variable	variable	ADJ
ajlm-1429	36	7	.	.	PUNCT
ajlm-1429	37	1	they	they	PRON
ajlm-1429	37	2	are	be	AUX
ajlm-1429	37	3	performed	perform	VERB
ajlm-1429	37	4	on	on	ADP
ajlm-1429	37	5	a	a	DET
ajlm-1429	37	6	variety	variety	NOUN
ajlm-1429	37	7	of	of	ADP
ajlm-1429	37	8	platforms	platform	NOUN
ajlm-1429	37	9	that	that	PRON
ajlm-1429	37	10	may	may	AUX
ajlm-1429	37	11	be	be	AUX
ajlm-1429	37	12	closed	close	VERB
ajlm-1429	37	13	(	(	PUNCT
ajlm-1429	37	14	dedicated	dedicated	ADJ
ajlm-1429	37	15	)	)	PUNCT
ajlm-1429	37	16	(	(	PUNCT
ajlm-1429	38	1	e.g.	e.g.	ADV
ajlm-1429	38	2	m2000	m2000	NOUN
ajlm-1429	38	3	®	®	PROPN
ajlm-1429	38	4	[	[	X
ajlm-1429	38	5	abbott	abbott	PROPN
ajlm-1429	38	6	,	,	PUNCT
ajlm-1429	38	7	chicago	chicago	PROPN
ajlm-1429	38	8	,	,	PUNCT
ajlm-1429	38	9	illinois	illinois	PROPN
ajlm-1429	38	10	,	,	PUNCT
ajlm-1429	38	11	united	united	PROPN
ajlm-1429	38	12	states	states	PROPN
ajlm-1429	38	13	]	]	PUNCT
ajlm-1429	38	14	)	)	PUNCT
ajlm-1429	38	15	or	or	CCONJ
ajlm-1429	38	16	open	open	ADJ
ajlm-1429	38	17	(	(	PUNCT
ajlm-1429	38	18	‘	'	PUNCT
ajlm-1429	38	19	plug	plug	VERB
ajlm-1429	38	20	-	-	PUNCT
ajlm-1429	38	21	and	and	CCONJ
ajlm-1429	38	22	-	-	PUNCT
ajlm-1429	38	23	play	play	NOUN
ajlm-1429	38	24	’	'	PUNCT
ajlm-1429	38	25	approach	approach	NOUN
ajlm-1429	38	26	subsequent	subsequent	ADJ
ajlm-1429	38	27	to	to	ADP
ajlm-1429	38	28	extraction	extraction	NOUN
ajlm-1429	38	29	using	use	VERB
ajlm-1429	38	30	different	different	ADJ
ajlm-1429	38	31	systems	system	NOUN
ajlm-1429	38	32	and	and	CCONJ
ajlm-1429	38	33	instruments	instrument	NOUN
ajlm-1429	38	34	)	)	PUNCT
ajlm-1429	38	35	.	.	PUNCT
ajlm-1429	39	1	the	the	DET
ajlm-1429	39	2	latter	latter	ADJ
ajlm-1429	39	3	requires	require	VERB
ajlm-1429	39	4	compatibility	compatibility	NOUN
ajlm-1429	39	5	with	with	ADP
ajlm-1429	39	6	real	real	ADJ
ajlm-1429	39	7	-	-	PUNCT
ajlm-1429	39	8	time	time	NOUN
ajlm-1429	39	9	thermocycler	thermocycler	NOUN
ajlm-1429	39	10	instruments	instrument	NOUN
ajlm-1429	39	11	(	(	PUNCT
ajlm-1429	39	12	e.g.	e.g.	ADV
ajlm-1429	39	13	cfx96	cfx96	ADJ
ajlm-1429	39	14	touch	touch	NOUN
ajlm-1429	39	15	™	™	ADJ
ajlm-1429	40	1	[	[	X
ajlm-1429	40	2	biorad	biorad	X
ajlm-1429	40	3	,	,	PUNCT
ajlm-1429	40	4	hercules	hercules	PROPN
ajlm-1429	40	5	,	,	PUNCT
ajlm-1429	40	6	california	california	PROPN
ajlm-1429	40	7	,	,	PUNCT
ajlm-1429	40	8	united	united	PROPN
ajlm-1429	40	9	states	states	PROPN
ajlm-1429	40	10	]	]	PUNCT
ajlm-1429	40	11	,	,	PUNCT
ajlm-1429	40	12	quantstudio	quantstudio	PROPN
ajlm-1429	41	1	[	[	X
ajlm-1429	41	2	thermo	thermo	NOUN
ajlm-1429	41	3	fisher	fisher	PROPN
ajlm-1429	41	4	scientific	scientific	PROPN
ajlm-1429	41	5	,	,	PUNCT
ajlm-1429	41	6	waltham	waltham	PROPN
ajlm-1429	41	7	,	,	PUNCT
ajlm-1429	41	8	massachusetts	massachusetts	PROPN
ajlm-1429	41	9	,	,	PUNCT
ajlm-1429	41	10	united	united	PROPN
ajlm-1429	41	11	states	states	PROPN
ajlm-1429	41	12	]	]	PUNCT
ajlm-1429	41	13	)	)	PUNCT
ajlm-1429	41	14	.	.	PUNCT
ajlm-1429	42	1	throughput	throughput	NOUN
ajlm-1429	42	2	ranges	range	VERB
ajlm-1429	42	3	from	from	ADP
ajlm-1429	42	4	a	a	DET
ajlm-1429	42	5	single	single	ADJ
ajlm-1429	42	6	test	test	NOUN
ajlm-1429	42	7	at	at	ADP
ajlm-1429	42	8	a	a	DET
ajlm-1429	42	9	time	time	NOUN
ajlm-1429	42	10	(	(	PUNCT
ajlm-1429	42	11	e.g.	e.g.	ADV
ajlm-1429	42	12	genexpert	genexpert	X
ajlm-1429	42	13	®	®	NOUN
ajlm-1429	42	14	[	[	X
ajlm-1429	42	15	cepheid	cepheid	PROPN
ajlm-1429	42	16	,	,	PUNCT
ajlm-1429	42	17	sunnyvale	sunnyvale	PROPN
ajlm-1429	42	18	,	,	PUNCT
ajlm-1429	42	19	california	california	PROPN
ajlm-1429	42	20	,	,	PUNCT
ajlm-1429	42	21	united	united	PROPN
ajlm-1429	42	22	states	states	PROPN
ajlm-1429	42	23	]	]	PUNCT
ajlm-1429	42	24	)	)	PUNCT
ajlm-1429	42	25	to	to	ADP
ajlm-1429	42	26	1000–1500	1000–1500	NUM
ajlm-1429	42	27	/	/	SYM
ajlm-1429	42	28	day	day	NOUN
ajlm-1429	42	29	(	(	PUNCT
ajlm-1429	42	30	e.g.	e.g.	ADV
ajlm-1429	42	31	cobas	cobas	ADJ
ajlm-1429	42	32	®	®	NOUN
ajlm-1429	42	33	[	[	X
ajlm-1429	42	34	roche	roche	X
ajlm-1429	42	35	,	,	PUNCT
ajlm-1429	42	36	basel	basel	PROPN
ajlm-1429	42	37	,	,	PUNCT
ajlm-1429	42	38	switzerland	switzerland	PROPN
ajlm-1429	42	39	]	]	PUNCT
ajlm-1429	42	40	)	)	PUNCT
ajlm-1429	42	41	.	.	PUNCT
ajlm-1429	43	1	many	many	ADJ
ajlm-1429	43	2	of	of	ADP
ajlm-1429	43	3	the	the	DET
ajlm-1429	43	4	open	open	ADJ
ajlm-1429	43	5	-	-	PUNCT
ajlm-1429	43	6	platform	platform	NOUN
ajlm-1429	43	7	thermocyclers	thermocycler	NOUN
ajlm-1429	43	8	use	use	VERB
ajlm-1429	43	9	96	96	NUM
ajlm-1429	43	10	-	-	PUNCT
ajlm-1429	43	11	well	well	NOUN
ajlm-1429	43	12	plates	plate	NOUN
ajlm-1429	43	13	and	and	CCONJ
ajlm-1429	43	14	may	may	AUX
ajlm-1429	43	15	require	require	VERB
ajlm-1429	43	16	specimen	speciman	NOUN
ajlm-1429	43	17	batching	batch	VERB
ajlm-1429	43	18	.	.	PUNCT
ajlm-1429	44	1	as	as	ADP
ajlm-1429	44	2	with	with	ADP
ajlm-1429	44	3	specimen	speciman	NOUN
ajlm-1429	44	4	input	input	NOUN
ajlm-1429	44	5	volume	volume	NOUN
ajlm-1429	44	6	,	,	PUNCT
ajlm-1429	44	7	the	the	DET
ajlm-1429	44	8	rna	rna	NOUN
ajlm-1429	44	9	input	input	NOUN
ajlm-1429	44	10	volume	volume	NOUN
ajlm-1429	44	11	also	also	ADV
ajlm-1429	44	12	varies	vary	VERB
ajlm-1429	44	13	between	between	ADP
ajlm-1429	44	14	assays	assay	NOUN
ajlm-1429	44	15	(	(	PUNCT
ajlm-1429	44	16	e.g.	e.g.	ADV
ajlm-1429	44	17	8	8	NUM
ajlm-1429	44	18	µl	µl	NOUN
ajlm-1429	44	19	for	for	ADP
ajlm-1429	44	20	the	the	DET
ajlm-1429	44	21	allplex	allplex	PROPN
ajlm-1429	44	22	sars	sar	NOUN
ajlm-1429	44	23	-	-	PUNCT
ajlm-1429	44	24	cov-2	cov-2	PART
ajlm-1429	44	25	assay	assay	NOUN
ajlm-1429	44	26	[	[	X
ajlm-1429	44	27	seegene	seegene	NOUN
ajlm-1429	44	28	,	,	PUNCT
ajlm-1429	44	29	seoul	seoul	PROPN
ajlm-1429	44	30	,	,	PUNCT
ajlm-1429	44	31	south	south	PROPN
ajlm-1429	44	32	korea	korea	PROPN
ajlm-1429	44	33	]	]	PUNCT
ajlm-1429	44	34	,	,	PUNCT
ajlm-1429	44	35	10	10	NUM
ajlm-1429	44	36	µl	µl	NOUN
ajlm-1429	44	37	for	for	ADP
ajlm-1429	44	38	the	the	DET
ajlm-1429	44	39	taqpath	taqpath	NOUN
ajlm-1429	44	40	™	™	ADJ
ajlm-1429	44	41	sars	sar	NOUN
ajlm-1429	44	42	-	-	PUNCT
ajlm-1429	44	43	cov-2	cov-2	NOUN
ajlm-1429	44	44	assay	assay	VERB
ajlm-1429	44	45	[	[	X
ajlm-1429	44	46	thermo	thermo	NOUN
ajlm-1429	44	47	fisher	fisher	PROPN
ajlm-1429	44	48	scientific	scientific	PROPN
ajlm-1429	44	49	,	,	PUNCT
ajlm-1429	44	50	waltham	waltham	PROPN
ajlm-1429	44	51	,	,	PUNCT
ajlm-1429	44	52	massachusetts	massachusetts	PROPN
ajlm-1429	44	53	,	,	PUNCT
ajlm-1429	44	54	united	united	PROPN
ajlm-1429	44	55	states	states	PROPN
ajlm-1429	44	56	]	]	PUNCT
ajlm-1429	44	57	,	,	PUNCT
ajlm-1429	44	58	and	and	CCONJ
ajlm-1429	44	59	14	14	NUM
ajlm-1429	44	60	µl	µl	NOUN
ajlm-1429	44	61	for	for	ADP
ajlm-1429	44	62	the	the	DET
ajlm-1429	44	63	perkinelmer	perkinelmer	NOUN
ajlm-1429	44	64	™	™	ADJ
ajlm-1429	44	65	sars	sar	NOUN
ajlm-1429	44	66	-	-	PUNCT
ajlm-1429	44	67	cov-2	cov-2	NOUN
ajlm-1429	44	68	rt	rt	NOUN
ajlm-1429	44	69	-	-	PUNCT
ajlm-1429	44	70	qpcr	qpcr	ADV
ajlm-1429	44	71	reagent	reagent	ADJ
ajlm-1429	44	72	kit	kit	NOUN
ajlm-1429	44	73	ce	ce	PROPN
ajlm-1429	44	74	-	-	PROPN
ajlm-1429	44	75	ivd	ivd	PROPN
ajlm-1429	44	76	[	[	X
ajlm-1429	44	77	perkinelmer	perkinelmer	NOUN
ajlm-1429	44	78	™	™	PROPN
ajlm-1429	44	79	,	,	PUNCT
ajlm-1429	44	80	waltham	waltham	PROPN
ajlm-1429	44	81	,	,	PUNCT
ajlm-1429	44	82	massachusetts	massachusetts	PROPN
ajlm-1429	44	83	,	,	PUNCT
ajlm-1429	44	84	united	united	PROPN
ajlm-1429	44	85	states	states	PROPN
ajlm-1429	44	86	]	]	PUNCT
ajlm-1429	44	87	.	.	PUNCT
ajlm-1429	45	1	a	a	DET
ajlm-1429	45	2	number	number	NOUN
ajlm-1429	45	3	of	of	ADP
ajlm-1429	45	4	novel	novel	ADJ
ajlm-1429	45	5	assays	assay	NOUN
ajlm-1429	45	6	have	have	VERB
ajlm-1429	45	7	rna	rna	NOUN
ajlm-1429	45	8	input	input	NOUN
ajlm-1429	45	9	volumes	volume	NOUN
ajlm-1429	45	10	as	as	ADV
ajlm-1429	45	11	low	low	ADJ
ajlm-1429	45	12	as	as	ADP
ajlm-1429	45	13	5	5	NUM
ajlm-1429	45	14	µl	µl	NOUN
ajlm-1429	45	15	.	.	PUNCT
ajlm-1429	46	1	the	the	DET
ajlm-1429	46	2	differences	difference	NOUN
ajlm-1429	46	3	in	in	ADP
ajlm-1429	46	4	volume	volume	NOUN
ajlm-1429	46	5	for	for	ADP
ajlm-1429	46	6	extraction	extraction	NOUN
ajlm-1429	46	7	or	or	CCONJ
ajlm-1429	46	8	pcr	pcr	NOUN
ajlm-1429	46	9	may	may	AUX
ajlm-1429	46	10	influence	influence	VERB
ajlm-1429	46	11	theoretical	theoretical	ADJ
ajlm-1429	46	12	limits	limit	NOUN
ajlm-1429	46	13	of	of	ADP
ajlm-1429	46	14	detection	detection	NOUN
ajlm-1429	46	15	.	.	PUNCT
ajlm-1429	47	1	in	in	ADP
ajlm-1429	47	2	addition	addition	NOUN
ajlm-1429	47	3	to	to	ADP
ajlm-1429	47	4	these	these	DET
ajlm-1429	47	5	complexities	complexity	NOUN
ajlm-1429	47	6	,	,	PUNCT
ajlm-1429	47	7	the	the	DET
ajlm-1429	47	8	sars	sar	NOUN
ajlm-1429	47	9	-	-	PUNCT
ajlm-1429	47	10	cov-2	cov-2	NOUN
ajlm-1429	47	11	genes	gene	NOUN
ajlm-1429	47	12	(	(	PUNCT
ajlm-1429	47	13	envelope	envelope	NOUN
ajlm-1429	47	14	[	[	X
ajlm-1429	47	15	e	e	X
ajlm-1429	47	16	]	]	X
ajlm-1429	47	17	,	,	PUNCT
ajlm-1429	47	18	nucleocapsid	nucleocapsid	ADJ
ajlm-1429	47	19	[	[	X
ajlm-1429	47	20	n	n	X
ajlm-1429	47	21	]	]	PUNCT
ajlm-1429	47	22	,	,	PUNCT
ajlm-1429	47	23	spike	spike	VERB
ajlm-1429	48	1	[	[	X
ajlm-1429	48	2	s	s	X
ajlm-1429	48	3	]	]	X
ajlm-1429	48	4	,	,	PUNCT
ajlm-1429	48	5	membrane	membrane	NOUN
ajlm-1429	49	1	[	[	X
ajlm-1429	49	2	m	m	X
ajlm-1429	49	3	]	]	X
ajlm-1429	49	4	,	,	PUNCT
ajlm-1429	49	5	open	open	ADJ
ajlm-1429	49	6	reading	reading	NOUN
ajlm-1429	49	7	frames	frame	NOUN
ajlm-1429	49	8	1a	1a	NOUN
ajlm-1429	49	9	and	and	CCONJ
ajlm-1429	49	10	1b	1b	NUM
ajlm-1429	50	1	[	[	X
ajlm-1429	50	2	orf1ab	orf1ab	X
ajlm-1429	50	3	]	]	X
ajlm-1429	50	4	,	,	PUNCT
ajlm-1429	50	5	rnase	rnase	PROPN
ajlm-1429	50	6	-	-	PUNCT
ajlm-1429	50	7	dependent	dependent	ADJ
ajlm-1429	50	8	rna	rna	NOUN
ajlm-1429	50	9	polymerase	polymerase	NOUN
ajlm-1429	51	1	[	[	X
ajlm-1429	51	2	rdrp	rdrp	NOUN
ajlm-1429	51	3	]	]	X
ajlm-1429	51	4	)	)	PUNCT
ajlm-1429	51	5	or	or	CCONJ
ajlm-1429	51	6	combination	combination	NOUN
ajlm-1429	51	7	of	of	ADP
ajlm-1429	51	8	genes	gene	NOUN
ajlm-1429	51	9	targeted	target	VERB
ajlm-1429	51	10	by	by	ADP
ajlm-1429	51	11	naat	naat	PROPN
ajlm-1429	51	12	are	be	AUX
ajlm-1429	51	13	inconsistent	inconsistent	ADJ
ajlm-1429	51	14	.	.	PUNCT
ajlm-1429	52	1	these	these	PRON
ajlm-1429	52	2	have	have	AUX
ajlm-1429	52	3	been	be	AUX
ajlm-1429	52	4	reported	report	VERB
ajlm-1429	52	5	to	to	PART
ajlm-1429	52	6	affect	affect	VERB
ajlm-1429	52	7	overall	overall	ADJ
ajlm-1429	52	8	assay	assay	NOUN
ajlm-1429	52	9	sensitivity	sensitivity	NOUN
ajlm-1429	52	10	and	and	CCONJ
ajlm-1429	52	11	specificity,13,14	specificity,13,14	ADV
ajlm-1429	52	12	and	and	CCONJ
ajlm-1429	52	13	may	may	AUX
ajlm-1429	52	14	also	also	ADV
ajlm-1429	52	15	be	be	AUX
ajlm-1429	52	16	impacted	impact	VERB
ajlm-1429	52	17	by	by	ADP
ajlm-1429	52	18	viral	viral	ADJ
ajlm-1429	52	19	genetic	genetic	ADJ
ajlm-1429	52	20	evolution	evolution	NOUN
ajlm-1429	52	21	that	that	PRON
ajlm-1429	52	22	can	can	AUX
ajlm-1429	52	23	affect	affect	VERB
ajlm-1429	52	24	gene	gene	NOUN
ajlm-1429	52	25	targets.15	targets.15	NOUN
ajlm-1429	52	26	furthermore	furthermore	ADV
ajlm-1429	52	27	,	,	PUNCT
ajlm-1429	52	28	there	there	PRON
ajlm-1429	52	29	is	be	VERB
ajlm-1429	52	30	the	the	DET
ajlm-1429	52	31	complex	complex	ADJ
ajlm-1429	52	32	layer	layer	NOUN
ajlm-1429	52	33	of	of	ADP
ajlm-1429	52	34	different	different	ADJ
ajlm-1429	52	35	diagnostic	diagnostic	ADJ
ajlm-1429	52	36	algorithms	algorithm	NOUN
ajlm-1429	52	37	implemented	implement	VERB
ajlm-1429	52	38	within	within	ADP
ajlm-1429	52	39	countries	country	NOUN
ajlm-1429	52	40	that	that	PRON
ajlm-1429	52	41	often	often	ADV
ajlm-1429	52	42	change	change	VERB
ajlm-1429	52	43	over	over	ADP
ajlm-1429	52	44	time	time	NOUN
ajlm-1429	52	45	.	.	PUNCT
ajlm-1429	53	1	for	for	ADP
ajlm-1429	53	2	example	example	NOUN
ajlm-1429	53	3	,	,	PUNCT
ajlm-1429	53	4	some	some	DET
ajlm-1429	53	5	settings	setting	NOUN
ajlm-1429	53	6	report	report	VERB
ajlm-1429	53	7	specimen	speciman	NOUN
ajlm-1429	53	8	results	result	VERB
ajlm-1429	53	9	based	base	VERB
ajlm-1429	53	10	on	on	ADP
ajlm-1429	53	11	a	a	DET
ajlm-1429	53	12	single	single	ADJ
ajlm-1429	53	13	gene	gene	NOUN
ajlm-1429	53	14	target	target	NOUN
ajlm-1429	53	15	,	,	PUNCT
ajlm-1429	53	16	while	while	SCONJ
ajlm-1429	53	17	others	other	NOUN
ajlm-1429	53	18	require	require	VERB
ajlm-1429	53	19	two	two	NUM
ajlm-1429	53	20	or	or	CCONJ
ajlm-1429	53	21	more	more	ADJ
ajlm-1429	53	22	gene	gene	NOUN
ajlm-1429	53	23	targets	target	NOUN
ajlm-1429	53	24	or	or	CCONJ
ajlm-1429	53	25	result	result	VERB
ajlm-1429	53	26	confirmation	confirmation	NOUN
ajlm-1429	53	27	by	by	ADP
ajlm-1429	53	28	a	a	DET
ajlm-1429	53	29	second	second	ADJ
ajlm-1429	53	30	naat	naat	NOUN
ajlm-1429	53	31	method	method	NOUN
ajlm-1429	53	32	using	use	VERB
ajlm-1429	53	33	a	a	DET
ajlm-1429	53	34	different	different	ADJ
ajlm-1429	53	35	gene	gene	NOUN
ajlm-1429	53	36	target	target	NOUN
ajlm-1429	53	37	.	.	PUNCT
ajlm-1429	54	1	automated	automate	VERB
ajlm-1429	54	2	software	software	NOUN
ajlm-1429	54	3	algorithms	algorithm	NOUN
ajlm-1429	54	4	are	be	AUX
ajlm-1429	54	5	not	not	PART
ajlm-1429	54	6	always	always	ADV
ajlm-1429	54	7	available	available	ADJ
ajlm-1429	54	8	for	for	ADP
ajlm-1429	54	9	all	all	DET
ajlm-1429	54	10	pcr	pcr	NOUN
ajlm-1429	54	11	platforms	platform	NOUN
ajlm-1429	54	12	,	,	PUNCT
ajlm-1429	54	13	and	and	CCONJ
ajlm-1429	54	14	result	result	VERB
ajlm-1429	54	15	analysis	analysis	NOUN
ajlm-1429	54	16	may	may	AUX
ajlm-1429	54	17	require	require	VERB
ajlm-1429	54	18	skilled	skilled	ADJ
ajlm-1429	54	19	user	user	NOUN
ajlm-1429	54	20	input	input	NOUN
ajlm-1429	54	21	(	(	PUNCT
ajlm-1429	54	22	e.g.	e.g.	ADV
ajlm-1429	54	23	visual	visual	ADJ
ajlm-1429	54	24	interpretation	interpretation	NOUN
ajlm-1429	54	25	of	of	ADP
ajlm-1429	54	26	amplification	amplification	NOUN
ajlm-1429	54	27	curves	curve	NOUN
ajlm-1429	54	28	or	or	CCONJ
ajlm-1429	54	29	adjustment	adjustment	NOUN
ajlm-1429	54	30	of	of	ADP
ajlm-1429	54	31	threshold	threshold	NOUN
ajlm-1429	54	32	settings	setting	NOUN
ajlm-1429	54	33	and	and	CCONJ
ajlm-1429	54	34	thus	thus	ADV
ajlm-1429	54	35	cycle	cycle	NOUN
ajlm-1429	54	36	thresholds	threshold	NOUN
ajlm-1429	54	37	[	[	X
ajlm-1429	54	38	ct	ct	X
ajlm-1429	54	39	]	]	X
ajlm-1429	54	40	)	)	PUNCT
ajlm-1429	54	41	.	.	PUNCT
ajlm-1429	55	1	this	this	PRON
ajlm-1429	55	2	adds	add	VERB
ajlm-1429	55	3	another	another	PRON
ajlm-1429	55	4	,	,	PUNCT
ajlm-1429	55	5	potentially	potentially	ADV
ajlm-1429	55	6	subjective	subjective	ADJ
ajlm-1429	55	7	,	,	PUNCT
ajlm-1429	55	8	layer	layer	NOUN
ajlm-1429	55	9	of	of	ADP
ajlm-1429	55	10	variability	variability	NOUN
ajlm-1429	55	11	.	.	PUNCT
ajlm-1429	56	1	challenges	challenge	NOUN
ajlm-1429	56	2	of	of	ADP
ajlm-1429	56	3	robust	robust	ADJ
ajlm-1429	56	4	and	and	CCONJ
ajlm-1429	56	5	rapid	rapid	ADJ
ajlm-1429	56	6	naat	naat	NOUN
ajlm-1429	56	7	evaluations	evaluation	NOUN
ajlm-1429	56	8	the	the	DET
ajlm-1429	56	9	complex	complex	ADJ
ajlm-1429	56	10	variables	variable	NOUN
ajlm-1429	56	11	described	describe	VERB
ajlm-1429	56	12	above	above	ADP
ajlm-1429	56	13	come	come	VERB
ajlm-1429	56	14	to	to	ADP
ajlm-1429	56	15	the	the	DET
ajlm-1429	56	16	fore	fore	NOUN
ajlm-1429	56	17	when	when	SCONJ
ajlm-1429	56	18	clear	clear	ADJ
ajlm-1429	56	19	,	,	PUNCT
ajlm-1429	56	20	comparative	comparative	ADJ
ajlm-1429	56	21	standardised	standardise	VERB
ajlm-1429	56	22	evaluations	evaluation	NOUN
ajlm-1429	56	23	are	be	AUX
ajlm-1429	56	24	conducted	conduct	VERB
ajlm-1429	56	25	.	.	PUNCT
ajlm-1429	57	1	such	such	ADJ
ajlm-1429	57	2	evaluations	evaluation	NOUN
ajlm-1429	57	3	generally	generally	ADV
ajlm-1429	57	4	had	have	VERB
ajlm-1429	57	5	to	to	PART
ajlm-1429	57	6	be	be	AUX
ajlm-1429	57	7	performed	perform	VERB
ajlm-1429	57	8	in	in	ADP
ajlm-1429	57	9	parallel	parallel	NOUN
ajlm-1429	57	10	with	with	ADP
ajlm-1429	57	11	managing	manage	VERB
ajlm-1429	57	12	covid-19	covid-19	PROPN
ajlm-1429	57	13	testing	testing	NOUN
ajlm-1429	57	14	emergencies	emergency	NOUN
ajlm-1429	57	15	.	.	PUNCT
ajlm-1429	58	1	in	in	ADP
ajlm-1429	58	2	our	our	PRON
ajlm-1429	58	3	case	case	NOUN
ajlm-1429	58	4	,	,	PUNCT
ajlm-1429	58	5	the	the	DET
ajlm-1429	58	6	most	most	ADV
ajlm-1429	58	7	challenging	challenging	ADJ
ajlm-1429	58	8	issue	issue	NOUN
ajlm-1429	58	9	experienced	experience	VERB
ajlm-1429	58	10	early	early	ADV
ajlm-1429	58	11	in	in	ADP
ajlm-1429	58	12	the	the	DET
ajlm-1429	58	13	pandemic	pandemic	NOUN
ajlm-1429	58	14	was	be	AUX
ajlm-1429	58	15	access	access	NOUN
ajlm-1429	58	16	to	to	ADP
ajlm-1429	58	17	sufficient	sufficient	ADJ
ajlm-1429	58	18	numbers	number	NOUN
ajlm-1429	58	19	of	of	ADP
ajlm-1429	58	20	relevant	relevant	ADJ
ajlm-1429	58	21	clinical	clinical	ADJ
ajlm-1429	58	22	specimens	specimen	NOUN
ajlm-1429	58	23	available	available	ADJ
ajlm-1429	58	24	for	for	ADP
ajlm-1429	58	25	inclusion	inclusion	NOUN
ajlm-1429	58	26	in	in	ADP
ajlm-1429	58	27	evaluation	evaluation	NOUN
ajlm-1429	58	28	challenge	challenge	NOUN
ajlm-1429	58	29	panels	panel	NOUN
ajlm-1429	58	30	.	.	PUNCT
ajlm-1429	59	1	the	the	DET
ajlm-1429	59	2	volume	volume	NOUN
ajlm-1429	59	3	of	of	ADP
ajlm-1429	59	4	extracted	extract	VERB
ajlm-1429	59	5	rna	rna	NOUN
ajlm-1429	59	6	per	per	ADP
ajlm-1429	59	7	specimen	speciman	NOUN
ajlm-1429	59	8	was	be	AUX
ajlm-1429	59	9	often	often	ADV
ajlm-1429	59	10	only	only	ADV
ajlm-1429	59	11	sufficient	sufficient	ADJ
ajlm-1429	59	12	to	to	PART
ajlm-1429	59	13	test	test	VERB
ajlm-1429	59	14	a	a	DET
ajlm-1429	59	15	limited	limited	ADJ
ajlm-1429	59	16	number	number	NOUN
ajlm-1429	59	17	of	of	ADP
ajlm-1429	59	18	naats	naat	NOUN
ajlm-1429	59	19	.	.	PUNCT
ajlm-1429	60	1	thus	thus	ADV
ajlm-1429	60	2	,	,	PUNCT
ajlm-1429	60	3	constant	constant	ADJ
ajlm-1429	60	4	panel	panel	NOUN
ajlm-1429	60	5	‘	'	PUNCT
ajlm-1429	60	6	manufacture	manufacture	NOUN
ajlm-1429	60	7	’	'	PUNCT
ajlm-1429	60	8	was	be	AUX
ajlm-1429	60	9	required	require	VERB
ajlm-1429	60	10	,	,	PUNCT
ajlm-1429	60	11	with	with	ADP
ajlm-1429	60	12	the	the	DET
ajlm-1429	60	13	potential	potential	NOUN
ajlm-1429	60	14	to	to	PART
ajlm-1429	60	15	introduce	introduce	VERB
ajlm-1429	60	16	variability	variability	NOUN
ajlm-1429	60	17	(	(	PUNCT
ajlm-1429	60	18	e.g.	e.g.	ADV
ajlm-1429	60	19	different	different	ADJ
ajlm-1429	60	20	specimens	specimen	NOUN
ajlm-1429	60	21	)	)	PUNCT
ajlm-1429	60	22	across	across	ADP
ajlm-1429	60	23	evaluations	evaluation	NOUN
ajlm-1429	60	24	.	.	PUNCT
ajlm-1429	61	1	the	the	DET
ajlm-1429	61	2	sample	sample	NOUN
ajlm-1429	61	3	size	size	NOUN
ajlm-1429	61	4	,	,	PUNCT
ajlm-1429	61	5	the	the	DET
ajlm-1429	61	6	numbers	number	NOUN
ajlm-1429	61	7	of	of	ADP
ajlm-1429	61	8	positive	positive	ADJ
ajlm-1429	61	9	and	and	CCONJ
ajlm-1429	61	10	negative	negative	ADJ
ajlm-1429	61	11	panel	panel	NOUN
ajlm-1429	61	12	specimens	specimen	NOUN
ajlm-1429	61	13	,	,	PUNCT
ajlm-1429	61	14	and	and	CCONJ
ajlm-1429	61	15	the	the	DET
ajlm-1429	61	16	range	range	NOUN
ajlm-1429	61	17	in	in	ADP
ajlm-1429	61	18	viral	viral	ADJ
ajlm-1429	61	19	concentration	concentration	NOUN
ajlm-1429	61	20	(	(	PUNCT
ajlm-1429	61	21	high	high	ADJ
ajlm-1429	61	22	,	,	PUNCT
ajlm-1429	61	23	medium	medium	ADJ
ajlm-1429	61	24	or	or	CCONJ
ajlm-1429	61	25	low	low	ADJ
ajlm-1429	61	26	)	)	PUNCT
ajlm-1429	61	27	of	of	ADP
ajlm-1429	61	28	challenge	challenge	NOUN
ajlm-1429	61	29	specimens	specimen	NOUN
ajlm-1429	61	30	may	may	AUX
ajlm-1429	61	31	influence	influence	VERB
ajlm-1429	61	32	sensitivity	sensitivity	NOUN
ajlm-1429	61	33	scores	score	NOUN
ajlm-1429	61	34	.	.	PUNCT
ajlm-1429	62	1	the	the	DET
ajlm-1429	62	2	last	last	ADJ
ajlm-1429	62	3	addresses	address	NOUN
ajlm-1429	62	4	the	the	DET
ajlm-1429	62	5	need	need	NOUN
ajlm-1429	62	6	for	for	SCONJ
ajlm-1429	62	7	assays	assay	NOUN
ajlm-1429	62	8	to	to	PART
ajlm-1429	62	9	correctly	correctly	ADV
ajlm-1429	62	10	identify	identify	VERB
ajlm-1429	62	11	differences	difference	NOUN
ajlm-1429	62	12	in	in	ADP
ajlm-1429	62	13	patient	patient	ADJ
ajlm-1429	62	14	risk	risk	NOUN
ajlm-1429	62	15	stratification	stratification	NOUN
ajlm-1429	62	16	:	:	PUNCT
ajlm-1429	62	17	while	while	SCONJ
ajlm-1429	62	18	there	there	PRON
ajlm-1429	62	19	does	do	AUX
ajlm-1429	62	20	not	not	PART
ajlm-1429	62	21	appear	appear	VERB
ajlm-1429	62	22	to	to	PART
ajlm-1429	62	23	be	be	AUX
ajlm-1429	62	24	a	a	DET
ajlm-1429	62	25	difference	difference	NOUN
ajlm-1429	62	26	in	in	ADP
ajlm-1429	62	27	median	median	PROPN
ajlm-1429	62	28	ct	ct	PROPN
ajlm-1429	62	29	between	between	ADP
ajlm-1429	62	30	symptomatic	symptomatic	ADJ
ajlm-1429	62	31	and	and	CCONJ
ajlm-1429	62	32	asymptomatic	asymptomatic	ADJ
ajlm-1429	62	33	patients,16	patients,16	VERB
ajlm-1429	62	34	a	a	DET
ajlm-1429	62	35	lower	low	ADJ
ajlm-1429	62	36	ct	ct	NOUN
ajlm-1429	62	37	(	(	PUNCT
ajlm-1429	62	38	higher	high	ADJ
ajlm-1429	62	39	viral	viral	ADJ
ajlm-1429	62	40	load	load	NOUN
ajlm-1429	62	41	[	[	X
ajlm-1429	62	42	vl	vl	X
ajlm-1429	62	43	]	]	X
ajlm-1429	62	44	)	)	PUNCT
ajlm-1429	62	45	in	in	ADP
ajlm-1429	62	46	real	real	ADJ
ajlm-1429	62	47	-	-	PUNCT
ajlm-1429	62	48	time	time	NOUN
ajlm-1429	62	49	pcr	pcr	ADJ
ajlm-1429	62	50	assays	assay	NOUN
ajlm-1429	62	51	may	may	AUX
ajlm-1429	62	52	indicate	indicate	VERB
ajlm-1429	62	53	increased	increase	VERB
ajlm-1429	62	54	virus	virus	NOUN
ajlm-1429	62	55	transmissibility16,17	transmissibility16,17	PROPN
ajlm-1429	62	56	and	and	CCONJ
ajlm-1429	62	57	may	may	AUX
ajlm-1429	62	58	impact	impact	VERB
ajlm-1429	62	59	patient	patient	ADJ
ajlm-1429	62	60	outcomes.17,18	outcomes.17,18	NOUN
ajlm-1429	62	61	the	the	DET
ajlm-1429	62	62	impact	impact	NOUN
ajlm-1429	62	63	of	of	ADP
ajlm-1429	62	64	sars	sar	NOUN
ajlm-1429	62	65	-	-	PUNCT
ajlm-1429	62	66	cov-2	cov-2	NOUN
ajlm-1429	62	67	variants	variant	NOUN
ajlm-1429	62	68	on	on	ADP
ajlm-1429	62	69	technologies15	technologies15	NOUN
ajlm-1429	62	70	should	should	AUX
ajlm-1429	62	71	also	also	ADV
ajlm-1429	62	72	be	be	AUX
ajlm-1429	62	73	considered	consider	VERB
ajlm-1429	62	74	,	,	PUNCT
ajlm-1429	62	75	as	as	SCONJ
ajlm-1429	62	76	specimens	specimen	NOUN
ajlm-1429	62	77	selected	select	VERB
ajlm-1429	62	78	from	from	ADP
ajlm-1429	62	79	waves	wave	NOUN
ajlm-1429	62	80	of	of	ADP
ajlm-1429	62	81	infection	infection	NOUN
ajlm-1429	62	82	driven	drive	VERB
ajlm-1429	62	83	by	by	ADP
ajlm-1429	62	84	different	different	ADJ
ajlm-1429	62	85	variants	variant	NOUN
ajlm-1429	62	86	could	could	AUX
ajlm-1429	62	87	affect	affect	VERB
ajlm-1429	62	88	the	the	DET
ajlm-1429	62	89	technology	technology	NOUN
ajlm-1429	62	90	(	(	PUNCT
ajlm-1429	62	91	e.g.	e.g.	ADV
ajlm-1429	62	92	s	s	NOUN
ajlm-1429	62	93	gene	gene	NOUN
ajlm-1429	62	94	target	target	NOUN
ajlm-1429	62	95	failure	failure	NOUN
ajlm-1429	62	96	of	of	ADP
ajlm-1429	62	97	the	the	DET
ajlm-1429	62	98	taqpath	taqpath	NOUN
ajlm-1429	62	99	sars	sar	NOUN
ajlm-1429	62	100	-	-	PUNCT
ajlm-1429	62	101	cov-2	cov-2	NOUN
ajlm-1429	62	102	assay	assay	VERB
ajlm-1429	62	103	[	[	X
ajlm-1429	62	104	thermo	thermo	NOUN
ajlm-1429	62	105	fisher	fisher	PROPN
ajlm-1429	62	106	scientific	scientific	PROPN
ajlm-1429	62	107	,	,	PUNCT
ajlm-1429	62	108	waltham	waltham	PROPN
ajlm-1429	62	109	,	,	PUNCT
ajlm-1429	62	110	massachusetts	massachusetts	PROPN
ajlm-1429	62	111	,	,	PUNCT
ajlm-1429	62	112	united	united	PROPN
ajlm-1429	62	113	states	states	PROPN
ajlm-1429	62	114	]	]	PUNCT
ajlm-1429	62	115	with	with	ADP
ajlm-1429	62	116	the	the	DET
ajlm-1429	62	117	alpha19	alpha19	NOUN
ajlm-1429	62	118	and	and	CCONJ
ajlm-1429	62	119	omicron20	omicron20	NOUN
ajlm-1429	62	120	variants	variant	NOUN
ajlm-1429	62	121	)	)	PUNCT
ajlm-1429	62	122	.	.	PUNCT
ajlm-1429	63	1	these	these	DET
ajlm-1429	63	2	challenges	challenge	NOUN
ajlm-1429	63	3	contribute	contribute	VERB
ajlm-1429	63	4	to	to	ADP
ajlm-1429	63	5	generating	generate	VERB
ajlm-1429	63	6	variability	variability	NOUN
ajlm-1429	63	7	in	in	ADP
ajlm-1429	63	8	the	the	DET
ajlm-1429	63	9	assay	assay	NOUN
ajlm-1429	63	10	performance	performance	NOUN
ajlm-1429	63	11	outcome	outcome	NOUN
ajlm-1429	63	12	and	and	CCONJ
ajlm-1429	63	13	may	may	AUX
ajlm-1429	63	14	make	make	VERB
ajlm-1429	63	15	the	the	DET
ajlm-1429	63	16	difference	difference	NOUN
ajlm-1429	63	17	between	between	ADP
ajlm-1429	63	18	accepting	accept	VERB
ajlm-1429	63	19	different	different	ADJ
ajlm-1429	63	20	assays	assay	NOUN
ajlm-1429	63	21	and	and	CCONJ
ajlm-1429	63	22	criteria	criterion	NOUN
ajlm-1429	63	23	.	.	PUNCT
ajlm-1429	64	1	false	false	ADJ
ajlm-1429	64	2	negative	negative	ADJ
ajlm-1429	64	3	results	result	NOUN
ajlm-1429	64	4	can	can	AUX
ajlm-1429	64	5	arise	arise	VERB
ajlm-1429	64	6	from	from	ADP
ajlm-1429	64	7	low	low	ADJ
ajlm-1429	64	8	levels	level	NOUN
ajlm-1429	64	9	of	of	ADP
ajlm-1429	64	10	virus	virus	NOUN
ajlm-1429	64	11	due	due	ADP
ajlm-1429	64	12	to	to	ADP
ajlm-1429	64	13	patient	patient	ADJ
ajlm-1429	64	14	or	or	CCONJ
ajlm-1429	64	15	sample	sample	NOUN
ajlm-1429	64	16	characteristics	characteristic	NOUN
ajlm-1429	64	17	(	(	PUNCT
ajlm-1429	64	18	i.e.	i.e.	X
ajlm-1429	64	19	either	either	CCONJ
ajlm-1429	64	20	biologically	biologically	ADV
ajlm-1429	64	21	or	or	CCONJ
ajlm-1429	64	22	artefactually	artefactually	ADV
ajlm-1429	64	23	)	)	PUNCT
ajlm-1429	64	24	,	,	PUNCT
ajlm-1429	64	25	degraded	degrade	VERB
ajlm-1429	64	26	viral	viral	ADJ
ajlm-1429	64	27	rna	rna	NOUN
ajlm-1429	64	28	,	,	PUNCT
ajlm-1429	64	29	viral	viral	ADJ
ajlm-1429	64	30	genetic	genetic	ADJ
ajlm-1429	64	31	variation	variation	NOUN
ajlm-1429	64	32	or	or	CCONJ
ajlm-1429	64	33	presence	presence	NOUN
ajlm-1429	64	34	of	of	ADP
ajlm-1429	64	35	inhibitors	inhibitor	NOUN
ajlm-1429	64	36	.	.	PUNCT
ajlm-1429	65	1	false	false	ADJ
ajlm-1429	65	2	positive	positive	ADJ
ajlm-1429	65	3	results	result	NOUN
ajlm-1429	65	4	can	can	AUX
ajlm-1429	65	5	arise	arise	VERB
ajlm-1429	65	6	from	from	ADP
ajlm-1429	65	7	inaccurate	inaccurate	ADJ
ajlm-1429	65	8	ct	ct	NUM
ajlm-1429	65	9	threshold	threshold	NOUN
ajlm-1429	65	10	settings	setting	NOUN
ajlm-1429	65	11	,	,	PUNCT
ajlm-1429	65	12	and	and	CCONJ
ajlm-1429	65	13	contamination	contamination	NOUN
ajlm-1429	65	14	during	during	ADP
ajlm-1429	65	15	processing	processing	NOUN
ajlm-1429	65	16	.	.	PUNCT
ajlm-1429	66	1	the	the	DET
ajlm-1429	66	2	correct	correct	ADJ
ajlm-1429	66	3	placement	placement	NOUN
ajlm-1429	66	4	of	of	ADP
ajlm-1429	66	5	naat	naat	PROPN
ajlm-1429	66	6	technologies	technology	NOUN
ajlm-1429	66	7	should	should	AUX
ajlm-1429	66	8	also	also	ADV
ajlm-1429	66	9	be	be	AUX
ajlm-1429	66	10	considered	consider	VERB
ajlm-1429	66	11	.	.	PUNCT
ajlm-1429	67	1	a	a	DET
ajlm-1429	67	2	less	less	ADV
ajlm-1429	67	3	sensitive	sensitive	ADJ
ajlm-1429	67	4	assay	assay	NOUN
ajlm-1429	67	5	may	may	AUX
ajlm-1429	67	6	be	be	AUX
ajlm-1429	67	7	valuable	valuable	ADJ
ajlm-1429	67	8	in	in	ADP
ajlm-1429	67	9	settings	setting	NOUN
ajlm-1429	67	10	that	that	PRON
ajlm-1429	67	11	receive	receive	VERB
ajlm-1429	67	12	specimens	specimen	NOUN
ajlm-1429	67	13	from	from	ADP
ajlm-1429	67	14	patients	patient	NOUN
ajlm-1429	67	15	with	with	ADP
ajlm-1429	67	16	high	high	ADJ
ajlm-1429	67	17	vl	vl	NOUN
ajlm-1429	67	18	concentrations	concentration	NOUN
ajlm-1429	67	19	(	(	PUNCT
ajlm-1429	67	20	low	low	ADJ
ajlm-1429	67	21	ct	ct	PROPN
ajlm-1429	67	22	values	value	NOUN
ajlm-1429	67	23	)	)	PUNCT
ajlm-1429	67	24	,	,	PUNCT
ajlm-1429	67	25	that	that	ADV
ajlm-1429	67	26	is	is	ADV
ajlm-1429	67	27	,	,	PUNCT
ajlm-1429	67	28	emergency	emergency	NOUN
ajlm-1429	67	29	settings	setting	NOUN
ajlm-1429	67	30	or	or	CCONJ
ajlm-1429	67	31	referral	referral	ADJ
ajlm-1429	67	32	centres	centre	NOUN
ajlm-1429	67	33	.	.	PUNCT
ajlm-1429	68	1	in	in	ADP
ajlm-1429	68	2	contrast	contrast	NOUN
ajlm-1429	68	3	,	,	PUNCT
ajlm-1429	68	4	community	community	NOUN
ajlm-1429	68	5	or	or	CCONJ
ajlm-1429	68	6	mobile	mobile	ADJ
ajlm-1429	68	7	screening	screening	NOUN
ajlm-1429	68	8	and	and	CCONJ
ajlm-1429	68	9	testing	testing	NOUN
ajlm-1429	68	10	sites	site	NOUN
ajlm-1429	68	11	will	will	AUX
ajlm-1429	68	12	require	require	VERB
ajlm-1429	68	13	assays	assay	NOUN
ajlm-1429	68	14	with	with	ADP
ajlm-1429	68	15	greater	great	ADJ
ajlm-1429	68	16	sensitivity	sensitivity	NOUN
ajlm-1429	68	17	.	.	PUNCT
ajlm-1429	69	1	in	in	ADP
ajlm-1429	69	2	addition	addition	NOUN
ajlm-1429	69	3	to	to	ADP
ajlm-1429	69	4	clinical	clinical	ADJ
ajlm-1429	69	5	specimens	specimen	NOUN
ajlm-1429	69	6	,	,	PUNCT
ajlm-1429	69	7	several	several	ADJ
ajlm-1429	69	8	types	type	NOUN
ajlm-1429	69	9	of	of	ADP
ajlm-1429	69	10	reference	reference	NOUN
ajlm-1429	69	11	materials	material	NOUN
ajlm-1429	69	12	(	(	PUNCT
ajlm-1429	69	13	plasmids	plasmid	NOUN
ajlm-1429	69	14	,	,	PUNCT
ajlm-1429	69	15	biomimetic	biomimetic	ADJ
ajlm-1429	69	16	standards	standard	NOUN
ajlm-1429	69	17	,	,	PUNCT
ajlm-1429	69	18	or	or	CCONJ
ajlm-1429	69	19	viable	viable	ADJ
ajlm-1429	69	20	,	,	PUNCT
ajlm-1429	69	21	inactivated	inactivated	ADJ
ajlm-1429	69	22	or	or	CCONJ
ajlm-1429	69	23	lysed	lyse	VERB
ajlm-1429	69	24	virus	virus	NOUN
ajlm-1429	69	25	)	)	PUNCT
ajlm-1429	69	26	have	have	AUX
ajlm-1429	69	27	become	become	VERB
ajlm-1429	69	28	commercially	commercially	ADV
ajlm-1429	69	29	available	available	ADJ
ajlm-1429	69	30	(	(	PUNCT
ajlm-1429	69	31	e.g.	e.g.	ADV
ajlm-1429	69	32	accuplex	accuplex	ADJ
ajlm-1429	69	33	™	™	ADJ
ajlm-1429	69	34	sars	sar	NOUN
ajlm-1429	69	35	-	-	PUNCT
ajlm-1429	69	36	cov-2	cov-2	PART
ajlm-1429	69	37	reference	reference	NOUN
ajlm-1429	69	38	material	material	NOUN
ajlm-1429	69	39	kit	kit	NOUN
ajlm-1429	70	1	[	[	X
ajlm-1429	70	2	seracare	seracare	NOUN
ajlm-1429	70	3	,	,	PUNCT
ajlm-1429	70	4	milford	milford	PROPN
ajlm-1429	70	5	,	,	PUNCT
ajlm-1429	70	6	massachusetts	massachusetts	PROPN
ajlm-1429	70	7	,	,	PUNCT
ajlm-1429	70	8	united	united	PROPN
ajlm-1429	70	9	states	states	PROPN
ajlm-1429	70	10	]	]	PUNCT
ajlm-1429	70	11	)	)	PUNCT
ajlm-1429	70	12	,	,	PUNCT
ajlm-1429	70	13	although	although	SCONJ
ajlm-1429	70	14	these	these	PRON
ajlm-1429	70	15	may	may	AUX
ajlm-1429	70	16	not	not	PART
ajlm-1429	70	17	always	always	ADV
ajlm-1429	70	18	be	be	AUX
ajlm-1429	70	19	compatible	compatible	ADJ
ajlm-1429	70	20	with	with	ADP
ajlm-1429	70	21	naat	naat	NOUN
ajlm-1429	70	22	primer	primer	NOUN
ajlm-1429	70	23	or	or	CCONJ
ajlm-1429	70	24	probe	probe	VERB
ajlm-1429	70	25	sequences	sequence	NOUN
ajlm-1429	70	26	.	.	PUNCT
ajlm-1429	71	1	access	access	NOUN
ajlm-1429	71	2	to	to	ADP
ajlm-1429	71	3	locally	locally	ADV
ajlm-1429	71	4	manufactured	manufacture	VERB
ajlm-1429	71	5	sars	sar	NOUN
ajlm-1429	71	6	-	-	PUNCT
ajlm-1429	71	7	cov-2	cov-2	NOUN
ajlm-1429	71	8	viral	viral	ADJ
ajlm-1429	71	9	culture	culture	NOUN
ajlm-1429	71	10	supernatant	supernatant	NOUN
ajlm-1429	71	11	is	be	AUX
ajlm-1429	71	12	an	an	DET
ajlm-1429	71	13	asset	asset	NOUN
ajlm-1429	71	14	to	to	ADP
ajlm-1429	71	15	expanding	expand	VERB
ajlm-1429	71	16	an	an	DET
ajlm-1429	71	17	evaluation	evaluation	NOUN
ajlm-1429	71	18	panel	panel	NOUN
ajlm-1429	71	19	,	,	PUNCT
ajlm-1429	71	20	independent	independent	ADJ
ajlm-1429	71	21	of	of	ADP
ajlm-1429	71	22	naat	naat	PROPN
ajlm-1429	71	23	target	target	NOUN
ajlm-1429	71	24	genes	gene	NOUN
ajlm-1429	71	25	.	.	PUNCT
ajlm-1429	72	1	culture	culture	NOUN
ajlm-1429	72	2	dilutions	dilution	NOUN
ajlm-1429	72	3	may	may	AUX
ajlm-1429	72	4	be	be	AUX
ajlm-1429	72	5	used	use	VERB
ajlm-1429	72	6	to	to	PART
ajlm-1429	72	7	measure	measure	VERB
ajlm-1429	72	8	assay	assay	NOUN
ajlm-1429	72	9	precision	precision	NOUN
ajlm-1429	72	10	,	,	PUNCT
ajlm-1429	72	11	linearity	linearity	NOUN
ajlm-1429	72	12	and	and	CCONJ
ajlm-1429	72	13	,	,	PUNCT
ajlm-1429	72	14	potentially	potentially	ADV
ajlm-1429	72	15	,	,	PUNCT
ajlm-1429	72	16	the	the	DET
ajlm-1429	72	17	limit	limit	NOUN
ajlm-1429	72	18	of	of	ADP
ajlm-1429	72	19	detection	detection	NOUN
ajlm-1429	72	20	.	.	PUNCT
ajlm-1429	73	1	another	another	DET
ajlm-1429	73	2	limitation	limitation	NOUN
ajlm-1429	73	3	is	be	AUX
ajlm-1429	73	4	often	often	ADV
ajlm-1429	73	5	kit	kit	NOUN
ajlm-1429	73	6	size	size	NOUN
ajlm-1429	73	7	,	,	PUNCT
ajlm-1429	73	8	where	where	SCONJ
ajlm-1429	73	9	only	only	ADV
ajlm-1429	73	10	a	a	DET
ajlm-1429	73	11	limited	limited	ADJ
ajlm-1429	73	12	number	number	NOUN
ajlm-1429	73	13	of	of	ADP
ajlm-1429	73	14	specimens	specimen	NOUN
ajlm-1429	73	15	can	can	AUX
ajlm-1429	73	16	be	be	AUX
ajlm-1429	73	17	tested	test	VERB
ajlm-1429	73	18	per	per	ADP
ajlm-1429	73	19	kit	kit	NOUN
ajlm-1429	73	20	supplied	supply	VERB
ajlm-1429	73	21	or	or	CCONJ
ajlm-1429	73	22	where	where	SCONJ
ajlm-1429	73	23	single	single	ADJ
ajlm-1429	73	24	-	-	PUNCT
ajlm-1429	73	25	plex	plex	ADJ
ajlm-1429	73	26	pcr	pcr	NOUN
ajlm-1429	73	27	assays	assay	NOUN
ajlm-1429	73	28	limit	limit	VERB
ajlm-1429	73	29	the	the	DET
ajlm-1429	73	30	number	number	NOUN
ajlm-1429	73	31	of	of	ADP
ajlm-1429	73	32	specimens	specimen	NOUN
ajlm-1429	73	33	in	in	ADP
ajlm-1429	73	34	a	a	DET
ajlm-1429	73	35	test	test	NOUN
ajlm-1429	73	36	run	run	NOUN
ajlm-1429	73	37	(	(	PUNCT
ajlm-1429	73	38	e.g.	e.g.	ADV
ajlm-1429	73	39	single	single	ADJ
ajlm-1429	73	40	-	-	PUNCT
ajlm-1429	73	41	plex	plex	NOUN
ajlm-1429	73	42	with	with	ADP
ajlm-1429	73	43	3	3	NUM
ajlm-1429	73	44	gene	gene	NOUN
ajlm-1429	73	45	targets	target	NOUN
ajlm-1429	73	46	can	can	AUX
ajlm-1429	73	47	only	only	ADV
ajlm-1429	73	48	assess	assess	VERB
ajlm-1429	73	49	32	32	NUM
ajlm-1429	73	50	specimens	specimen	NOUN
ajlm-1429	73	51	per	per	ADP
ajlm-1429	73	52	96	96	NUM
ajlm-1429	73	53	-	-	PUNCT
ajlm-1429	73	54	well	well	NOUN
ajlm-1429	73	55	rna	rna	NOUN
ajlm-1429	73	56	extraction	extraction	NOUN
ajlm-1429	73	57	plate	plate	NOUN
ajlm-1429	73	58	including	include	VERB
ajlm-1429	73	59	controls	control	NOUN
ajlm-1429	73	60	)	)	PUNCT
ajlm-1429	73	61	.	.	PUNCT
ajlm-1429	74	1	other	other	ADJ
ajlm-1429	74	2	considerations	consideration	NOUN
ajlm-1429	74	3	determined	determine	VERB
ajlm-1429	74	4	during	during	ADP
ajlm-1429	74	5	performance	performance	NOUN
ajlm-1429	74	6	evaluation	evaluation	NOUN
ajlm-1429	74	7	are	be	AUX
ajlm-1429	74	8	assay	assay	NOUN
ajlm-1429	74	9	ease	ease	NOUN
ajlm-1429	74	10	of	of	ADP
ajlm-1429	74	11	use	use	NOUN
ajlm-1429	74	12	,	,	PUNCT
ajlm-1429	74	13	time	time	NOUN
ajlm-1429	74	14	to	to	ADP
ajlm-1429	74	15	reportable	reportable	ADJ
ajlm-1429	74	16	result	result	NOUN
ajlm-1429	74	17	and	and	CCONJ
ajlm-1429	74	18	throughput	throughput	NOUN
ajlm-1429	74	19	.	.	PUNCT
ajlm-1429	75	1	general	general	ADJ
ajlm-1429	75	2	considerations	consideration	NOUN
ajlm-1429	75	3	,	,	PUNCT
ajlm-1429	75	4	often	often	ADV
ajlm-1429	75	5	listed	list	VERB
ajlm-1429	75	6	in	in	ADP
ajlm-1429	75	7	a	a	DET
ajlm-1429	75	8	tpp	tpp	NOUN
ajlm-1429	75	9	are	be	AUX
ajlm-1429	75	10	:	:	PUNCT
ajlm-1429	75	11	testing	test	VERB
ajlm-1429	75	12	footprint	footprint	NOUN
ajlm-1429	75	13	,	,	PUNCT
ajlm-1429	75	14	number	number	NOUN
ajlm-1429	75	15	of	of	ADP
ajlm-1429	75	16	testing	testing	NOUN
ajlm-1429	75	17	steps	step	NOUN
ajlm-1429	75	18	,	,	PUNCT
ajlm-1429	75	19	operator	operator	NOUN
ajlm-1429	75	20	skills	skill	NOUN
ajlm-1429	75	21	required	require	VERB
ajlm-1429	75	22	to	to	PART
ajlm-1429	75	23	perform	perform	VERB
ajlm-1429	75	24	the	the	DET
ajlm-1429	75	25	test	test	NOUN
ajlm-1429	75	26	,	,	PUNCT
ajlm-1429	75	27	minimum	minimum	ADJ
ajlm-1429	75	28	pipetting	pipetting	NOUN
ajlm-1429	75	29	volume	volume	NOUN
ajlm-1429	75	30	,	,	PUNCT
ajlm-1429	75	31	biosafety	biosafety	NOUN
ajlm-1429	75	32	requirements	requirement	NOUN
ajlm-1429	75	33	,	,	PUNCT
ajlm-1429	75	34	internal	internal	ADJ
ajlm-1429	75	35	controls	control	NOUN
ajlm-1429	75	36	,	,	PUNCT
ajlm-1429	75	37	positive	positive	ADJ
ajlm-1429	75	38	and	and	CCONJ
ajlm-1429	75	39	negative	negative	ADJ
ajlm-1429	75	40	batch	batch	NOUN
ajlm-1429	75	41	controls	control	NOUN
ajlm-1429	75	42	,	,	PUNCT
ajlm-1429	75	43	reagent	reagent	ADJ
ajlm-1429	75	44	storage	storage	NOUN
ajlm-1429	75	45	stability	stability	NOUN
ajlm-1429	75	46	,	,	PUNCT
ajlm-1429	75	47	reagent	reagent	ADJ
ajlm-1429	75	48	reconstitution	reconstitution	NOUN
ajlm-1429	75	49	required	require	VERB
ajlm-1429	75	50	,	,	PUNCT
ajlm-1429	75	51	training	training	NOUN
ajlm-1429	75	52	needs	need	NOUN
ajlm-1429	75	53	,	,	PUNCT
ajlm-1429	75	54	maintenance	maintenance	NOUN
ajlm-1429	75	55	,	,	PUNCT
ajlm-1429	75	56	additional	additional	ADJ
ajlm-1429	75	57	consumables	consumable	NOUN
ajlm-1429	75	58	and	and	CCONJ
ajlm-1429	75	59	connectivity	connectivity	NOUN
ajlm-1429	75	60	options	option	NOUN
ajlm-1429	75	61	,	,	PUNCT
ajlm-1429	75	62	to	to	PART
ajlm-1429	75	63	name	name	VERB
ajlm-1429	75	64	a	a	DET
ajlm-1429	75	65	few	few	ADJ
ajlm-1429	75	66	.	.	PUNCT
ajlm-1429	76	1	moreover	moreover	ADV
ajlm-1429	76	2	,	,	PUNCT
ajlm-1429	76	3	it	it	PRON
ajlm-1429	76	4	is	be	AUX
ajlm-1429	76	5	important	important	ADJ
ajlm-1429	76	6	to	to	PART
ajlm-1429	76	7	select	select	VERB
ajlm-1429	76	8	suitable	suitable	ADJ
ajlm-1429	76	9	comparator	comparator	NOUN
ajlm-1429	76	10	technology	technology	NOUN
ajlm-1429	76	11	,	,	PUNCT
ajlm-1429	76	12	a	a	DET
ajlm-1429	76	13	limitation	limitation	NOUN
ajlm-1429	76	14	also	also	ADV
ajlm-1429	76	15	described	describe	VERB
ajlm-1429	76	16	by	by	ADP
ajlm-1429	76	17	axell	axell	PROPN
ajlm-1429	76	18	-	-	PUNCT
ajlm-1429	76	19	house	house	PROPN
ajlm-1429	76	20	et	et	PROPN
ajlm-1429	76	21	al.21	al.21	PROPN
ajlm-1429	76	22	this	this	PRON
ajlm-1429	76	23	may	may	AUX
ajlm-1429	76	24	be	be	AUX
ajlm-1429	76	25	based	base	VERB
ajlm-1429	76	26	on	on	ADP
ajlm-1429	76	27	who	who	PRON
ajlm-1429	76	28	recommendations	recommendation	VERB
ajlm-1429	76	29	,	,	PUNCT
ajlm-1429	76	30	or	or	CCONJ
ajlm-1429	76	31	,	,	PUNCT
ajlm-1429	76	32	under	under	ADP
ajlm-1429	76	33	emergency	emergency	NOUN
ajlm-1429	76	34	use	use	NOUN
ajlm-1429	76	35	,	,	PUNCT
ajlm-1429	76	36	current	current	ADJ
ajlm-1429	76	37	in	in	ADP
ajlm-1429	76	38	-	-	PUNCT
ajlm-1429	76	39	county	county	NOUN
ajlm-1429	76	40	methodology	methodology	NOUN
ajlm-1429	76	41	already	already	ADV
ajlm-1429	76	42	approved	approve	VERB
ajlm-1429	76	43	for	for	ADP
ajlm-1429	76	44	standard	standard	NOUN
ajlm-1429	76	45	of	of	ADP
ajlm-1429	76	46	care	care	NOUN
ajlm-1429	76	47	(	(	PUNCT
ajlm-1429	76	48	soc	soc	NOUN
ajlm-1429	76	49	)	)	PUNCT
ajlm-1429	76	50	.	.	PUNCT
ajlm-1429	77	1	in	in	ADP
ajlm-1429	77	2	our	our	PRON
ajlm-1429	77	3	case	case	NOUN
ajlm-1429	77	4	,	,	PUNCT
ajlm-1429	77	5	at	at	ADP
ajlm-1429	77	6	least	least	ADJ
ajlm-1429	77	7	seven	seven	NUM
ajlm-1429	77	8	soc	soc	NOUN
ajlm-1429	77	9	technologies	technology	NOUN
ajlm-1429	77	10	are	be	AUX
ajlm-1429	77	11	in	in	ADP
ajlm-1429	77	12	use	use	NOUN
ajlm-1429	77	13	to	to	PART
ajlm-1429	77	14	report	report	VERB
ajlm-1429	77	15	patient	patient	ADJ
ajlm-1429	77	16	results	result	NOUN
ajlm-1429	77	17	across	across	ADP
ajlm-1429	77	18	south	south	PROPN
ajlm-1429	77	19	africa	africa	PROPN
ajlm-1429	77	20	,	,	PUNCT
ajlm-1429	77	21	and	and	CCONJ
ajlm-1429	77	22	residual	residual	ADJ
ajlm-1429	77	23	specimens	specimen	NOUN
ajlm-1429	77	24	from	from	ADP
ajlm-1429	77	25	these	these	DET
ajlm-1429	77	26	assays	assay	NOUN
ajlm-1429	77	27	were	be	AUX
ajlm-1429	77	28	available	available	ADJ
ajlm-1429	77	29	for	for	ADP
ajlm-1429	77	30	challenge	challenge	NOUN
ajlm-1429	77	31	panels	panel	NOUN
ajlm-1429	77	32	.	.	PUNCT
ajlm-1429	78	1	the	the	DET
ajlm-1429	78	2	goal	goal	NOUN
ajlm-1429	78	3	of	of	ADP
ajlm-1429	78	4	performance	performance	NOUN
ajlm-1429	78	5	evaluation	evaluation	NOUN
ajlm-1429	78	6	is	be	AUX
ajlm-1429	78	7	to	to	PART
ajlm-1429	78	8	determine	determine	VERB
ajlm-1429	78	9	whether	whether	SCONJ
ajlm-1429	78	10	a	a	DET
ajlm-1429	78	11	new	new	ADJ
ajlm-1429	78	12	method	method	NOUN
ajlm-1429	78	13	or	or	CCONJ
ajlm-1429	78	14	technology	technology	NOUN
ajlm-1429	78	15	is	be	AUX
ajlm-1429	78	16	as	as	ADV
ajlm-1429	78	17	good	good	ADJ
ajlm-1429	78	18	as	as	ADP
ajlm-1429	78	19	soc	soc	NOUN
ajlm-1429	78	20	and	and	CCONJ
ajlm-1429	78	21	use	use	NOUN
ajlm-1429	78	22	thereof	thereof	ADV
ajlm-1429	78	23	will	will	AUX
ajlm-1429	78	24	not	not	PART
ajlm-1429	78	25	alter	alter	VERB
ajlm-1429	78	26	patient	patient	ADJ
ajlm-1429	78	27	care	care	NOUN
ajlm-1429	78	28	.	.	PUNCT
ajlm-1429	79	1	however	however	ADV
ajlm-1429	79	2	,	,	PUNCT
ajlm-1429	79	3	this	this	PRON
ajlm-1429	79	4	does	do	AUX
ajlm-1429	79	5	pose	pose	VERB
ajlm-1429	79	6	a	a	DET
ajlm-1429	79	7	challenge	challenge	NOUN
ajlm-1429	79	8	if	if	SCONJ
ajlm-1429	79	9	soc	soc	NOUN
ajlm-1429	79	10	specimens	specimen	NOUN
ajlm-1429	79	11	are	be	AUX
ajlm-1429	79	12	in	in	ADP
ajlm-1429	79	13	a	a	DET
ajlm-1429	79	14	different	different	ADJ
ajlm-1429	79	15	format	format	NOUN
ajlm-1429	79	16	or	or	CCONJ
ajlm-1429	79	17	rna	rna	NOUN
ajlm-1429	79	18	degrades	degrade	VERB
ajlm-1429	79	19	during	during	ADP
ajlm-1429	79	20	specimen	speciman	NOUN
ajlm-1429	79	21	storage	storage	NOUN
ajlm-1429	79	22	.	.	PUNCT
ajlm-1429	80	1	our	our	PRON
ajlm-1429	80	2	group	group	NOUN
ajlm-1429	80	3	obtained	obtain	VERB
ajlm-1429	80	4	institutional	institutional	ADJ
ajlm-1429	80	5	review	review	NOUN
ajlm-1429	80	6	board	board	NOUN
ajlm-1429	80	7	approval	approval	NOUN
ajlm-1429	80	8	to	to	PART
ajlm-1429	80	9	use	use	VERB
ajlm-1429	80	10	residual	residual	ADJ
ajlm-1429	80	11	patient	patient	ADJ
ajlm-1429	80	12	specimens	specimen	NOUN
ajlm-1429	80	13	for	for	ADP
ajlm-1429	80	14	evaluations	evaluation	NOUN
ajlm-1429	80	15	with	with	ADP
ajlm-1429	80	16	an	an	DET
ajlm-1429	80	17	informed	informed	ADJ
ajlm-1429	80	18	consent	consent	NOUN
ajlm-1429	80	19	waiver	waiver	NOUN
ajlm-1429	80	20	.	.	PUNCT
ajlm-1429	81	1	where	where	SCONJ
ajlm-1429	81	2	fresh	fresh	ADJ
ajlm-1429	81	3	or	or	CCONJ
ajlm-1429	81	4	paired	pair	VERB
ajlm-1429	81	5	specimens	specimen	NOUN
ajlm-1429	81	6	were	be	AUX
ajlm-1429	81	7	needed	need	VERB
ajlm-1429	81	8	,	,	PUNCT
ajlm-1429	81	9	a	a	DET
ajlm-1429	81	10	full	full	ADJ
ajlm-1429	81	11	clinical	clinical	ADJ
ajlm-1429	81	12	trial	trial	NOUN
ajlm-1429	81	13	was	be	AUX
ajlm-1429	81	14	required	require	VERB
ajlm-1429	81	15	with	with	ADP
ajlm-1429	81	16	informed	informed	ADJ
ajlm-1429	81	17	consent	consent	NOUN
ajlm-1429	81	18	,	,	PUNCT
ajlm-1429	81	19	which	which	PRON
ajlm-1429	81	20	increased	increase	VERB
ajlm-1429	81	21	the	the	DET
ajlm-1429	81	22	time	time	NOUN
ajlm-1429	81	23	needed	need	VERB
ajlm-1429	81	24	and	and	CCONJ
ajlm-1429	81	25	cost	cost	NOUN
ajlm-1429	81	26	of	of	ADP
ajlm-1429	81	27	evaluations	evaluation	NOUN
ajlm-1429	81	28	.	.	PUNCT
ajlm-1429	82	1	once	once	ADV
ajlm-1429	82	2	an	an	DET
ajlm-1429	82	3	evaluation	evaluation	NOUN
ajlm-1429	82	4	is	be	AUX
ajlm-1429	82	5	completed	complete	VERB
ajlm-1429	82	6	,	,	PUNCT
ajlm-1429	82	7	method	method	ADJ
ajlm-1429	82	8	comparison	comparison	NOUN
ajlm-1429	82	9	involves	involve	VERB
ajlm-1429	82	10	determining	determine	VERB
ajlm-1429	82	11	accuracy	accuracy	NOUN
ajlm-1429	82	12	(	(	PUNCT
ajlm-1429	82	13	sensitivity	sensitivity	NOUN
ajlm-1429	82	14	and	and	CCONJ
ajlm-1429	82	15	specificity	specificity	NOUN
ajlm-1429	82	16	)	)	PUNCT
ajlm-1429	82	17	or	or	CCONJ
ajlm-1429	82	18	agreement	agreement	NOUN
ajlm-1429	82	19	,	,	PUNCT
ajlm-1429	82	20	precision	precision	NOUN
ajlm-1429	82	21	(	(	PUNCT
ajlm-1429	82	22	reproducibility	reproducibility	NOUN
ajlm-1429	82	23	)	)	PUNCT
ajlm-1429	82	24	,	,	PUNCT
ajlm-1429	82	25	linearity	linearity	NOUN
ajlm-1429	82	26	and	and	CCONJ
ajlm-1429	82	27	limit	limit	NOUN
ajlm-1429	82	28	of	of	ADP
ajlm-1429	82	29	detection	detection	NOUN
ajlm-1429	82	30	.	.	PUNCT
ajlm-1429	83	1	recommendations	recommendation	NOUN
ajlm-1429	83	2	are	be	AUX
ajlm-1429	83	3	made	make	VERB
ajlm-1429	83	4	based	base	VERB
ajlm-1429	83	5	on	on	ADP
ajlm-1429	83	6	analytical	analytical	ADJ
ajlm-1429	83	7	performance	performance	NOUN
ajlm-1429	83	8	,	,	PUNCT
ajlm-1429	83	9	as	as	ADV
ajlm-1429	83	10	well	well	ADV
ajlm-1429	83	11	as	as	ADP
ajlm-1429	83	12	ease	ease	NOUN
ajlm-1429	83	13	of	of	ADP
ajlm-1429	83	14	use	use	NOUN
ajlm-1429	83	15	.	.	PUNCT
ajlm-1429	84	1	in	in	ADP
ajlm-1429	84	2	the	the	DET
ajlm-1429	84	3	absence	absence	NOUN
ajlm-1429	84	4	of	of	ADP
ajlm-1429	84	5	acceptance	acceptance	NOUN
ajlm-1429	84	6	criteria	criterion	NOUN
ajlm-1429	84	7	guidelines	guideline	NOUN
ajlm-1429	84	8	,	,	PUNCT
ajlm-1429	84	9	we	we	PRON
ajlm-1429	84	10	investigated	investigate	VERB
ajlm-1429	84	11	these	these	DET
ajlm-1429	84	12	parameters	parameter	NOUN
ajlm-1429	84	13	for	for	ADP
ajlm-1429	84	14	an	an	DET
ajlm-1429	84	15	initial	initial	ADJ
ajlm-1429	84	16	24	24	NUM
ajlm-1429	84	17	assays	assay	NOUN
ajlm-1429	84	18	using	use	VERB
ajlm-1429	84	19	a	a	DET
ajlm-1429	84	20	standardised	standardised	ADJ
ajlm-1429	84	21	evaluation	evaluation	NOUN
ajlm-1429	84	22	protocol	protocol	NOUN
ajlm-1429	84	23	approach	approach	NOUN
ajlm-1429	84	24	as	as	SCONJ
ajlm-1429	84	25	described	describe	VERB
ajlm-1429	84	26	in	in	ADP
ajlm-1429	84	27	table	table	NOUN
ajlm-1429	84	28	1	1	NUM
ajlm-1429	84	29	.	.	PUNCT
ajlm-1429	85	1	over	over	ADP
ajlm-1429	85	2	and	and	CCONJ
ajlm-1429	85	3	above	above	ADP
ajlm-1429	85	4	the	the	DET
ajlm-1429	85	5	already	already	ADV
ajlm-1429	85	6	mentioned	mention	VERB
ajlm-1429	85	7	complexities	complexity	NOUN
ajlm-1429	85	8	and	and	CCONJ
ajlm-1429	85	9	challenges	challenge	NOUN
ajlm-1429	85	10	,	,	PUNCT
ajlm-1429	85	11	it	it	PRON
ajlm-1429	85	12	became	become	VERB
ajlm-1429	85	13	apparent	apparent	ADJ
ajlm-1429	85	14	that	that	SCONJ
ajlm-1429	85	15	single	single	ADJ
ajlm-1429	85	16	method	method	NOUN
ajlm-1429	85	17	comparison	comparison	NOUN
ajlm-1429	85	18	acceptance	acceptance	NOUN
ajlm-1429	85	19	criteria	criterion	NOUN
ajlm-1429	85	20	might	might	AUX
ajlm-1429	85	21	not	not	PART
ajlm-1429	85	22	be	be	AUX
ajlm-1429	85	23	applicable	applicable	ADJ
ajlm-1429	85	24	to	to	ADP
ajlm-1429	85	25	all	all	DET
ajlm-1429	85	26	assays	assay	NOUN
ajlm-1429	85	27	.	.	PUNCT
ajlm-1429	86	1	we	we	PRON
ajlm-1429	86	2	identified	identify	VERB
ajlm-1429	86	3	four	four	NUM
ajlm-1429	86	4	types	type	NOUN
ajlm-1429	86	5	or	or	CCONJ
ajlm-1429	86	6	categories	category	NOUN
ajlm-1429	86	7	of	of	ADP
ajlm-1429	86	8	assays	assay	NOUN
ajlm-1429	86	9	submitted	submit	VERB
ajlm-1429	86	10	for	for	ADP
ajlm-1429	86	11	evaluation	evaluation	NOUN
ajlm-1429	86	12	:	:	PUNCT
ajlm-1429	86	13	(	(	PUNCT
ajlm-1429	86	14	1	1	X
ajlm-1429	86	15	)	)	PUNCT
ajlm-1429	86	16	closed	closed	ADJ
ajlm-1429	86	17	systems	system	NOUN
ajlm-1429	86	18	(	(	PUNCT
ajlm-1429	86	19	incorporating	incorporate	VERB
ajlm-1429	86	20	rna	rna	NOUN
ajlm-1429	86	21	extraction	extraction	NOUN
ajlm-1429	86	22	and	and	CCONJ
ajlm-1429	86	23	naat	naat	PROPN
ajlm-1429	86	24	)	)	PUNCT
ajlm-1429	86	25	,	,	PUNCT
ajlm-1429	86	26	(	(	PUNCT
ajlm-1429	86	27	2	2	X
ajlm-1429	86	28	)	)	PUNCT
ajlm-1429	86	29	standalone	standalone	ADJ
ajlm-1429	86	30	pcr	pcr	ADJ
ajlm-1429	86	31	kits	kit	NOUN
ajlm-1429	86	32	to	to	PART
ajlm-1429	86	33	be	be	AUX
ajlm-1429	86	34	performed	perform	VERB
ajlm-1429	86	35	off	off	ADP
ajlm-1429	86	36	already	already	ADV
ajlm-1429	86	37	purified	purify	VERB
ajlm-1429	86	38	rna	rna	NOUN
ajlm-1429	86	39	,	,	PUNCT
ajlm-1429	86	40	(	(	PUNCT
ajlm-1429	86	41	3	3	X
ajlm-1429	86	42	)	)	PUNCT
ajlm-1429	86	43	direct	direct	ADJ
ajlm-1429	86	44	lyse	lyse	NOUN
ajlm-1429	86	45	-	-	PUNCT
ajlm-1429	86	46	to	to	ADP
ajlm-1429	86	47	-	-	PUNCT
ajlm-1429	86	48	pcr	pcr	NOUN
ajlm-1429	86	49	,	,	PUNCT
ajlm-1429	86	50	where	where	SCONJ
ajlm-1429	86	51	no	no	DET
ajlm-1429	86	52	front	front	ADJ
ajlm-1429	86	53	-	-	PUNCT
ajlm-1429	86	54	end	end	NOUN
ajlm-1429	86	55	rna	rna	NOUN
ajlm-1429	86	56	purification	purification	NOUN
ajlm-1429	86	57	or	or	CCONJ
ajlm-1429	86	58	extraction	extraction	NOUN
ajlm-1429	86	59	is	be	AUX
ajlm-1429	86	60	available	available	ADJ
ajlm-1429	86	61	or	or	CCONJ
ajlm-1429	86	62	where	where	SCONJ
ajlm-1429	86	63	there	there	PRON
ajlm-1429	86	64	is	be	VERB
ajlm-1429	86	65	a	a	DET
ajlm-1429	86	66	need	need	NOUN
ajlm-1429	86	67	for	for	ADP
ajlm-1429	86	68	rapid	rapid	ADJ
ajlm-1429	86	69	testing	testing	NOUN
ajlm-1429	86	70	,	,	PUNCT
ajlm-1429	86	71	and	and	CCONJ
ajlm-1429	86	72	(	(	PUNCT
ajlm-1429	86	73	4	4	X
ajlm-1429	86	74	)	)	PUNCT
ajlm-1429	86	75	standalone	standalone	NOUN
ajlm-1429	86	76	rna	rna	NOUN
ajlm-1429	86	77	extraction	extraction	NOUN
ajlm-1429	86	78	or	or	CCONJ
ajlm-1429	86	79	purification	purification	NOUN
ajlm-1429	86	80	kits	kit	NOUN
ajlm-1429	86	81	.	.	PUNCT
ajlm-1429	87	1	the	the	DET
ajlm-1429	87	2	24	24	NUM
ajlm-1429	87	3	assays	assay	NOUN
ajlm-1429	87	4	were	be	AUX
ajlm-1429	87	5	among	among	ADP
ajlm-1429	87	6	groups	group	NOUN
ajlm-1429	87	7	1	1	NUM
ajlm-1429	87	8	(	(	PUNCT
ajlm-1429	87	9	n	n	NOUN
ajlm-1429	87	10	=	=	SYM
ajlm-1429	87	11	9	9	NUM
ajlm-1429	87	12	)	)	PUNCT
ajlm-1429	87	13	,	,	PUNCT
ajlm-1429	87	14	2	2	NUM
ajlm-1429	87	15	(	(	PUNCT
ajlm-1429	87	16	n	n	NOUN
ajlm-1429	87	17	=	=	NUM
ajlm-1429	87	18	12	12	NUM
ajlm-1429	87	19	)	)	PUNCT
ajlm-1429	87	20	and	and	CCONJ
ajlm-1429	87	21	3	3	NUM
ajlm-1429	87	22	(	(	PUNCT
ajlm-1429	87	23	n	n	NOUN
ajlm-1429	87	24	=	=	SYM
ajlm-1429	87	25	3	3	NUM
ajlm-1429	87	26	)	)	PUNCT
ajlm-1429	87	27	,	,	PUNCT
ajlm-1429	87	28	with	with	ADP
ajlm-1429	87	29	the	the	DET
ajlm-1429	87	30	predominant	predominant	ADJ
ajlm-1429	87	31	viral	viral	ADJ
ajlm-1429	87	32	gene	gene	NOUN
ajlm-1429	87	33	targets	target	NOUN
ajlm-1429	87	34	being	be	AUX
ajlm-1429	87	35	n	n	PRON
ajlm-1429	87	36	(	(	PUNCT
ajlm-1429	87	37	35.0	35.0	NUM
ajlm-1429	87	38	%	%	NOUN
ajlm-1429	87	39	)	)	PUNCT
ajlm-1429	87	40	,	,	PUNCT
ajlm-1429	87	41	followed	follow	VERB
ajlm-1429	87	42	by	by	ADP
ajlm-1429	87	43	orf1ab	orf1ab	PROPN
ajlm-1429	87	44	(	(	PUNCT
ajlm-1429	87	45	25.0	25.0	NUM
ajlm-1429	87	46	%	%	NOUN
ajlm-1429	87	47	)	)	PUNCT
ajlm-1429	87	48	,	,	PUNCT
ajlm-1429	87	49	e	e	X
ajlm-1429	87	50	(	(	PUNCT
ajlm-1429	87	51	20	20	NUM
ajlm-1429	87	52	%	%	NOUN
ajlm-1429	87	53	)	)	PUNCT
ajlm-1429	87	54	,	,	PUNCT
ajlm-1429	87	55	s	s	X
ajlm-1429	87	56	(	(	PUNCT
ajlm-1429	87	57	10.0	10.0	NUM
ajlm-1429	87	58	%	%	NOUN
ajlm-1429	87	59	)	)	PUNCT
ajlm-1429	87	60	and	and	CCONJ
ajlm-1429	87	61	rdrp	rdrp	NOUN
ajlm-1429	87	62	(	(	PUNCT
ajlm-1429	87	63	10.0	10.0	NUM
ajlm-1429	87	64	%	%	NOUN
ajlm-1429	87	65	)	)	PUNCT
ajlm-1429	87	66	.	.	PUNCT
ajlm-1429	88	1	a	a	DET
ajlm-1429	88	2	sensitivity	sensitivity	NOUN
ajlm-1429	88	3	score	score	NOUN
ajlm-1429	88	4	of	of	ADP
ajlm-1429	88	5	>	>	SYM
ajlm-1429	88	6	90	90	NUM
ajlm-1429	88	7	%	%	NOUN
ajlm-1429	88	8	was	be	AUX
ajlm-1429	88	9	achieved	achieve	VERB
ajlm-1429	88	10	by	by	ADP
ajlm-1429	88	11	62.5	62.5	NUM
ajlm-1429	88	12	%	%	NOUN
ajlm-1429	88	13	(	(	PUNCT
ajlm-1429	88	14	15/24	15/24	NUM
ajlm-1429	88	15	)	)	PUNCT
ajlm-1429	88	16	of	of	ADP
ajlm-1429	88	17	assays	assay	NOUN
ajlm-1429	88	18	and	and	CCONJ
ajlm-1429	88	19	>	>	X
ajlm-1429	88	20	95	95	NUM
ajlm-1429	88	21	%	%	NOUN
ajlm-1429	88	22	sensitivity	sensitivity	NOUN
ajlm-1429	88	23	achieved	achieve	VERB
ajlm-1429	88	24	by	by	ADP
ajlm-1429	88	25	37.5	37.5	NUM
ajlm-1429	88	26	%	%	NOUN
ajlm-1429	88	27	(	(	PUNCT
ajlm-1429	88	28	9/24	9/24	NUM
ajlm-1429	88	29	)	)	PUNCT
ajlm-1429	88	30	compared	compare	VERB
ajlm-1429	88	31	to	to	ADP
ajlm-1429	88	32	soc	soc	NOUN
ajlm-1429	88	33	.	.	PUNCT
ajlm-1429	89	1	those	those	PRON
ajlm-1429	89	2	that	that	PRON
ajlm-1429	89	3	employ	employ	VERB
ajlm-1429	89	4	direct	direct	ADJ
ajlm-1429	89	5	lyse	lyse	NOUN
ajlm-1429	89	6	-	-	PUNCT
ajlm-1429	89	7	to	to	ADP
ajlm-1429	89	8	-	-	PUNCT
ajlm-1429	89	9	pcr	pcr	NOUN
ajlm-1429	89	10	(	(	PUNCT
ajlm-1429	89	11	group	group	NOUN
ajlm-1429	89	12	3	3	NUM
ajlm-1429	89	13	)	)	PUNCT
ajlm-1429	89	14	were	be	AUX
ajlm-1429	89	15	below	below	ADP
ajlm-1429	89	16	the	the	DET
ajlm-1429	89	17	acceptance	acceptance	NOUN
ajlm-1429	89	18	criteria	criterion	NOUN
ajlm-1429	89	19	by	by	ADP
ajlm-1429	89	20	at	at	ADV
ajlm-1429	89	21	least	least	ADV
ajlm-1429	89	22	a	a	DET
ajlm-1429	89	23	20	20	NUM
ajlm-1429	89	24	%	%	NOUN
ajlm-1429	89	25	drop	drop	NOUN
ajlm-1429	89	26	in	in	ADP
ajlm-1429	89	27	median	median	ADJ
ajlm-1429	89	28	sensitivity	sensitivity	NOUN
ajlm-1429	89	29	(	(	PUNCT
ajlm-1429	89	30	72.0	72.0	NUM
ajlm-1429	89	31	%	%	NOUN
ajlm-1429	89	32	)	)	PUNCT
ajlm-1429	89	33	compared	compare	VERB
ajlm-1429	89	34	to	to	ADP
ajlm-1429	89	35	the	the	DET
ajlm-1429	89	36	median	median	ADJ
ajlm-1429	89	37	sensitivity	sensitivity	NOUN
ajlm-1429	89	38	in	in	ADP
ajlm-1429	89	39	group	group	NOUN
ajlm-1429	89	40	1	1	NUM
ajlm-1429	89	41	(	(	PUNCT
ajlm-1429	89	42	95	95	NUM
ajlm-1429	89	43	%	%	NOUN
ajlm-1429	89	44	)	)	PUNCT
ajlm-1429	89	45	and	and	CCONJ
ajlm-1429	89	46	group	group	NOUN
ajlm-1429	89	47	2	2	NUM
ajlm-1429	89	48	(	(	PUNCT
ajlm-1429	89	49	92.0	92.0	NUM
ajlm-1429	89	50	%	%	NOUN
ajlm-1429	89	51	)	)	PUNCT
ajlm-1429	89	52	.	.	PUNCT
ajlm-1429	90	1	the	the	DET
ajlm-1429	90	2	clinical	clinical	ADJ
ajlm-1429	90	3	specimens	specimen	NOUN
ajlm-1429	90	4	used	use	VERB
ajlm-1429	90	5	in	in	ADP
ajlm-1429	90	6	these	these	DET
ajlm-1429	90	7	assays	assay	NOUN
ajlm-1429	90	8	’	'	PUNCT
ajlm-1429	90	9	evaluation	evaluation	NOUN
ajlm-1429	90	10	panels	panel	NOUN
ajlm-1429	90	11	covered	cover	VERB
ajlm-1429	90	12	a	a	DET
ajlm-1429	90	13	range	range	NOUN
ajlm-1429	90	14	in	in	ADP
ajlm-1429	90	15	sars	sar	NOUN
ajlm-1429	90	16	-	-	PUNCT
ajlm-1429	90	17	cov-2	cov-2	NOUN
ajlm-1429	90	18	vl	vl	NOUN
ajlm-1429	90	19	,	,	PUNCT
ajlm-1429	90	20	with	with	ADP
ajlm-1429	90	21	a	a	DET
ajlm-1429	90	22	median	median	ADJ
ajlm-1429	90	23	target	target	NOUN
ajlm-1429	90	24	ct	ct	NOUN
ajlm-1429	90	25	=	=	SYM
ajlm-1429	90	26	27	27	NUM
ajlm-1429	90	27	.	.	PUNCT
ajlm-1429	91	1	group	group	NOUN
ajlm-1429	91	2	3	3	NUM
ajlm-1429	91	3	performed	perform	VERB
ajlm-1429	91	4	well	well	ADV
ajlm-1429	91	5	on	on	ADP
ajlm-1429	91	6	specimens	specimen	NOUN
ajlm-1429	91	7	with	with	ADP
ajlm-1429	91	8	high	high	ADJ
ajlm-1429	91	9	vl	vl	PROPN
ajlm-1429	91	10	(	(	PUNCT
ajlm-1429	91	11	ct	ct	X
ajlm-1429	91	12	<	<	X
ajlm-1429	91	13	30	30	NUM
ajlm-1429	91	14	)	)	PUNCT
ajlm-1429	91	15	,	,	PUNCT
ajlm-1429	91	16	and	and	CCONJ
ajlm-1429	91	17	hence	hence	ADV
ajlm-1429	91	18	another	another	DET
ajlm-1429	91	19	challenge	challenge	NOUN
ajlm-1429	91	20	is	be	AUX
ajlm-1429	91	21	not	not	PART
ajlm-1429	91	22	only	only	ADV
ajlm-1429	91	23	in	in	ADP
ajlm-1429	91	24	the	the	DET
ajlm-1429	91	25	choice	choice	NOUN
ajlm-1429	91	26	of	of	ADP
ajlm-1429	91	27	range	range	NOUN
ajlm-1429	91	28	in	in	ADP
ajlm-1429	91	29	clinical	clinical	ADJ
ajlm-1429	91	30	specimens	specimen	NOUN
ajlm-1429	91	31	being	be	AUX
ajlm-1429	91	32	evaluated	evaluate	VERB
ajlm-1429	91	33	,	,	PUNCT
ajlm-1429	91	34	but	but	CCONJ
ajlm-1429	91	35	potentially	potentially	ADV
ajlm-1429	91	36	the	the	DET
ajlm-1429	91	37	need	need	NOUN
ajlm-1429	91	38	to	to	PART
ajlm-1429	91	39	apply	apply	VERB
ajlm-1429	91	40	different	different	ADJ
ajlm-1429	91	41	acceptance	acceptance	NOUN
ajlm-1429	91	42	criteria	criterion	NOUN
ajlm-1429	91	43	,	,	PUNCT
ajlm-1429	91	44	bearing	bear	VERB
ajlm-1429	91	45	in	in	ADP
ajlm-1429	91	46	mind	mind	NOUN
ajlm-1429	91	47	that	that	SCONJ
ajlm-1429	91	48	group	group	NOUN
ajlm-1429	91	49	3	3	NUM
ajlm-1429	91	50	assays	assay	NOUN
ajlm-1429	91	51	are	be	AUX
ajlm-1429	91	52	designed	design	VERB
ajlm-1429	91	53	for	for	ADP
ajlm-1429	91	54	use	use	NOUN
ajlm-1429	91	55	where	where	SCONJ
ajlm-1429	91	56	no	no	DET
ajlm-1429	91	57	front	front	ADJ
ajlm-1429	91	58	-	-	PUNCT
ajlm-1429	91	59	end	end	NOUN
ajlm-1429	91	60	rna	rna	NOUN
ajlm-1429	91	61	extraction	extraction	NOUN
ajlm-1429	91	62	(	(	PUNCT
ajlm-1429	91	63	or	or	CCONJ
ajlm-1429	91	64	rapid	rapid	ADJ
ajlm-1429	91	65	)	)	PUNCT
ajlm-1429	91	66	system	system	NOUN
ajlm-1429	91	67	is	be	AUX
ajlm-1429	91	68	available	available	ADJ
ajlm-1429	91	69	.	.	PUNCT
ajlm-1429	92	1	the	the	DET
ajlm-1429	92	2	reduced	reduce	VERB
ajlm-1429	92	3	sensitivity	sensitivity	NOUN
ajlm-1429	92	4	needs	need	VERB
ajlm-1429	92	5	to	to	PART
ajlm-1429	92	6	be	be	AUX
ajlm-1429	92	7	weighed	weigh	VERB
ajlm-1429	92	8	against	against	ADP
ajlm-1429	92	9	the	the	DET
ajlm-1429	92	10	rapid	rapid	ADJ
ajlm-1429	92	11	availability	availability	NOUN
ajlm-1429	92	12	of	of	ADP
ajlm-1429	92	13	a	a	DET
ajlm-1429	92	14	result	result	NOUN
ajlm-1429	92	15	which	which	PRON
ajlm-1429	92	16	would	would	AUX
ajlm-1429	92	17	likely	likely	ADV
ajlm-1429	92	18	identify	identify	VERB
ajlm-1429	92	19	patients	patient	NOUN
ajlm-1429	92	20	who	who	PRON
ajlm-1429	92	21	are	be	AUX
ajlm-1429	92	22	newly	newly	ADV
ajlm-1429	92	23	symptomatic	symptomatic	ADJ
ajlm-1429	92	24	and	and	CCONJ
ajlm-1429	92	25	at	at	ADP
ajlm-1429	92	26	the	the	DET
ajlm-1429	92	27	height	height	NOUN
ajlm-1429	92	28	of	of	ADP
ajlm-1429	92	29	being	be	AUX
ajlm-1429	92	30	infectious	infectious	ADJ
ajlm-1429	92	31	.	.	PUNCT
ajlm-1429	93	1	therefore	therefore	ADV
ajlm-1429	93	2	,	,	PUNCT
ajlm-1429	93	3	the	the	DET
ajlm-1429	93	4	diagnostic	diagnostic	ADJ
ajlm-1429	93	5	dilemma	dilemma	NOUN
ajlm-1429	93	6	facing	face	VERB
ajlm-1429	93	7	regulators	regulator	NOUN
ajlm-1429	93	8	and	and	CCONJ
ajlm-1429	93	9	end	end	VERB
ajlm-1429	93	10	users	user	NOUN
ajlm-1429	93	11	could	could	AUX
ajlm-1429	93	12	be	be	AUX
ajlm-1429	93	13	‘	'	PUNCT
ajlm-1429	93	14	no	no	DET
ajlm-1429	93	15	available	available	ADJ
ajlm-1429	93	16	test	test	NOUN
ajlm-1429	93	17	’	'	PUNCT
ajlm-1429	93	18	or	or	CCONJ
ajlm-1429	93	19	‘	'	PUNCT
ajlm-1429	93	20	specimens	specimen	NOUN
ajlm-1429	93	21	routed	route	VERB
ajlm-1429	93	22	a	a	DET
ajlm-1429	93	23	further	further	ADJ
ajlm-1429	93	24	distance	distance	NOUN
ajlm-1429	93	25	(	(	PUNCT
ajlm-1429	93	26	with	with	ADP
ajlm-1429	93	27	ensuing	ensue	VERB
ajlm-1429	93	28	longer	long	ADJ
ajlm-1429	93	29	tat	tat	NOUN
ajlm-1429	93	30	)	)	PUNCT
ajlm-1429	93	31	to	to	ADP
ajlm-1429	93	32	a	a	DET
ajlm-1429	93	33	testing	testing	NOUN
ajlm-1429	93	34	laboratory	laboratory	NOUN
ajlm-1429	93	35	with	with	ADP
ajlm-1429	93	36	access	access	NOUN
ajlm-1429	93	37	to	to	ADP
ajlm-1429	93	38	front	front	ADJ
ajlm-1429	93	39	-	-	PUNCT
ajlm-1429	93	40	end	end	NOUN
ajlm-1429	93	41	rna	rna	NOUN
ajlm-1429	93	42	extraction	extraction	NOUN
ajlm-1429	93	43	technology	technology	NOUN
ajlm-1429	93	44	’	'	PUNCT
ajlm-1429	93	45	,	,	PUNCT
ajlm-1429	93	46	or	or	CCONJ
ajlm-1429	93	47	a	a	DET
ajlm-1429	93	48	‘	'	PUNCT
ajlm-1429	93	49	less	less	ADV
ajlm-1429	93	50	sensitive	sensitive	ADJ
ajlm-1429	93	51	test	test	NOUN
ajlm-1429	93	52	with	with	ADP
ajlm-1429	93	53	potentially	potentially	ADV
ajlm-1429	93	54	shorter	short	ADJ
ajlm-1429	93	55	tat	tat	NOUN
ajlm-1429	93	56	and	and	CCONJ
ajlm-1429	93	57	greater	great	ADJ
ajlm-1429	93	58	clinical	clinical	ADJ
ajlm-1429	93	59	relevance	relevance	NOUN
ajlm-1429	93	60	’	'	PUNCT
ajlm-1429	93	61	.	.	PUNCT
ajlm-1429	94	1	table	table	NOUN
ajlm-1429	94	2	1	1	NUM
ajlm-1429	94	3	:	:	PUNCT
ajlm-1429	94	4	 	 	SPACE
ajlm-1429	94	5	key	key	ADJ
ajlm-1429	94	6	evaluation	evaluation	NOUN
ajlm-1429	94	7	features	feature	NOUN
ajlm-1429	94	8	of	of	ADP
ajlm-1429	94	9	a	a	DET
ajlm-1429	94	10	protocol	protocol	NOUN
ajlm-1429	94	11	applied	apply	VERB
ajlm-1429	94	12	under	under	ADP
ajlm-1429	94	13	emergency	emergency	NOUN
ajlm-1429	94	14	use	use	NOUN
ajlm-1429	94	15	and	and	CCONJ
ajlm-1429	94	16	acceptance	acceptance	NOUN
ajlm-1429	94	17	criteria	criterion	NOUN
ajlm-1429	94	18	.	.	PUNCT
ajlm-1429	95	1	conclusion	conclusion	NOUN
ajlm-1429	95	2	selecting	select	VERB
ajlm-1429	95	3	clinically	clinically	ADV
ajlm-1429	95	4	relevant	relevant	ADJ
ajlm-1429	95	5	,	,	PUNCT
ajlm-1429	95	6	laboratory	laboratory	NOUN
ajlm-1429	95	7	-	-	PUNCT
ajlm-1429	95	8	compatible	compatible	ADJ
ajlm-1429	95	9	and	and	CCONJ
ajlm-1429	95	10	well	well	ADV
ajlm-1429	95	11	-	-	PUNCT
ajlm-1429	95	12	performing	perform	VERB
ajlm-1429	95	13	sars	sar	NOUN
ajlm-1429	95	14	-	-	PUNCT
ajlm-1429	95	15	cov-2	cov-2	NOUN
ajlm-1429	95	16	naat	naat	NOUN
ajlm-1429	95	17	assays	assay	NOUN
ajlm-1429	95	18	or	or	CCONJ
ajlm-1429	95	19	systems	system	NOUN
ajlm-1429	95	20	for	for	ADP
ajlm-1429	95	21	patient	patient	ADJ
ajlm-1429	95	22	care	care	NOUN
ajlm-1429	95	23	is	be	AUX
ajlm-1429	95	24	complex	complex	ADJ
ajlm-1429	95	25	and	and	CCONJ
ajlm-1429	95	26	subject	subject	ADJ
ajlm-1429	95	27	to	to	ADP
ajlm-1429	95	28	several	several	ADJ
ajlm-1429	95	29	challenges	challenge	NOUN
ajlm-1429	95	30	,	,	PUNCT
ajlm-1429	95	31	as	as	SCONJ
ajlm-1429	95	32	also	also	ADV
ajlm-1429	95	33	highlighted	highlight	VERB
ajlm-1429	95	34	elsewhere.9,22	elsewhere.9,22	PROPN
ajlm-1429	95	35	current	current	ADJ
ajlm-1429	95	36	evaluation	evaluation	NOUN
ajlm-1429	95	37	protocols	protocol	NOUN
ajlm-1429	95	38	are	be	AUX
ajlm-1429	95	39	not	not	PART
ajlm-1429	95	40	robustly	robustly	ADV
ajlm-1429	95	41	performed	perform	VERB
ajlm-1429	95	42	under	under	ADP
ajlm-1429	95	43	emergency	emergency	NOUN
ajlm-1429	95	44	circumstances,21	circumstances,21	NOUN
ajlm-1429	95	45	and	and	CCONJ
ajlm-1429	95	46	performance	performance	NOUN
ajlm-1429	95	47	acceptance	acceptance	NOUN
ajlm-1429	95	48	criteria	criterion	NOUN
ajlm-1429	95	49	and	and	CCONJ
ajlm-1429	95	50	technology	technology	NOUN
ajlm-1429	95	51	placement	placement	NOUN
ajlm-1429	95	52	may	may	AUX
ajlm-1429	95	53	require	require	VERB
ajlm-1429	95	54	flexibility.23	flexibility.23	ADJ
ajlm-1429	95	55	assays	assay	NOUN
ajlm-1429	95	56	themselves	themselves	PRON
ajlm-1429	95	57	have	have	AUX
ajlm-1429	95	58	also	also	ADV
ajlm-1429	95	59	improved	improve	VERB
ajlm-1429	95	60	with	with	ADP
ajlm-1429	95	61	time	time	NOUN
ajlm-1429	95	62	.	.	PUNCT
ajlm-1429	96	1	added	add	VERB
ajlm-1429	96	2	layers	layer	NOUN
ajlm-1429	96	3	of	of	ADP
ajlm-1429	96	4	complexity	complexity	NOUN
ajlm-1429	96	5	that	that	PRON
ajlm-1429	96	6	we	we	PRON
ajlm-1429	96	7	experienced	experience	VERB
ajlm-1429	96	8	were	be	AUX
ajlm-1429	96	9	donated	donate	VERB
ajlm-1429	96	10	tests	test	NOUN
ajlm-1429	96	11	that	that	PRON
ajlm-1429	96	12	did	do	AUX
ajlm-1429	96	13	not	not	PART
ajlm-1429	96	14	always	always	ADV
ajlm-1429	96	15	follow	follow	VERB
ajlm-1429	96	16	required	require	VERB
ajlm-1429	96	17	regulatory	regulatory	ADJ
ajlm-1429	96	18	pathways	pathway	NOUN
ajlm-1429	96	19	prior	prior	ADV
ajlm-1429	96	20	to	to	ADP
ajlm-1429	96	21	implementation	implementation	NOUN
ajlm-1429	96	22	,	,	PUNCT
ajlm-1429	96	23	and	and	CCONJ
ajlm-1429	96	24	suppliers	supplier	NOUN
ajlm-1429	96	25	requesting	request	VERB
ajlm-1429	96	26	evaluation	evaluation	NOUN
ajlm-1429	96	27	from	from	ADP
ajlm-1429	96	28	multiple	multiple	ADJ
ajlm-1429	96	29	laboratories	laboratory	NOUN
ajlm-1429	96	30	in	in	ADP
ajlm-1429	96	31	the	the	DET
ajlm-1429	96	32	hope	hope	NOUN
ajlm-1429	96	33	of	of	ADP
ajlm-1429	96	34	improving	improve	VERB
ajlm-1429	96	35	their	their	PRON
ajlm-1429	96	36	performance	performance	NOUN
ajlm-1429	96	37	score	score	NOUN
ajlm-1429	96	38	.	.	PUNCT
ajlm-1429	97	1	however	however	ADV
ajlm-1429	97	2	,	,	PUNCT
ajlm-1429	97	3	having	have	VERB
ajlm-1429	97	4	a	a	DET
ajlm-1429	97	5	new	new	ADJ
ajlm-1429	97	6	test	test	NOUN
ajlm-1429	97	7	ready	ready	ADJ
ajlm-1429	97	8	for	for	ADP
ajlm-1429	97	9	use	use	NOUN
ajlm-1429	97	10	is	be	AUX
ajlm-1429	97	11	only	only	ADV
ajlm-1429	97	12	half	half	DET
ajlm-1429	97	13	the	the	DET
ajlm-1429	97	14	battle	battle	NOUN
ajlm-1429	97	15	,	,	PUNCT
ajlm-1429	97	16	and	and	CCONJ
ajlm-1429	97	17	still	still	ADV
ajlm-1429	97	18	requires	require	VERB
ajlm-1429	97	19	rapid	rapid	ADJ
ajlm-1429	97	20	implementation	implementation	NOUN
ajlm-1429	97	21	and	and	CCONJ
ajlm-1429	97	22	scale	scale	NOUN
ajlm-1429	97	23	-	-	PUNCT
ajlm-1429	97	24	up	up	NOUN
ajlm-1429	97	25	,	,	PUNCT
ajlm-1429	97	26	with	with	ADP
ajlm-1429	97	27	further	further	ADJ
ajlm-1429	97	28	factors	factor	NOUN
ajlm-1429	97	29	requiring	require	VERB
ajlm-1429	97	30	investigation	investigation	NOUN
ajlm-1429	97	31	such	such	ADJ
ajlm-1429	97	32	as	as	ADP
ajlm-1429	97	33	cost	cost	NOUN
ajlm-1429	97	34	,	,	PUNCT
ajlm-1429	97	35	supply	supply	NOUN
ajlm-1429	97	36	chain	chain	NOUN
ajlm-1429	97	37	management	management	NOUN
ajlm-1429	97	38	,	,	PUNCT
ajlm-1429	97	39	training	training	NOUN
ajlm-1429	97	40	,	,	PUNCT
ajlm-1429	97	41	quality	quality	NOUN
ajlm-1429	97	42	assessment	assessment	NOUN
ajlm-1429	97	43	,	,	PUNCT
ajlm-1429	97	44	interfacing	interface	VERB
ajlm-1429	97	45	to	to	ADP
ajlm-1429	97	46	existing	exist	VERB
ajlm-1429	97	47	laboratory	laboratory	NOUN
ajlm-1429	97	48	information	information	NOUN
ajlm-1429	97	49	systems	system	NOUN
ajlm-1429	97	50	,	,	PUNCT
ajlm-1429	97	51	compatibility	compatibility	NOUN
ajlm-1429	97	52	to	to	ADP
ajlm-1429	97	53	existing	exist	VERB
ajlm-1429	97	54	testing	testing	NOUN
ajlm-1429	97	55	landscapes	landscape	NOUN
ajlm-1429	97	56	,	,	PUNCT
ajlm-1429	97	57	continuous	continuous	ADJ
ajlm-1429	97	58	quality	quality	NOUN
ajlm-1429	97	59	monitoring	monitoring	NOUN
ajlm-1429	97	60	and	and	CCONJ
ajlm-1429	97	61	post	post	ADJ
ajlm-1429	97	62	-	-	ADJ
ajlm-1429	97	63	market	market	ADJ
ajlm-1429	97	64	surveillance	surveillance	NOUN
ajlm-1429	97	65	,	,	PUNCT
ajlm-1429	97	66	to	to	PART
ajlm-1429	97	67	name	name	VERB
ajlm-1429	97	68	a	a	DET
ajlm-1429	97	69	few	few	ADJ
ajlm-1429	97	70	.	.	PUNCT
ajlm-1429	98	1	acknowledgements	acknowledgement	NOUN
ajlm-1429	98	2	network	network	NOUN
ajlm-1429	98	3	of	of	ADP
ajlm-1429	98	4	evaluating	evaluate	VERB
ajlm-1429	98	5	laboratories	laboratory	NOUN
ajlm-1429	98	6	:	:	PUNCT
ajlm-1429	98	7	national	national	PROPN
ajlm-1429	98	8	health	health	PROPN
ajlm-1429	98	9	laboratory	laboratory	PROPN
ajlm-1429	98	10	service	service	NOUN
ajlm-1429	98	11	(	(	PUNCT
ajlm-1429	98	12	lucia	lucia	PROPN
ajlm-1429	98	13	hans	hans	PROPN
ajlm-1429	98	14	,	,	PUNCT
ajlm-1429	98	15	kim	kim	PROPN
ajlm-1429	98	16	steegen	steegen	PROPN
ajlm-1429	98	17	,	,	PUNCT
ajlm-1429	98	18	irene	irene	PROPN
ajlm-1429	98	19	ketseoglou	ketseoglou	PROPN
ajlm-1429	98	20	,	,	PUNCT
ajlm-1429	98	21	puleng	puleng	PROPN
ajlm-1429	98	22	marokane	marokane	PROPN
ajlm-1429	98	23	,	,	PUNCT
ajlm-1429	98	24	pedro	pedro	PROPN
ajlm-1429	98	25	da	da	PROPN
ajlm-1429	98	26	silva	silva	PROPN
ajlm-1429	98	27	,	,	PUNCT
ajlm-1429	98	28	somayya	somayya	PROPN
ajlm-1429	98	29	sarang	sarang	PROPN
ajlm-1429	98	30	,	,	PUNCT
ajlm-1429	98	31	koleka	koleka	PROPN
ajlm-1429	98	32	mlisana	mlisana	PROPN
ajlm-1429	98	33	)	)	PUNCT
ajlm-1429	98	34	,	,	PUNCT
ajlm-1429	98	35	national	national	PROPN
ajlm-1429	98	36	institute	institute	PROPN
ajlm-1429	98	37	of	of	ADP
ajlm-1429	98	38	communicable	communicable	NOUN
ajlm-1429	98	39	diseases	disease	NOUN
ajlm-1429	98	40	(	(	PUNCT
ajlm-1429	98	41	olga	olga	PROPN
ajlm-1429	98	42	perovic	perovic	PROPN
ajlm-1429	98	43	,	,	PUNCT
ajlm-1429	98	44	mignon	mignon	PROPN
ajlm-1429	98	45	du	du	PROPN
ajlm-1429	98	46	plessis	plessis	PROPN
ajlm-1429	98	47	)	)	PUNCT
ajlm-1429	98	48	,	,	PUNCT
ajlm-1429	98	49	clinical	clinical	ADJ
ajlm-1429	98	50	laboratory	laboratory	NOUN
ajlm-1429	98	51	service	service	NOUN
ajlm-1429	98	52	(	(	PUNCT
ajlm-1429	98	53	blessing	blessing	PROPN
ajlm-1429	98	54	kadira	kadira	PROPN
ajlm-1429	98	55	,	,	PUNCT
ajlm-1429	98	56	lyndel	lyndel	PROPN
ajlm-1429	98	57	singh	singh	PROPN
ajlm-1429	98	58	,	,	PUNCT
ajlm-1429	98	59	timothy	timothy	PROPN
ajlm-1429	98	60	moshema	moshema	PROPN
ajlm-1429	98	61	)	)	PUNCT
ajlm-1429	98	62	.	.	PUNCT
ajlm-1429	99	1	developers	developer	NOUN
ajlm-1429	99	2	of	of	ADP
ajlm-1429	99	3	viral	viral	ADJ
ajlm-1429	99	4	culture	culture	NOUN
ajlm-1429	99	5	stock	stock	NOUN
ajlm-1429	99	6	:	:	PUNCT
ajlm-1429	99	7	universities	university	NOUN
ajlm-1429	99	8	of	of	ADP
ajlm-1429	99	9	stellenbosch	stellenbosch	PROPN
ajlm-1429	99	10	and	and	CCONJ
ajlm-1429	99	11	the	the	DET
ajlm-1429	99	12	western	western	ADJ
ajlm-1429	99	13	cape	cape	NOUN
ajlm-1429	99	14	(	(	PUNCT
ajlm-1429	99	15	tasnim	tasnim	NOUN
ajlm-1429	99	16	suliman	suliman	NOUN
ajlm-1429	99	17	)	)	PUNCT
ajlm-1429	99	18	,	,	PUNCT
ajlm-1429	99	19	national	national	PROPN
ajlm-1429	99	20	health	health	PROPN
ajlm-1429	99	21	laboratory	laboratory	PROPN
ajlm-1429	99	22	service	service	NOUN
ajlm-1429	99	23	(	(	PUNCT
ajlm-1429	99	24	bavesh	bavesh	PROPN
ajlm-1429	99	25	kana	kana	PROPN
ajlm-1429	99	26	,	,	PUNCT
ajlm-1429	99	27	bhavna	bhavna	NOUN
ajlm-1429	99	28	gordhan	gordhan	NOUN
ajlm-1429	99	29	)	)	PUNCT
ajlm-1429	99	30	and	and	CCONJ
ajlm-1429	99	31	harsha	harsha	PROPN
ajlm-1429	99	32	desai	desai	PROPN
ajlm-1429	99	33	and	and	CCONJ
ajlm-1429	99	34	mohapi	mohapi	VERB
ajlm-1429	99	35	mokone	mokone	NOUN
ajlm-1429	99	36	(	(	PUNCT
ajlm-1429	99	37	programme	programme	NOUN
ajlm-1429	99	38	managers	manager	NOUN
ajlm-1429	99	39	engaging	engage	VERB
ajlm-1429	99	40	with	with	ADP
ajlm-1429	99	41	suppliers	supplier	NOUN
ajlm-1429	99	42	and	and	CCONJ
ajlm-1429	99	43	regulators	regulator	NOUN
ajlm-1429	99	44	)	)	PUNCT
ajlm-1429	99	45	.	.	PUNCT
ajlm-1429	100	1	competing	compete	VERB
ajlm-1429	100	2	interests	interest	NOUN
ajlm-1429	100	3	the	the	DET
ajlm-1429	100	4	authors	author	NOUN
ajlm-1429	100	5	declare	declare	VERB
ajlm-1429	100	6	that	that	SCONJ
ajlm-1429	100	7	they	they	PRON
ajlm-1429	100	8	have	have	VERB
ajlm-1429	100	9	no	no	DET
ajlm-1429	100	10	financial	financial	ADJ
ajlm-1429	100	11	or	or	CCONJ
ajlm-1429	100	12	personal	personal	ADJ
ajlm-1429	100	13	relationships	relationship	NOUN
ajlm-1429	100	14	that	that	PRON
ajlm-1429	100	15	may	may	AUX
ajlm-1429	100	16	have	have	AUX
ajlm-1429	100	17	inappropriately	inappropriately	ADV
ajlm-1429	100	18	influenced	influence	VERB
ajlm-1429	100	19	them	they	PRON
ajlm-1429	100	20	in	in	ADP
ajlm-1429	100	21	writing	write	VERB
ajlm-1429	100	22	this	this	DET
ajlm-1429	100	23	article	article	NOUN
ajlm-1429	100	24	.	.	PUNCT
ajlm-1429	101	1	authors	author	NOUN
ajlm-1429	101	2	’	’	PART
ajlm-1429	101	3	contributions	contribution	NOUN
ajlm-1429	101	4	l.e.s	l.e.s	VERB
ajlm-1429	101	5	.	.	PUNCT
ajlm-1429	101	6	,	,	PUNCT
ajlm-1429	101	7	l.d.n	l.d.n	PROPN
ajlm-1429	101	8	.	.	PROPN
ajlm-1429	101	9	,	,	PUNCT
ajlm-1429	101	10	a.s.-m	a.s.-m	PROPN
ajlm-1429	101	11	.	.	PROPN
ajlm-1429	101	12	,	,	PUNCT
ajlm-1429	101	13	t.k	t.k	PROPN
ajlm-1429	101	14	.	.	PROPN
ajlm-1429	101	15	,	,	PUNCT
ajlm-1429	101	16	d.r.h	d.r.h	PROPN
ajlm-1429	101	17	.	.	PROPN
ajlm-1429	101	18	,	,	PUNCT
ajlm-1429	101	19	w.p	w.p	PROPN
ajlm-1429	101	20	.	.	PROPN
ajlm-1429	101	21	and	and	CCONJ
ajlm-1429	101	22	w.s.s	w.s.s	PROPN
ajlm-1429	101	23	.	.	PUNCT
ajlm-1429	102	1	contributed	contribute	VERB
ajlm-1429	102	2	equally	equally	ADV
ajlm-1429	102	3	to	to	ADP
ajlm-1429	102	4	the	the	DET
ajlm-1429	102	5	design	design	NOUN
ajlm-1429	102	6	and	and	CCONJ
ajlm-1429	102	7	implementation	implementation	NOUN
ajlm-1429	102	8	of	of	ADP
ajlm-1429	102	9	the	the	DET
ajlm-1429	102	10	research	research	NOUN
ajlm-1429	102	11	,	,	PUNCT
ajlm-1429	102	12	to	to	ADP
ajlm-1429	102	13	the	the	DET
ajlm-1429	102	14	analysis	analysis	NOUN
ajlm-1429	102	15	of	of	ADP
ajlm-1429	102	16	the	the	DET
ajlm-1429	102	17	results	result	NOUN
ajlm-1429	102	18	and	and	CCONJ
ajlm-1429	102	19	to	to	ADP
ajlm-1429	102	20	the	the	DET
ajlm-1429	102	21	writing	writing	NOUN
ajlm-1429	102	22	of	of	ADP
ajlm-1429	102	23	the	the	DET
ajlm-1429	102	24	article	article	NOUN
ajlm-1429	102	25	.	.	PUNCT
ajlm-1429	103	1	ethical	ethical	ADJ
ajlm-1429	103	2	considerations	consideration	NOUN
ajlm-1429	103	3	the	the	DET
ajlm-1429	103	4	use	use	NOUN
ajlm-1429	103	5	of	of	ADP
ajlm-1429	103	6	residual	residual	ADJ
ajlm-1429	103	7	blood	blood	NOUN
ajlm-1429	103	8	,	,	PUNCT
ajlm-1429	103	9	swab	swab	NOUN
ajlm-1429	103	10	and	and	CCONJ
ajlm-1429	103	11	universal	universal	ADJ
ajlm-1429	103	12	transport	transport	NOUN
ajlm-1429	103	13	medium	medium	ADJ
ajlm-1429	103	14	specimens	specimen	NOUN
ajlm-1429	103	15	for	for	ADP
ajlm-1429	103	16	research	research	NOUN
ajlm-1429	103	17	and	and	CCONJ
ajlm-1429	103	18	development	development	NOUN
ajlm-1429	103	19	of	of	ADP
ajlm-1429	103	20	molecular	molecular	ADJ
ajlm-1429	103	21	and	and	CCONJ
ajlm-1429	103	22	serology	serology	NOUN
ajlm-1429	103	23	assays	assay	NOUN
ajlm-1429	103	24	for	for	ADP
ajlm-1429	103	25	sars	sar	NOUN
ajlm-1429	103	26	-	-	PUNCT
ajlm-1429	103	27	cov-2	cov-2	PART
ajlm-1429	103	28	was	be	AUX
ajlm-1429	103	29	approved	approve	VERB
ajlm-1429	103	30	by	by	ADP
ajlm-1429	103	31	the	the	DET
ajlm-1429	103	32	university	university	NOUN
ajlm-1429	103	33	of	of	ADP
ajlm-1429	103	34	the	the	DET
ajlm-1429	103	35	witwatersrand	witwatersrand	NOUN
ajlm-1429	103	36	human	human	PROPN
ajlm-1429	103	37	research	research	PROPN
ajlm-1429	103	38	ethics	ethic	NOUN
ajlm-1429	103	39	committee	committee	PROPN
ajlm-1429	103	40	(	(	PUNCT
ajlm-1429	103	41	medical	medical	ADJ
ajlm-1429	103	42	):	):	PUNCT
ajlm-1429	103	43	m1911201	m1911201	NOUN
ajlm-1429	103	44	.	.	PUNCT
ajlm-1429	104	1	sources	source	NOUN
ajlm-1429	104	2	of	of	ADP
ajlm-1429	104	3	support	support	NOUN
ajlm-1429	104	4	w.s.s	w.s.s	PROPN
ajlm-1429	104	5	.	.	PUNCT
ajlm-1429	104	6	,	,	PUNCT
ajlm-1429	104	7	l.e.s	l.e.s	PROPN
ajlm-1429	104	8	.	.	PUNCT
ajlm-1429	104	9	,	,	PUNCT
ajlm-1429	104	10	l.d.n	l.d.n	PROPN
ajlm-1429	104	11	.	.	PUNCT
ajlm-1429	104	12	and	and	CCONJ
ajlm-1429	104	13	t.k	t.k	PROPN
ajlm-1429	104	14	.	.	PROPN
ajlm-1429	104	15	are	be	AUX
ajlm-1429	104	16	supported	support	VERB
ajlm-1429	104	17	by	by	ADP
ajlm-1429	104	18	funding	funding	NOUN
ajlm-1429	104	19	received	receive	VERB
ajlm-1429	104	20	from	from	ADP
ajlm-1429	104	21	the	the	DET
ajlm-1429	104	22	bill	bill	NOUN
ajlm-1429	104	23	and	and	CCONJ
ajlm-1429	104	24	melinda	melinda	PROPN
ajlm-1429	104	25	gates	gates	PROPN
ajlm-1429	104	26	foundation	foundation	VERB
ajlm-1429	104	27	through	through	ADP
ajlm-1429	104	28	the	the	DET
ajlm-1429	104	29	innovation	innovation	NOUN
ajlm-1429	104	30	in	in	ADP
ajlm-1429	104	31	laboratory	laboratory	NOUN
ajlm-1429	104	32	engineered	engineer	VERB
ajlm-1429	104	33	accelerated	accelerate	VERB
ajlm-1429	104	34	diagnostics	diagnostic	NOUN
ajlm-1429	104	35	investment	investment	NOUN
ajlm-1429	104	36	(	(	PUNCT
ajlm-1429	104	37	grant	grant	NOUN
ajlm-1429	104	38	number	number	NOUN
ajlm-1429	104	39	opp1171455	opp1171455	ADV
ajlm-1429	104	40	)	)	PUNCT
ajlm-1429	104	41	.	.	PUNCT
ajlm-1429	105	1	data	datum	NOUN
ajlm-1429	105	2	availability	availability	NOUN
ajlm-1429	105	3	data	datum	NOUN
ajlm-1429	105	4	sharing	sharing	NOUN
ajlm-1429	105	5	is	be	AUX
ajlm-1429	105	6	not	not	PART
ajlm-1429	105	7	applicable	applicable	ADJ
ajlm-1429	105	8	to	to	ADP
ajlm-1429	105	9	this	this	DET
ajlm-1429	105	10	article	article	NOUN
ajlm-1429	105	11	as	as	SCONJ
ajlm-1429	105	12	no	no	DET
ajlm-1429	105	13	new	new	ADJ
ajlm-1429	105	14	data	datum	NOUN
ajlm-1429	105	15	were	be	AUX
ajlm-1429	105	16	created	create	VERB
ajlm-1429	105	17	or	or	CCONJ
ajlm-1429	105	18	analysed	analyse	VERB
ajlm-1429	105	19	in	in	ADP
ajlm-1429	105	20	this	this	DET
ajlm-1429	105	21	study	study	NOUN
ajlm-1429	105	22	.	.	PUNCT
ajlm-1429	106	1	disclaimer	disclaimer	VERB
ajlm-1429	106	2	the	the	DET
ajlm-1429	106	3	views	view	NOUN
ajlm-1429	106	4	and	and	CCONJ
ajlm-1429	106	5	opinions	opinion	NOUN
ajlm-1429	106	6	expressed	express	VERB
ajlm-1429	106	7	in	in	ADP
ajlm-1429	106	8	this	this	DET
ajlm-1429	106	9	article	article	NOUN
ajlm-1429	106	10	are	be	AUX
ajlm-1429	106	11	those	those	PRON
ajlm-1429	106	12	of	of	ADP
ajlm-1429	106	13	the	the	DET
ajlm-1429	106	14	authors	author	NOUN
ajlm-1429	106	15	and	and	CCONJ
ajlm-1429	106	16	do	do	AUX
ajlm-1429	106	17	not	not	PART
ajlm-1429	106	18	necessarily	necessarily	ADV
ajlm-1429	106	19	reflect	reflect	VERB
ajlm-1429	106	20	the	the	DET
ajlm-1429	106	21	official	official	ADJ
ajlm-1429	106	22	policy	policy	NOUN
ajlm-1429	106	23	or	or	CCONJ
ajlm-1429	106	24	position	position	NOUN
ajlm-1429	106	25	of	of	ADP
ajlm-1429	106	26	any	any	DET
ajlm-1429	106	27	affiliated	affiliated	ADJ
ajlm-1429	106	28	agency	agency	NOUN
ajlm-1429	106	29	of	of	ADP
ajlm-1429	106	30	the	the	DET
ajlm-1429	106	31	authors	author	NOUN
ajlm-1429	106	32	.	.	PUNCT
ajlm-1429	107	1	references	reference	NOUN
ajlm-1429	107	2	zhu	zhu	PROPN
ajlm-1429	107	3	n	n	CCONJ
ajlm-1429	107	4	,	,	PUNCT
ajlm-1429	107	5	zhang	zhang	PROPN
ajlm-1429	107	6	d	d	PROPN
ajlm-1429	107	7	,	,	PUNCT
ajlm-1429	107	8	wang	wang	PROPN
ajlm-1429	107	9	w	w	PROPN
ajlm-1429	107	10	,	,	PUNCT
ajlm-1429	107	11	et	et	PROPN
ajlm-1429	107	12	al	al	PROPN
ajlm-1429	107	13	.	.	PUNCT
ajlm-1429	108	1	a	a	DET
ajlm-1429	108	2	novel	novel	ADJ
ajlm-1429	108	3	coronavirus	coronavirus	NOUN
ajlm-1429	108	4	from	from	ADP
ajlm-1429	108	5	patients	patient	NOUN
ajlm-1429	108	6	with	with	ADP
ajlm-1429	108	7	pneumonia	pneumonia	NOUN
ajlm-1429	108	8	in	in	ADP
ajlm-1429	108	9	china	china	PROPN
ajlm-1429	108	10	,	,	PUNCT
ajlm-1429	108	11	2019	2019	NUM
ajlm-1429	108	12	.	.	PUNCT
ajlm-1429	109	1	new	new	ADJ
ajlm-1429	109	2	engl	engl	PROPN
ajlm-1429	109	3	j	j	PROPN
ajlm-1429	109	4	med	med	PROPN
ajlm-1429	109	5	.	.	PUNCT
ajlm-1429	110	1	2020;382(8):727–733	2020;382(8):727–733	NUM
ajlm-1429	110	2	.	.	PUNCT
ajlm-1429	111	1	https://doi.org/10.1056/nejmoa2001017	https://doi.org/10.1056/nejmoa2001017	PROPN
ajlm-1429	111	2	world	world	PROPN
ajlm-1429	111	3	health	health	NOUN
ajlm-1429	111	4	organization	organization	PROPN
ajlm-1429	111	5	.	.	PUNCT
ajlm-1429	112	1	who	who	PRON
ajlm-1429	112	2	director	director	NOUN
ajlm-1429	112	3	-	-	PUNCT
ajlm-1429	112	4	general	general	NOUN
ajlm-1429	112	5	’s	’s	PART
ajlm-1429	112	6	opening	opening	NOUN
ajlm-1429	112	7	remarks	remark	NOUN
ajlm-1429	112	8	at	at	ADP
ajlm-1429	112	9	the	the	DET
ajlm-1429	112	10	media	medium	NOUN
ajlm-1429	112	11	briefing	briefing	NOUN
ajlm-1429	112	12	on	on	ADP
ajlm-1429	112	13	covid-19	covid-19	PROPN
ajlm-1429	112	14	–	–	PUNCT
ajlm-1429	112	15	11	11	NUM
ajlm-1429	112	16	march	march	NOUN
ajlm-1429	112	17	2020	2020	NUM
ajlm-1429	113	1	[	[	X
ajlm-1429	113	2	homepage	homepage	NOUN
ajlm-1429	113	3	on	on	ADP
ajlm-1429	113	4	the	the	DET
ajlm-1429	113	5	internet	internet	NOUN
ajlm-1429	113	6	]	]	PUNCT
ajlm-1429	113	7	.	.	PUNCT
ajlm-1429	113	8	2020	2020	NUM
ajlm-1429	114	1	[	[	X
ajlm-1429	114	2	cited	cite	VERB
ajlm-1429	114	3	2020	2020	NUM
ajlm-1429	114	4	apr	apr	NOUN
ajlm-1429	114	5	2	2	NUM
ajlm-1429	114	6	]	]	PUNCT
ajlm-1429	114	7	.	.	PUNCT
ajlm-1429	115	1	available	available	ADJ
ajlm-1429	115	2	from	from	ADP
ajlm-1429	115	3	:	:	PUNCT
ajlm-1429	115	4	https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020	https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020	NOUN
ajlm-1429	115	5	center	center	NOUN
ajlm-1429	115	6	for	for	ADP
ajlm-1429	115	7	systems	system	NOUN
ajlm-1429	115	8	science	science	NOUN
ajlm-1429	115	9	and	and	CCONJ
ajlm-1429	115	10	engineering	engineering	NOUN
ajlm-1429	115	11	(	(	PUNCT
ajlm-1429	115	12	csse	csse	NOUN
ajlm-1429	115	13	)	)	PUNCT
ajlm-1429	115	14	at	at	ADP
ajlm-1429	115	15	johns	johns	PROPN
ajlm-1429	115	16	hopkins	hopkins	PROPN
ajlm-1429	115	17	university	university	PROPN
ajlm-1429	115	18	(	(	PUNCT
ajlm-1429	115	19	jhu	jhu	PROPN
ajlm-1429	115	20	)	)	PUNCT
ajlm-1429	115	21	.	.	PUNCT
ajlm-1429	116	1	covid-19	covid-19	PROPN
ajlm-1429	116	2	dashboard	dashboard	NOUN
ajlm-1429	116	3	[	[	X
ajlm-1429	116	4	homepage	homepage	NOUN
ajlm-1429	116	5	on	on	ADP
ajlm-1429	116	6	the	the	DET
ajlm-1429	116	7	internet	internet	NOUN
ajlm-1429	116	8	]	]	PUNCT
ajlm-1429	116	9	.	.	PUNCT
ajlm-1429	117	1	©	©	ADP
ajlm-1429	117	2	2022	2022	NUM
ajlm-1429	117	3	[	[	X
ajlm-1429	117	4	cited	cite	VERB
ajlm-1429	117	5	2021	2021	NUM
ajlm-1429	117	6	dec	dec	PROPN
ajlm-1429	117	7	31	31	NUM
ajlm-1429	117	8	]	]	PUNCT
ajlm-1429	117	9	.	.	PUNCT
ajlm-1429	118	1	available	available	ADJ
ajlm-1429	118	2	from	from	ADP
ajlm-1429	118	3	:	:	PUNCT
ajlm-1429	118	4	https://coronavirus.jhu.edu/map.html	https://coronavirus.jhu.edu/map.html	PROPN
ajlm-1429	118	5	foundation	foundation	NOUN
ajlm-1429	118	6	for	for	ADP
ajlm-1429	118	7	innovative	innovative	ADJ
ajlm-1429	118	8	diagnostics	diagnostic	NOUN
ajlm-1429	118	9	(	(	PUNCT
ajlm-1429	118	10	find	find	NOUN
ajlm-1429	118	11	)	)	PUNCT
ajlm-1429	118	12	.	.	PUNCT
ajlm-1429	119	1	covid-19	covid-19	PROPN
ajlm-1429	119	2	test	test	NOUN
ajlm-1429	119	3	directory	directory	NOUN
ajlm-1429	120	1	[	[	X
ajlm-1429	120	2	homepage	homepage	NOUN
ajlm-1429	120	3	on	on	ADP
ajlm-1429	120	4	the	the	DET
ajlm-1429	120	5	internet	internet	NOUN
ajlm-1429	120	6	]	]	PUNCT
ajlm-1429	120	7	.	.	PUNCT
ajlm-1429	121	1	©	©	ADP
ajlm-1429	121	2	2022	2022	NUM
ajlm-1429	121	3	[	[	X
ajlm-1429	121	4	cited	cite	VERB
ajlm-1429	121	5	2021	2021	NUM
ajlm-1429	121	6	dec	dec	PROPN
ajlm-1429	121	7	28	28	NUM
ajlm-1429	121	8	]	]	PUNCT
ajlm-1429	121	9	.	.	PUNCT
ajlm-1429	122	1	available	available	ADJ
ajlm-1429	122	2	from	from	ADP
ajlm-1429	122	3	:	:	PUNCT
ajlm-1429	122	4	https://www.finddx.org/test-directory/	https://www.finddx.org/test-directory/	NOUN
ajlm-1429	122	5	shuren	shuren	PROPN
ajlm-1429	122	6	j	j	PROPN
ajlm-1429	122	7	,	,	PUNCT
ajlm-1429	122	8	stenzel	stenzel	ADJ
ajlm-1429	122	9	t.	t.	PROPN
ajlm-1429	122	10	covid-19	covid-19	PROPN
ajlm-1429	122	11	molecular	molecular	ADJ
ajlm-1429	122	12	diagnostic	diagnostic	ADJ
ajlm-1429	122	13	testing	testing	NOUN
ajlm-1429	122	14	–	–	PUNCT
ajlm-1429	122	15	lessons	lesson	NOUN
ajlm-1429	122	16	learned	learn	VERB
ajlm-1429	122	17	.	.	PUNCT
ajlm-1429	123	1	n	n	PRON
ajlm-1429	123	2	engl	engl	PROPN
ajlm-1429	123	3	j	j	PROPN
ajlm-1429	123	4	med	med	PROPN
ajlm-1429	123	5	.	.	PUNCT
ajlm-1429	124	1	2020;383	2020;383	NUM
ajlm-1429	124	2	:	:	PUNCT
ajlm-1429	124	3	e97	e97	X
ajlm-1429	124	4	.	.	PUNCT
ajlm-1429	125	1	https://doi.org/10.1056/nejmp2023830	https://doi.org/10.1056/nejmp2023830	PROPN
ajlm-1429	125	2	find	find	VERB
ajlm-1429	125	3	dx	dx	PROPN
ajlm-1429	125	4	.	.	PUNCT
ajlm-1429	126	1	sars	sars	PROPN
ajlm-1429	126	2	-	-	PUNCT
ajlm-1429	126	3	cov-2	cov-2	PART
ajlm-1429	126	4	molecular	molecular	ADJ
ajlm-1429	126	5	assay	assay	NOUN
ajlm-1429	126	6	evaluation	evaluation	NOUN
ajlm-1429	126	7	results	result	NOUN
ajlm-1429	126	8	(	(	PUNCT
ajlm-1429	126	9	3	3	NUM
ajlm-1429	126	10	july	july	NOUN
ajlm-1429	126	11	2020	2020	NUM
ajlm-1429	126	12	)	)	PUNCT
ajlm-1429	127	1	[	[	X
ajlm-1429	127	2	homepage	homepage	NOUN
ajlm-1429	127	3	on	on	ADP
ajlm-1429	127	4	the	the	DET
ajlm-1429	127	5	internet	internet	NOUN
ajlm-1429	127	6	]	]	PUNCT
ajlm-1429	127	7	.	.	PUNCT
ajlm-1429	127	8	2020	2020	NUM
ajlm-1429	128	1	[	[	X
ajlm-1429	128	2	cited	cite	VERB
ajlm-1429	128	3	2020	2020	NUM
ajlm-1429	128	4	jul	jul	PROPN
ajlm-1429	128	5	27	27	NUM
ajlm-1429	128	6	]	]	PUNCT
ajlm-1429	128	7	.	.	PUNCT
ajlm-1429	129	1	available	available	ADJ
ajlm-1429	129	2	from	from	ADP
ajlm-1429	129	3	:	:	PUNCT
ajlm-1429	129	4	https://www.finddx.org/covid-19/sarscov2-eval-molecular/molecular-eval-results/	https://www.finddx.org/covid-19/sarscov2-eval-molecular/molecular-eval-results/	PROPN
ajlm-1429	129	5	world	world	NOUN
ajlm-1429	129	6	health	health	NOUN
ajlm-1429	129	7	organization	organization	NOUN
ajlm-1429	129	8	.	.	PUNCT
ajlm-1429	130	1	covid-19	covid-19	PROPN
ajlm-1429	130	2	target	target	NOUN
ajlm-1429	130	3	product	product	NOUN
ajlm-1429	130	4	profiles	profile	NOUN
ajlm-1429	130	5	for	for	ADP
ajlm-1429	130	6	priority	priority	NOUN
ajlm-1429	130	7	diagnostics	diagnostic	NOUN
ajlm-1429	130	8	to	to	PART
ajlm-1429	130	9	support	support	VERB
ajlm-1429	130	10	response	response	NOUN
ajlm-1429	130	11	to	to	ADP
ajlm-1429	130	12	the	the	DET
ajlm-1429	130	13	covid-19	covid-19	PROPN
ajlm-1429	130	14	pandemic	pandemic	ADJ
ajlm-1429	130	15	v.0.1	v.0.1	NOUN
ajlm-1429	131	1	[	[	X
ajlm-1429	131	2	homepage	homepage	NOUN
ajlm-1429	131	3	on	on	ADP
ajlm-1429	131	4	the	the	DET
ajlm-1429	131	5	internet	internet	NOUN
ajlm-1429	131	6	]	]	PUNCT
ajlm-1429	131	7	.	.	PUNCT
ajlm-1429	131	8	2020	2020	NUM
ajlm-1429	132	1	[	[	X
ajlm-1429	132	2	cited	cite	VERB
ajlm-1429	132	3	2020	2020	NUM
ajlm-1429	132	4	aug	aug	PROPN
ajlm-1429	132	5	08	08	NUM
ajlm-1429	132	6	]	]	PUNCT
ajlm-1429	132	7	.	.	PUNCT
ajlm-1429	133	1	available	available	ADJ
ajlm-1429	133	2	from	from	ADP
ajlm-1429	133	3	:	:	PUNCT
ajlm-1429	133	4	https://www.who.int/publications/m/item/covid-19-target-product-profiles-for-priority-diagnostics-to-support-response-to-the-covid-19-pandemic-v.0.1	https://www.who.int/publications/m/item/covid-19-target-product-profiles-for-priority-diagnostics-to-support-response-to-the-covid-19-pandemic-v.0.1	PROPN
ajlm-1429	133	5	feng	feng	PROPN
ajlm-1429	133	6	w	w	PROPN
ajlm-1429	133	7	,	,	PUNCT
ajlm-1429	133	8	newbigging	newbigge	VERB
ajlm-1429	133	9	am	be	AUX
ajlm-1429	133	10	,	,	PUNCT
ajlm-1429	133	11	le	le	X
ajlm-1429	133	12	c	c	X
ajlm-1429	133	13	,	,	PUNCT
ajlm-1429	133	14	et	et	PROPN
ajlm-1429	133	15	al	al	PROPN
ajlm-1429	133	16	.	.	PUNCT
ajlm-1429	134	1	molecular	molecular	ADJ
ajlm-1429	134	2	diagnosis	diagnosis	NOUN
ajlm-1429	134	3	of	of	ADP
ajlm-1429	134	4	covid-19	covid-19	PROPN
ajlm-1429	134	5	:	:	PUNCT
ajlm-1429	134	6	challenges	challenge	NOUN
ajlm-1429	134	7	and	and	CCONJ
ajlm-1429	134	8	research	research	NOUN
ajlm-1429	134	9	needs	need	NOUN
ajlm-1429	134	10	.	.	PUNCT
ajlm-1429	135	1	anal	anal	ADJ
ajlm-1429	135	2	chem	chem	NOUN
ajlm-1429	135	3	.	.	PUNCT
ajlm-1429	136	1	2020;92(15):10196–10209	2020;92(15):10196–10209	NUM
ajlm-1429	136	2	.	.	PUNCT
ajlm-1429	137	1	https://doi.org/10.1021/acs.analchem.0c02060	https://doi.org/10.1021/acs.analchem.0c02060	NOUN
ajlm-1429	137	2	vandenberg	vandenberg	PROPN
ajlm-1429	137	3	o	o	PROPN
ajlm-1429	137	4	,	,	PUNCT
ajlm-1429	137	5	martiny	martiny	PROPN
ajlm-1429	137	6	d	d	PROPN
ajlm-1429	137	7	,	,	PUNCT
ajlm-1429	137	8	rochas	rochas	PROPN
ajlm-1429	137	9	o	o	PROPN
ajlm-1429	137	10	,	,	PUNCT
ajlm-1429	137	11	van	van	PROPN
ajlm-1429	137	12	belkum	belkum	PROPN
ajlm-1429	137	13	a	a	PROPN
ajlm-1429	137	14	,	,	PUNCT
ajlm-1429	137	15	kozlakidis	kozlakidis	PROPN
ajlm-1429	137	16	z.	z.	PROPN
ajlm-1429	137	17	considerations	consideration	NOUN
ajlm-1429	137	18	for	for	ADP
ajlm-1429	137	19	diagnostic	diagnostic	ADJ
ajlm-1429	137	20	covid-19	covid-19	PROPN
ajlm-1429	137	21	tests	test	NOUN
ajlm-1429	137	22	.	.	PUNCT
ajlm-1429	138	1	nat	nat	PROPN
ajlm-1429	138	2	rev	rev	VERB
ajlm-1429	138	3	microbiol	microbiol	PROPN
ajlm-1429	138	4	.	.	PUNCT
ajlm-1429	139	1	2021;19(3):171–183	2021;19(3):171–183	NUM
ajlm-1429	139	2	.	.	X
ajlm-1429	139	3	https://doi.org/10.1038/s41579-020-00461-z	https://doi.org/10.1038/s41579-020-00461-z	VERB
ajlm-1429	139	4	public	public	ADJ
ajlm-1429	139	5	health	health	PROPN
ajlm-1429	139	6	england	england	PROPN
ajlm-1429	139	7	.	.	PUNCT
ajlm-1429	140	1	guidance	guidance	VERB
ajlm-1429	140	2	covid-19	covid-19	PROPN
ajlm-1429	140	3	:	:	PUNCT
ajlm-1429	140	4	guidance	guidance	NOUN
ajlm-1429	140	5	on	on	ADP
ajlm-1429	140	6	alternative	alternative	ADJ
ajlm-1429	140	7	swab	swab	NOUN
ajlm-1429	140	8	types	type	NOUN
ajlm-1429	140	9	and	and	CCONJ
ajlm-1429	140	10	transport	transport	NOUN
ajlm-1429	140	11	media	medium	NOUN
ajlm-1429	141	1	[	[	X
ajlm-1429	141	2	homepage	homepage	NOUN
ajlm-1429	141	3	on	on	ADP
ajlm-1429	141	4	the	the	DET
ajlm-1429	141	5	internet	internet	NOUN
ajlm-1429	141	6	]	]	PUNCT
ajlm-1429	141	7	.	.	PUNCT
ajlm-1429	142	1	[	[	X
ajlm-1429	142	2	cited	cite	VERB
ajlm-1429	142	3	2021	2021	NUM
ajlm-1429	142	4	dec	dec	PROPN
ajlm-1429	142	5	22	22	NUM
ajlm-1429	142	6	]	]	PUNCT
ajlm-1429	142	7	.	.	PUNCT
ajlm-1429	143	1	available	available	ADJ
ajlm-1429	143	2	from	from	ADP
ajlm-1429	143	3	:	:	PUNCT
ajlm-1429	143	4	https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories/covid-19-guidance-for-alternative-swab-types-and-transport-media	https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories/covid-19-guidance-for-alternative-swab-types-and-transport-media	X
ajlm-1429	143	5	kahamba	kahamba	ADJ
ajlm-1429	143	6	tr	tr	VERB
ajlm-1429	143	7	,	,	PUNCT
ajlm-1429	143	8	noble	noble	ADJ
ajlm-1429	143	9	l	l	NOUN
ajlm-1429	143	10	,	,	PUNCT
ajlm-1429	143	11	stevens	stevens	PROPN
ajlm-1429	143	12	w	w	PROPN
ajlm-1429	143	13	,	,	PUNCT
ajlm-1429	143	14	scott	scott	PROPN
ajlm-1429	143	15	l.	l.	PROPN
ajlm-1429	143	16	comparison	comparison	NOUN
ajlm-1429	143	17	of	of	ADP
ajlm-1429	143	18	three	three	NUM
ajlm-1429	143	19	nasopharyngeal	nasopharyngeal	ADJ
ajlm-1429	143	20	swab	swab	NOUN
ajlm-1429	143	21	types	type	NOUN
ajlm-1429	143	22	and	and	CCONJ
ajlm-1429	143	23	the	the	DET
ajlm-1429	143	24	impact	impact	NOUN
ajlm-1429	143	25	of	of	ADP
ajlm-1429	143	26	physiochemical	physiochemical	ADJ
ajlm-1429	143	27	properties	property	NOUN
ajlm-1429	143	28	for	for	ADP
ajlm-1429	143	29	optimal	optimal	ADJ
ajlm-1429	143	30	sars	sar	NOUN
ajlm-1429	143	31	-	-	PUNCT
ajlm-1429	143	32	cov-2	cov-2	NOUN
ajlm-1429	143	33	detection	detection	NOUN
ajlm-1429	143	34	.	.	PUNCT
ajlm-1429	144	1	j	j	PROPN
ajlm-1429	144	2	vaccines	vaccines	PROPN
ajlm-1429	144	3	vaccin	vaccin	PROPN
ajlm-1429	144	4	.	.	PUNCT
ajlm-1429	145	1	2020;s6:005	2020;s6:005	X
ajlm-1429	145	2	.	.	PUNCT
ajlm-1429	146	1	https://doi.org/10.1101/2020.10.21.20206078	https://doi.org/10.1101/2020.10.21.20206078	PROPN
ajlm-1429	146	2	marais	marais	PROPN
ajlm-1429	146	3	g	g	PROPN
ajlm-1429	146	4	,	,	PUNCT
ajlm-1429	146	5	naidoo	naidoo	PROPN
ajlm-1429	146	6	m	m	PROPN
ajlm-1429	146	7	,	,	PUNCT
ajlm-1429	146	8	hsiao	hsiao	PROPN
ajlm-1429	146	9	n	n	PROPN
ajlm-1429	146	10	-	-	PUNCT
ajlm-1429	146	11	y	y	PROPN
ajlm-1429	146	12	,	,	PUNCT
ajlm-1429	146	13	valley	valley	NOUN
ajlm-1429	146	14	-	-	PUNCT
ajlm-1429	146	15	omar	omar	PROPN
ajlm-1429	146	16	z	z	PROPN
ajlm-1429	146	17	,	,	PUNCT
ajlm-1429	146	18	smuts	smut	NOUN
ajlm-1429	146	19	h	h	NOUN
ajlm-1429	146	20	,	,	PUNCT
ajlm-1429	146	21	hardie	hardie	PROPN
ajlm-1429	146	22	d.	d.	PROPN
ajlm-1429	146	23	the	the	DET
ajlm-1429	146	24	implementation	implementation	NOUN
ajlm-1429	146	25	of	of	ADP
ajlm-1429	146	26	a	a	DET
ajlm-1429	146	27	rapid	rapid	ADJ
ajlm-1429	146	28	sample	sample	NOUN
ajlm-1429	146	29	preparation	preparation	NOUN
ajlm-1429	146	30	method	method	NOUN
ajlm-1429	146	31	for	for	ADP
ajlm-1429	146	32	the	the	DET
ajlm-1429	146	33	detection	detection	NOUN
ajlm-1429	146	34	of	of	ADP
ajlm-1429	146	35	sars	sar	NOUN
ajlm-1429	146	36	-	-	PUNCT
ajlm-1429	146	37	cov-2	cov-2	NOUN
ajlm-1429	146	38	in	in	ADP
ajlm-1429	146	39	a	a	DET
ajlm-1429	146	40	diagnostic	diagnostic	ADJ
ajlm-1429	146	41	laboratory	laboratory	NOUN
ajlm-1429	146	42	in	in	ADP
ajlm-1429	146	43	south	south	PROPN
ajlm-1429	146	44	africa	africa	PROPN
ajlm-1429	146	45	2020	2020	NUM
ajlm-1429	146	46	.	.	PUNCT
ajlm-1429	147	1	plos	plos	PROPN
ajlm-1429	147	2	one	one	NUM
ajlm-1429	147	3	.	.	PUNCT
ajlm-1429	148	1	2020	2020	NUM
ajlm-1429	148	2	oct	oct	PROPN
ajlm-1429	148	3	20;15(10):e0241029	20;15(10):e0241029	PROPN
ajlm-1429	148	4	.	.	PUNCT
ajlm-1429	149	1	https://doi.org/10.1371/journal.pone.0241029	https://doi.org/10.1371/journal.pone.0241029	PROPN
ajlm-1429	149	2	.	.	PUNCT
ajlm-1429	150	1	ecollection	ecollection	NOUN
ajlm-1429	150	2	2020	2020	NUM
ajlm-1429	151	1	li	li	PROPN
ajlm-1429	151	2	d	d	PROPN
ajlm-1429	151	3	,	,	PUNCT
ajlm-1429	151	4	zhang	zhang	PROPN
ajlm-1429	151	5	j	j	PROPN
ajlm-1429	151	6	,	,	PUNCT
ajlm-1429	151	7	li	li	PROPN
ajlm-1429	151	8	j.	j.	PROPN
ajlm-1429	151	9	primer	primer	PROPN
ajlm-1429	151	10	design	design	PROPN
ajlm-1429	151	11	for	for	ADP
ajlm-1429	151	12	quantitative	quantitative	ADJ
ajlm-1429	151	13	real	real	ADJ
ajlm-1429	151	14	-	-	PUNCT
ajlm-1429	151	15	time	time	NOUN
ajlm-1429	151	16	pcr	pcr	NOUN
ajlm-1429	151	17	for	for	ADP
ajlm-1429	151	18	the	the	DET
ajlm-1429	151	19	emerging	emerge	VERB
ajlm-1429	151	20	coronavirus	coronavirus	NOUN
ajlm-1429	151	21	sars	sar	NOUN
ajlm-1429	151	22	-	-	PUNCT
ajlm-1429	151	23	cov-2	cov-2	NOUN
ajlm-1429	151	24	.	.	PUNCT
ajlm-1429	151	25	theranostics	theranostic	NOUN
ajlm-1429	151	26	.	.	PUNCT
ajlm-1429	152	1	2020;10(16):7150–7162	2020;10(16):7150–7162	NOUN
ajlm-1429	152	2	.	.	PUNCT
ajlm-1429	153	1	https://doi.org/10.7150/thno.47649	https://doi.org/10.7150/thno.47649	X
ajlm-1429	153	2	gand	gand	PROPN
ajlm-1429	153	3	m	m	PROPN
ajlm-1429	153	4	,	,	PUNCT
ajlm-1429	153	5	vanneste	vanneste	VERB
ajlm-1429	153	6	k	k	PROPN
ajlm-1429	153	7	,	,	PUNCT
ajlm-1429	153	8	thomas	thomas	PROPN
ajlm-1429	154	1	i	i	PROPN
ajlm-1429	154	2	,	,	PUNCT
ajlm-1429	154	3	et	et	PROPN
ajlm-1429	154	4	al	al	PROPN
ajlm-1429	154	5	.	.	PUNCT
ajlm-1429	154	6	use	use	NOUN
ajlm-1429	154	7	of	of	ADP
ajlm-1429	154	8	whole	whole	ADJ
ajlm-1429	154	9	genome	genome	NOUN
ajlm-1429	154	10	sequencing	sequence	VERB
ajlm-1429	154	11	data	datum	NOUN
ajlm-1429	154	12	for	for	ADP
ajlm-1429	154	13	a	a	DET
ajlm-1429	154	14	first	first	ADJ
ajlm-1429	154	15	in	in	ADP
ajlm-1429	154	16	silico	silico	NOUN
ajlm-1429	154	17	specificity	specificity	NOUN
ajlm-1429	154	18	evaluation	evaluation	NOUN
ajlm-1429	154	19	of	of	ADP
ajlm-1429	154	20	the	the	DET
ajlm-1429	154	21	rt	rt	NOUN
ajlm-1429	154	22	-	-	PUNCT
ajlm-1429	154	23	qpcr	qpcr	ADJ
ajlm-1429	154	24	assays	assay	NOUN
ajlm-1429	154	25	used	use	VERB
ajlm-1429	154	26	for	for	ADP
ajlm-1429	154	27	sars	sar	NOUN
ajlm-1429	154	28	-	-	PUNCT
ajlm-1429	154	29	cov-2	cov-2	NOUN
ajlm-1429	154	30	detection	detection	NOUN
ajlm-1429	154	31	.	.	PUNCT
ajlm-1429	155	1	int	int	PROPN
ajlm-1429	155	2	j	j	PROPN
ajlm-1429	155	3	mol	mol	ADP
ajlm-1429	155	4	sci	sci	PROPN
ajlm-1429	155	5	.	.	PUNCT
ajlm-1429	156	1	2020;21(15):5585	2020;21(15):5585	X
ajlm-1429	156	2	.	.	X
ajlm-1429	156	3	https://doi.org/10.3390/ijms21155585	https://doi.org/10.3390/ijms21155585	PROPN
ajlm-1429	156	4	world	world	PROPN
ajlm-1429	156	5	health	health	PROPN
ajlm-1429	156	6	organization	organization	PROPN
ajlm-1429	156	7	.	.	PUNCT
ajlm-1429	157	1	tracking	track	VERB
ajlm-1429	157	2	sars	sar	NOUN
ajlm-1429	157	3	-	-	PUNCT
ajlm-1429	157	4	cov-2	cov-2	PART
ajlm-1429	157	5	variants	variant	NOUN
ajlm-1429	157	6	[	[	X
ajlm-1429	157	7	homepage	homepage	NOUN
ajlm-1429	157	8	on	on	ADP
ajlm-1429	157	9	the	the	DET
ajlm-1429	157	10	internet	internet	NOUN
ajlm-1429	157	11	]	]	PUNCT
ajlm-1429	157	12	.	.	PUNCT
ajlm-1429	158	1	2020	2020	NUM
ajlm-1429	159	1	[	[	X
ajlm-1429	159	2	cited	cite	VERB
ajlm-1429	159	3	2021	2021	NUM
ajlm-1429	159	4	dec	dec	PROPN
ajlm-1429	159	5	17	17	NUM
ajlm-1429	159	6	]	]	PUNCT
ajlm-1429	159	7	.	.	PUNCT
ajlm-1429	160	1	available	available	ADJ
ajlm-1429	160	2	from	from	ADP
ajlm-1429	160	3	:	:	PUNCT
ajlm-1429	160	4	https://www.who.int/en/activities/tracking-sars-cov-2-variants/	https://www.who.int/en/activities/tracking-sars-cov-2-variants/	ADV
ajlm-1429	160	5	singanayagam	singanayagam	NOUN
ajlm-1429	160	6	a	a	NOUN
ajlm-1429	160	7	,	,	PUNCT
ajlm-1429	160	8	patel	patel	PROPN
ajlm-1429	160	9	m	m	PROPN
ajlm-1429	160	10	,	,	PUNCT
ajlm-1429	160	11	charlett	charlett	VERB
ajlm-1429	160	12	a	a	X
ajlm-1429	160	13	,	,	PUNCT
ajlm-1429	160	14	et	et	PROPN
ajlm-1429	160	15	al	al	PROPN
ajlm-1429	160	16	.	.	PUNCT
ajlm-1429	160	17	duration	duration	NOUN
ajlm-1429	160	18	of	of	ADP
ajlm-1429	160	19	infectiousness	infectiousness	NOUN
ajlm-1429	160	20	and	and	CCONJ
ajlm-1429	160	21	correlation	correlation	NOUN
ajlm-1429	160	22	with	with	ADP
ajlm-1429	160	23	rt	rt	ADJ
ajlm-1429	160	24	-	-	PUNCT
ajlm-1429	160	25	pcr	pcr	ADJ
ajlm-1429	160	26	cycle	cycle	NOUN
ajlm-1429	160	27	threshold	threshold	NOUN
ajlm-1429	160	28	values	value	NOUN
ajlm-1429	160	29	in	in	ADP
ajlm-1429	160	30	cases	case	NOUN
ajlm-1429	160	31	of	of	ADP
ajlm-1429	160	32	covid-19	covid-19	PROPN
ajlm-1429	160	33	,	,	PUNCT
ajlm-1429	160	34	england	england	PROPN
ajlm-1429	160	35	,	,	PUNCT
ajlm-1429	160	36	january	january	PROPN
ajlm-1429	160	37	to	to	ADP
ajlm-1429	160	38	may	may	PROPN
ajlm-1429	160	39	2020	2020	NUM
ajlm-1429	160	40	.	.	PUNCT
ajlm-1429	161	1	euro	euro	NOUN
ajlm-1429	161	2	surveill	surveill	NOUN
ajlm-1429	161	3	.	.	PUNCT
ajlm-1429	162	1	2020;25(32):pii=2001483	2020;25(32):pii=2001483	NOUN
ajlm-1429	162	2	.	.	PUNCT
ajlm-1429	163	1	https://doi.org/10.2807/1560-7917.es.2020.25.32.2001483	https://doi.org/10.2807/1560-7917.es.2020.25.32.2001483	PROPN
ajlm-1429	163	2	rao	rao	PROPN
ajlm-1429	163	3	sn	sn	PROPN
ajlm-1429	163	4	,	,	PUNCT
ajlm-1429	163	5	manissero	manissero	PROPN
ajlm-1429	163	6	d	d	PROPN
ajlm-1429	163	7	,	,	PUNCT
ajlm-1429	163	8	steele	steele	PROPN
ajlm-1429	163	9	vr	vr	PROPN
ajlm-1429	163	10	,	,	PUNCT
ajlm-1429	163	11	pareja	pareja	PROPN
ajlm-1429	163	12	j.	j.	PROPN
ajlm-1429	163	13	a	a	DET
ajlm-1429	163	14	systematic	systematic	ADJ
ajlm-1429	163	15	review	review	NOUN
ajlm-1429	163	16	of	of	ADP
ajlm-1429	163	17	the	the	DET
ajlm-1429	163	18	clinical	clinical	ADJ
ajlm-1429	163	19	utility	utility	NOUN
ajlm-1429	163	20	of	of	ADP
ajlm-1429	163	21	cycle	cycle	NOUN
ajlm-1429	163	22	threshold	threshold	NOUN
ajlm-1429	163	23	values	value	NOUN
ajlm-1429	163	24	in	in	ADP
ajlm-1429	163	25	the	the	DET
ajlm-1429	163	26	context	context	NOUN
ajlm-1429	163	27	of	of	ADP
ajlm-1429	163	28	covid-19	covid-19	PROPN
ajlm-1429	163	29	.	.	PUNCT
ajlm-1429	163	30	infect	infect	VERB
ajlm-1429	163	31	dis	dis	PROPN
ajlm-1429	163	32	ther	ther	ADV
ajlm-1429	163	33	.	.	PUNCT
ajlm-1429	164	1	2020;9(3):573–586	2020;9(3):573–586	X
ajlm-1429	164	2	.	.	PUNCT
ajlm-1429	165	1	https://doi.org/10.1007/s40121-020-00324-3	https://doi.org/10.1007/s40121-020-00324-3	NUM
ajlm-1429	165	2	prebensen	prebensen	PROPN
ajlm-1429	165	3	c	c	PROPN
ajlm-1429	165	4	,	,	PUNCT
ajlm-1429	165	5	hre	hre	PROPN
ajlm-1429	165	6	plm	plm	PROPN
ajlm-1429	165	7	,	,	PUNCT
ajlm-1429	165	8	jonassen	jonassen	PROPN
ajlm-1429	165	9	c	c	PROPN
ajlm-1429	165	10	,	,	PUNCT
ajlm-1429	165	11	et	et	PROPN
ajlm-1429	165	12	al	al	PROPN
ajlm-1429	165	13	.	.	PUNCT
ajlm-1429	166	1	sars	sars	PROPN
ajlm-1429	166	2	-	-	PUNCT
ajlm-1429	166	3	cov-2	cov-2	NOUN
ajlm-1429	166	4	rna	rna	NOUN
ajlm-1429	166	5	in	in	ADP
ajlm-1429	166	6	plasma	plasma	NOUN
ajlm-1429	166	7	is	be	AUX
ajlm-1429	166	8	associated	associate	VERB
ajlm-1429	166	9	with	with	ADP
ajlm-1429	166	10	icu	icu	PROPN
ajlm-1429	166	11	admission	admission	NOUN
ajlm-1429	166	12	and	and	CCONJ
ajlm-1429	166	13	mortality	mortality	NOUN
ajlm-1429	166	14	in	in	ADP
ajlm-1429	166	15	patients	patient	NOUN
ajlm-1429	166	16	hospitalized	hospitalize	VERB
ajlm-1429	166	17	with	with	ADP
ajlm-1429	166	18	covid-19	covid-19	PROPN
ajlm-1429	166	19	.	.	PUNCT
ajlm-1429	167	1	clin	clin	PROPN
ajlm-1429	167	2	infect	infect	PROPN
ajlm-1429	167	3	dis	dis	PROPN
ajlm-1429	167	4	.	.	PUNCT
ajlm-1429	168	1	2020;73(3):e799	2020;73(3):e799	NUM
ajlm-1429	168	2	–	–	PUNCT
ajlm-1429	168	3	e802	e802	PROPN
ajlm-1429	168	4	.	.	PUNCT
ajlm-1429	168	5	https://doi.org/10.1093/cid/ciaa1338	https://doi.org/10.1093/cid/ciaa1338	PROPN
ajlm-1429	168	6	european	european	PROPN
ajlm-1429	168	7	centres	centre	NOUN
ajlm-1429	168	8	for	for	ADP
ajlm-1429	168	9	disease	disease	NOUN
ajlm-1429	168	10	prevention	prevention	NOUN
ajlm-1429	168	11	and	and	CCONJ
ajlm-1429	168	12	control	control	NOUN
ajlm-1429	168	13	.	.	PUNCT
ajlm-1429	169	1	rapid	rapid	ADJ
ajlm-1429	169	2	increase	increase	NOUN
ajlm-1429	169	3	of	of	ADP
ajlm-1429	169	4	a	a	DET
ajlm-1429	169	5	sars	sar	NOUN
ajlm-1429	169	6	-	-	PUNCT
ajlm-1429	169	7	cov-2	cov-2	NOUN
ajlm-1429	169	8	variant	variant	NOUN
ajlm-1429	169	9	with	with	ADP
ajlm-1429	169	10	multiple	multiple	ADJ
ajlm-1429	169	11	spike	spike	ADJ
ajlm-1429	169	12	protein	protein	NOUN
ajlm-1429	169	13	mutations	mutation	NOUN
ajlm-1429	169	14	observed	observe	VERB
ajlm-1429	169	15	in	in	ADP
ajlm-1429	169	16	the	the	DET
ajlm-1429	169	17	united	united	ADJ
ajlm-1429	169	18	kingdom	kingdom	NOUN
ajlm-1429	169	19	(	(	PUNCT
ajlm-1429	169	20	20	20	NUM
ajlm-1429	169	21	december	december	PROPN
ajlm-1429	169	22	2020	2020	NUM
ajlm-1429	169	23	)	)	PUNCT
ajlm-1429	170	1	[	[	X
ajlm-1429	170	2	homepage	homepage	NOUN
ajlm-1429	170	3	on	on	ADP
ajlm-1429	170	4	the	the	DET
ajlm-1429	170	5	internet	internet	NOUN
ajlm-1429	170	6	]	]	PUNCT
ajlm-1429	170	7	.	.	PUNCT
ajlm-1429	170	8	2020	2020	NUM
ajlm-1429	171	1	[	[	X
ajlm-1429	171	2	cited	cite	VERB
ajlm-1429	171	3	2021	2021	NUM
ajlm-1429	171	4	jan	jan	PROPN
ajlm-1429	171	5	12	12	NUM
ajlm-1429	171	6	]	]	PUNCT
ajlm-1429	171	7	.	.	PUNCT
ajlm-1429	172	1	available	available	ADJ
ajlm-1429	172	2	from	from	ADP
ajlm-1429	172	3	:	:	PUNCT
ajlm-1429	172	4	https://www.ecdc.europa.eu/sites/default/files/documents/sars-cov-2-variant-multiple-spike-protein-mutations-united-kingdom.pdf	https://www.ecdc.europa.eu/sites/default/files/documents/sars-cov-2-variant-multiple-spike-protein-mutations-united-kingdom.pdf	PROPN
ajlm-1429	172	5	national	national	PROPN
ajlm-1429	172	6	institute	institute	PROPN
ajlm-1429	172	7	for	for	ADP
ajlm-1429	172	8	communicable	communicable	NOUN
ajlm-1429	172	9	diseases	disease	NOUN
ajlm-1429	172	10	.	.	PUNCT
ajlm-1429	173	1	sars	sar	NOUN
ajlm-1429	173	2	-	-	PUNCT
ajlm-1429	173	3	cov-2	cov-2	ADV
ajlm-1429	173	4	sequencing	sequence	VERB
ajlm-1429	173	5	update	update	NOUN
ajlm-1429	173	6	26	26	NUM
ajlm-1429	173	7	november	november	PROPN
ajlm-1429	173	8	2021	2021	NUM
ajlm-1429	173	9	.	.	PUNCT
ajlm-1429	174	1	prepared	prepare	VERB
ajlm-1429	174	2	by	by	ADP
ajlm-1429	174	3	the	the	DET
ajlm-1429	174	4	national	national	PROPN
ajlm-1429	174	5	institute	institute	PROPN
ajlm-1429	174	6	for	for	ADP
ajlm-1429	174	7	communicable	communicable	NOUN
ajlm-1429	174	8	diseases	disease	NOUN
ajlm-1429	174	9	(	(	PUNCT
ajlm-1429	174	10	nicd	nicd	NOUN
ajlm-1429	174	11	)	)	PUNCT
ajlm-1429	174	12	of	of	ADP
ajlm-1429	174	13	the	the	DET
ajlm-1429	174	14	national	national	PROPN
ajlm-1429	174	15	health	health	PROPN
ajlm-1429	174	16	laboratory	laboratory	NOUN
ajlm-1429	174	17	(	(	PUNCT
ajlm-1429	174	18	nhls	nhls	PROPN
ajlm-1429	174	19	)	)	PUNCT
ajlm-1429	174	20	on	on	ADP
ajlm-1429	174	21	behalf	behalf	NOUN
ajlm-1429	174	22	of	of	ADP
ajlm-1429	174	23	the	the	DET
ajlm-1429	174	24	network	network	NOUN
ajlm-1429	174	25	for	for	ADP
ajlm-1429	174	26	genomics	genomic	NOUN
ajlm-1429	174	27	surveillance	surveillance	NOUN
ajlm-1429	174	28	in	in	ADP
ajlm-1429	174	29	south	south	PROPN
ajlm-1429	174	30	africa	africa	PROPN
ajlm-1429	174	31	(	(	PUNCT
ajlm-1429	174	32	ngs	ngs	PROPN
ajlm-1429	174	33	-	-	PUNCT
ajlm-1429	174	34	sa	sa	NOUN
ajlm-1429	174	35	)	)	PUNCT
ajlm-1429	175	1	[	[	X
ajlm-1429	175	2	homepage	homepage	NOUN
ajlm-1429	175	3	on	on	ADP
ajlm-1429	175	4	the	the	DET
ajlm-1429	175	5	internet	internet	NOUN
ajlm-1429	175	6	]	]	PUNCT
ajlm-1429	175	7	.	.	PUNCT
ajlm-1429	175	8	2021	2021	NUM
ajlm-1429	176	1	[	[	X
ajlm-1429	176	2	cited	cite	VERB
ajlm-1429	176	3	2021	2021	NUM
ajlm-1429	176	4	nov	nov	NOUN
ajlm-1429	176	5	27	27	NUM
ajlm-1429	176	6	]	]	PUNCT
ajlm-1429	176	7	.	.	PUNCT
ajlm-1429	177	1	availalbe	availalbe	VERB
ajlm-1429	177	2	from	from	ADP
ajlm-1429	177	3	:	:	PUNCT
ajlm-1429	177	4	https://www.nicd.ac.za/wp-content/uploads/2021/11/update-of-sa-sequencing-data-from-gisaid-26-nov_final.pdf	https://www.nicd.ac.za/wp-content/uploads/2021/11/update-of-sa-sequencing-data-from-gisaid-26-nov_final.pdf	PROPN
ajlm-1429	177	5	axell	axell	PROPN
ajlm-1429	177	6	-	-	PUNCT
ajlm-1429	177	7	house	house	PROPN
ajlm-1429	177	8	db	db	PROPN
ajlm-1429	177	9	,	,	PUNCT
ajlm-1429	177	10	lavingia	lavingia	PROPN
ajlm-1429	177	11	r	r	PROPN
ajlm-1429	177	12	,	,	PUNCT
ajlm-1429	177	13	rafferty	rafferty	PROPN
ajlm-1429	177	14	m	m	PROPN
ajlm-1429	177	15	,	,	PUNCT
ajlm-1429	177	16	clark	clark	PROPN
ajlm-1429	177	17	e	e	PROPN
ajlm-1429	177	18	,	,	PUNCT
ajlm-1429	177	19	amirian	amirian	PROPN
ajlm-1429	177	20	es	es	PROPN
ajlm-1429	177	21	,	,	PUNCT
ajlm-1429	177	22	chiao	chiao	PROPN
ajlm-1429	177	23	ey	ey	PROPN
ajlm-1429	177	24	.	.	PUNCT
ajlm-1429	178	1	the	the	DET
ajlm-1429	178	2	estimation	estimation	NOUN
ajlm-1429	178	3	of	of	ADP
ajlm-1429	178	4	diagnostic	diagnostic	ADJ
ajlm-1429	178	5	accuracy	accuracy	NOUN
ajlm-1429	178	6	of	of	ADP
ajlm-1429	178	7	tests	test	NOUN
ajlm-1429	178	8	for	for	ADP
ajlm-1429	178	9	covid-19	covid-19	PROPN
ajlm-1429	178	10	:	:	PUNCT
ajlm-1429	178	11	a	a	DET
ajlm-1429	178	12	scoping	scope	VERB
ajlm-1429	178	13	review	review	NOUN
ajlm-1429	178	14	.	.	PUNCT
ajlm-1429	179	1	j	j	PROPN
ajlm-1429	179	2	infect	infect	VERB
ajlm-1429	179	3	.	.	PUNCT
ajlm-1429	180	1	2020;81(5):681–697	2020;81(5):681–697	X
ajlm-1429	180	2	.	.	X
ajlm-1429	180	3	https://doi.org/10.1016/j.jinf.2020.08.043	https://doi.org/10.1016/j.jinf.2020.08.043	NOUN
ajlm-1429	180	4	yuzhong	yuzhong	PROPN
ajlm-1429	181	1	xu	xu	PROPN
ajlm-1429	182	1	mc	mc	PROPN
ajlm-1429	182	2	,	,	PUNCT
ajlm-1429	182	3	xinchun	xinchun	PROPN
ajlm-1429	182	4	chen	chen	PROPN
ajlm-1429	182	5	,	,	PUNCT
ajlm-1429	182	6	jialou	jialou	PROPN
ajlm-1429	182	7	zhu	zhu	PROPN
ajlm-1429	182	8	.	.	PUNCT
ajlm-1429	183	1	current	current	ADJ
ajlm-1429	183	2	approach	approach	NOUN
ajlm-1429	183	3	in	in	ADP
ajlm-1429	183	4	laboratory	laboratory	NOUN
ajlm-1429	183	5	testing	testing	NOUN
ajlm-1429	183	6	for	for	ADP
ajlm-1429	183	7	sars	sar	NOUN
ajlm-1429	183	8	-	-	PUNCT
ajlm-1429	183	9	cov-2	cov-2	NOUN
ajlm-1429	183	10	.	.	PUNCT
ajlm-1429	184	1	int	int	PROPN
ajlm-1429	184	2	j	j	PROPN
ajlm-1429	184	3	infect	infect	VERB
ajlm-1429	184	4	dis	dis	PROPN
ajlm-1429	184	5	.	.	PUNCT
ajlm-1429	184	6	2020;100:7–9	2020;100:7–9	NUM
ajlm-1429	184	7	.	.	PUNCT
ajlm-1429	185	1	https://doi.org/10.1016/j.ijid.2020.08.041	https://doi.org/10.1016/j.ijid.2020.08.041	PROPN
ajlm-1429	185	2	mina	mina	PROPN
ajlm-1429	185	3	mj	mj	PROPN
ajlm-1429	185	4	,	,	PUNCT
ajlm-1429	185	5	parker	parker	PROPN
ajlm-1429	185	6	r	r	PROPN
ajlm-1429	185	7	,	,	PUNCT
ajlm-1429	185	8	larremore	larremore	NOUN
ajlm-1429	185	9	db	db	NOUN
ajlm-1429	185	10	.	.	PUNCT
ajlm-1429	186	1	rethinking	rethink	VERB
ajlm-1429	186	2	covid-19	covid-19	PROPN
ajlm-1429	186	3	test	test	NOUN
ajlm-1429	186	4	sensitivity	sensitivity	NOUN
ajlm-1429	186	5	–	–	PUNCT
ajlm-1429	186	6	a	a	DET
ajlm-1429	186	7	strategy	strategy	NOUN
ajlm-1429	186	8	for	for	ADP
ajlm-1429	186	9	containment	containment	NOUN
ajlm-1429	186	10	.	.	PUNCT
ajlm-1429	187	1	n	n	PROPN
ajlm-1429	187	2	engl	engl	PROPN
ajlm-1429	187	3	j	j	PROPN
ajlm-1429	187	4	med	med	PROPN
ajlm-1429	187	5	.	.	PUNCT
ajlm-1429	188	1	2020;383	2020;383	NUM
ajlm-1429	188	2	:	:	PUNCT
ajlm-1429	189	1	e120	e120	PROPN
ajlm-1429	189	2	.	.	PUNCT
ajlm-1429	190	1	https://doi.org/10.1056/nejmp2025631	https://doi.org/10.1056/nejmp2025631	PROPN
ajlm-1429	190	2	south	south	PROPN
ajlm-1429	190	3	african	african	ADJ
ajlm-1429	190	4	health	health	NOUN
ajlm-1429	190	5	products	product	NOUN
ajlm-1429	190	6	regulatory	regulatory	ADJ
ajlm-1429	190	7	authority	authority	NOUN
ajlm-1429	190	8	.	.	PUNCT
ajlm-1429	191	1	md018	md018	NOUN
ajlm-1429	191	2	:	:	PUNCT
ajlm-1429	191	3	specification	specification	NOUN
ajlm-1429	191	4	criteria	criterion	NOUN
ajlm-1429	191	5	for	for	ADP
ajlm-1429	191	6	covid-19	covid-19	PROPN
ajlm-1429	191	7	molecular	molecular	ADJ
ajlm-1429	191	8	test	test	NOUN
ajlm-1429	191	9	kits	kit	NOUN
ajlm-1429	192	1	[	[	X
ajlm-1429	192	2	homepage	homepage	NOUN
ajlm-1429	192	3	on	on	ADP
ajlm-1429	192	4	the	the	DET
ajlm-1429	192	5	internet	internet	NOUN
ajlm-1429	192	6	]	]	PUNCT
ajlm-1429	192	7	.	.	PUNCT
ajlm-1429	193	1	[	[	X
ajlm-1429	193	2	cited	cite	VERB
ajlm-1429	193	3	2020	2020	NUM
ajlm-1429	193	4	sep	sep	PROPN
ajlm-1429	193	5	14	14	NUM
ajlm-1429	193	6	]	]	PUNCT
ajlm-1429	193	7	.	.	PUNCT
ajlm-1429	194	1	available	available	ADJ
ajlm-1429	194	2	from	from	ADP
ajlm-1429	194	3	:	:	PUNCT
ajlm-1429	194	4	http://www.sahpra.org.za/wp-content/uploads/2020/07/md018-specifications-molecular-test-kits-v1-22072020.pdf	http://www.sahpra.org.za/wp-content/uploads/2020/07/md018-specifications-molecular-test-kits-v1-22072020.pdf	NOUN